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Extensive studies have implicated a myriad of functional roles for prolactin (PRL) and 
prolactin receptor (PRLR) across a variety of adult vertebrate species. However, much less is 
known about the physiological role(s) of PRL during embryonic/fetal development. Previously, 
we demonstrated that in vivo knockdown of PRL produced embryos with multiple morphological 
abnormalities. In this study, we explored the function of the PRLR family during embryogenesis 
and established the zebrafish as a useful model organism to examine embryonic functions of 
PRL. The combined results (1) define a role for PRL during early embryonic development, (2) 
provide plausible explanation(s) for the observed phenotypes in PRL-knockdown embryos, and 
(3) provide a foundation for the direction of future research using zebrafish as a model for 
studying physiological roles and molecular mechanisms of the PRL superfamily in vertebrates.  
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CHAPTER 1: PROLACTIN-DEPENDENT MODULATION OF ORGANOGENESIS IN THE 
VERTEBRATE: RECENT DISCOVERIES IN THE ZEBRAFISH 
Chapter Summary 
 The scientific literature is replete with evidence of the multifarious functions of the 
prolactin (PRL)/growth hormone (GH) superfamily in adult vertebrates. However, little 
information is available on the roles of PRL and related hormones prior to the adult stage of 
development. A limited number of studies suggest that GH functions to stimulate glucose 
transport and protein synthesis in mouse blastocysts and may be involved during mammalian 
embryogenesis. In contrast, the evidence for a role of PRL during vertebrate embryogenesis is 
limited and controversial. Genes encoding PRL/GH hormones and their respective receptors are 
actively transcribed and translated in various animals at different time points, particularly during 
tissue remodeling. We have addressed the potential function of PRL/GH hormones during 
embryonic development in zebrafish by the temporary inhibition of in vivo PRL translation. This 
treatment caused multiple morphological defects consistent with a role of PRL in embryonic-
stage organogenesis. The affected organs and tissues are known targets of PRL activity in fish 
and homologous structures in mammalian species. Traditionally, the PRL/GH hormones are 
viewed as classical endocrine hormones, mediating functions through the circulatory system. 
More recent evidence points to cytokine-like actions of these hormones through either an 
autocrine or a paracrine mechanism. In some situations they could mimic the actions of 
developmentally regulated genes, as suggested by experiments in mammals and fish. In this 
chapter, we present similarities and disparities between zebrafish and mammalian models in 
relation to PRL and PRLR activity. We conclude that the zebrafish could serve as a suitable 
alternative to the rodent model to study PRL functions in development.       
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Zebrafish as a Model Organism 
In recent years, the zebrafish (Danio rerio), has become the preferred vertebrate model 
for the study of early embryonic development. It has become clear that the rapid, optically clear, 
and external development of zebrafish embryos allows direct in vivo observation of many 
morphogenetic processes associated with early embryogenesis. Daily spawning of sexually 
mature zebrafish provides an abundant source of materials for experimental manipulations. At 
the molecular level, resources in genome sequencing, physical mapping of genes, gene 
expression profiling, and transgenic line development are continuing to advance, thus making 
genetic analysis easier and faster. The physical characteristics of the zebrafish embryo along with 
the available genetic resources has fostered the use of zebrafish for large scale mutagenesis, the 
modeling of human disease processes (Lieschke and Currie, 2007), drug discovery (Zon and 
Peterson, 2005), and environmental bio-monitoring (Alestrom et al., 2006).  
The use of zebrafish has also been extended to the field of endocrinology (McGonnell 
and Fowkes, 2006). Extensive knowledge has been obtained on the mode of pituitary 
morphogenesis, patterning and the spatial order of pituitary cell differentiation in zebrafish 
(Herzog et al., 2003). Moreover, it is easier to isolate and study specific pituitary cell types 
because, unlike in mammals, pituitary hormones are expressed in defined regions in fish (Herzog 
et al., 2004). The zebrafish provides an advantage for the current study due to its external 
development and a reduced number of genes in the PRL/GH family. This eliminates continued 
maternal contribution through the placenta and the potential effects of large number of placental 
lactogens, which are unavoidable in mammalian models. Furthermore, cognate receptors for 
pituitary hormones show greater specificity in fish than mammals; reducing redundancy of 
function that potentially obscures the true functions of PRL. The advantages afforded by the 
3 
 
zebrafish have led us to use the zebrafish to explore the potential biological function of PRL in 
relation to developmental endocrinology. 
Introduction 
 The prolactin (PRL) and growth hormone (GH) gene family regulate a variety of 
physiological processes, including growth and reproduction in juvenile and adult vertebrates 
(Ormandy et al., 1997; Zhou et al., 1997; Kopchick and Laron, 1999). The role of the PRL/GH 
gene family in embryogenesis, on the other hand, is controversial due to an absence of 
developmental defects in either hormone or cognate receptor knockout mice models (Horseman 
et al., 1997; Ormandy et al., 1997). Nonetheless, the presence of these hormones prior to the 
onset of pituitary gland ontogenesis and establishment of the circulatory system, in fish and 
mammals, implies that these hormones may act as local signaling factors, being involved in 
mechanisms that mediate the actions of developmental regulatory genes (Power and Canario, 
1992; Ayson et al., 1994; Yang et al., 1999; Santos et al., 2003). These hormones and their 
receptors are likely initially maternally-derived and are maintained, fluctuate, or are expressed in 
specific organs throughout development (de Jesus and Hirano, 1992; Power et al., 2001). In 
addition, recent knockdown of the PRL/GH family demonstrate their involvement during 
zebrafish embryogensis (Zhu et al., 2007). In this chapter, we discuss the functions of the 
PRL/GH superfamily with emphasis on PRL during early embryonic development. For detailed 
information regarding PRL functions in adults, please refer to recent reviews (Bole-Feysot et al., 
1998; Ben-Jonathan et al., 2008). From the perspective of zebrafish as an alternative to 
mammalian models, we present key similarities between the two models in their PRL’s or PRL 
receptor’s (PRLR) structure, function, expression, and signaling to define potential roles of PRL 
during embryogenesis 
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Prolactin (PRL) 
 Prolactin (PRL) is a multifaceted hormone that is involved in the modulation of a wide 
spectrum of physiological processes (Bole-Feysot et al., 1998; Ben-Jonathan et al., 2008). Based 
on sequence, structure, binding, and functional conservation, PRL is related to other pituitary-
derived hormones, including growth hormone (GH), placental lactogen (PL) of mammalian 
placenta origin, and two forms of somatolactins (SLs) in teleosts, all of which belong to the 
PRL/GH superfamily (Niall et al., 1971; Nicoll et al., 1986; Wallis, 2000; Freeman et al., 2000; 
Zhu et al., 2004). The existence of PRL has been documented in every vertebrate examined, 
including fish, reptiles, and mammals. The primary structure of PRL is highly conserved within a 
given class, but sequences from distantly related species show a high degree of divergence 
(Sinha, 1995; Bole-Feysot et al., 1998). As an example of their conservation, four conserved 
PRL domains that are believed to be necessary for binding to specific PRLR and play 
indispensable roles in the expression of PRL-specific activities are present in both fish and 
mammalian species (Watahiki et al., 1989). Moreover, the secondary structures of the PRLs from 
fish and mammalian species possess two conserved disulfide bridges in the mid- and C-terminal 
regions.  These conserved disulfide bridges have also been suggested to be critical for specific 
binding to PRLRs and may be important for PRL-specific activities (Sinha, 1995). Although fish 
lack the typical N-terminal disulphide bridge found in mammalian PRL, this may simply reflect 
fundamentally divergent functions between mammals and fish as exemplified by the role of PRL 
in mammalian lactation or osmoregulation in teleosts. Interestingly, mammalian growth hormone 
(GH) like the teleost PRL possesses only two disulphide bonds with a four helix bundle motif 
similar to fish PRL (Nicoll et al., 1986; Goffin et al., 1996). Similarities between the structure 
and sequence of PRL and GH are hypothesized to confer overlapping functions between these 
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hormones, which may arise as a consequence of the capacity of GH to bind to PRLR (Somers et 
al., 1994). By comparison to these generally conserved features, mammalian species possess 
extensive structural heterogeneity in PRL resulting from alternative splicing of the primary 
transcript, proteolytic cleavage, and other post-translational modification (Smith and Norman, 
1990; Walker, 1994; Sinha, 1995). Structural modifications in the PRL molecule are partly 
responsible for its functional heterogeneity, providing both unique functions (i.e., 16kDa form of 
PRL induces anti-angiogenic properties) and regulated PRL activities (i.e., dimerization, 
polymerization, and glycosylation decreased biological activity of PRL probably resulting from 
changes in conformation) (Freeman et al., 2000). In fish, on the other hand, few PRL isoforms 
have been documented. One notable exception is the presence of two distinct PRL isoforms in 
Nile tilapia and Mozambique tilapia (Specker et al., 1985; Yamaguchi et al., 1988; Rentier-
Delrue et al., 1989). One PRL of 188 amino acids long and the other PRL of 177 amino acids 
long share 70% amino acid similarity in the two tilapia species. Based on a comparison of 
synonymous/nonsynonymous substitutions between the conserved amino acids in the coding 
sequences of these two PRL paralogs, it was determined that positive selection followed the gene 
duplication event that generated these PRL paralogs. This duplication may have been related to 
the unique maternal care behavior characteristic of these cichlid species (Summers and Zhu, 
2008). By comparison, two PRLs found in chum salmon (Yasuda et al., 1986; Kuwana et al., 
1988; Song et al., 1988), chinook salmon (Xiong et al., 1992), common carp (Yasuda et al., 
1987), and eel (Suzuki et al., 1991) were highly conserved (>95%). These genetic variants in 
salmon, eel, and carp differ only by a number of substitutions or deletions in amino acids (1-
11aa) and their biological significance has not been investigated.  In contrast, a novel PRL 
(named as PRL2 compared to the classical PRL, PRL1) was recently identified in a teleost as 
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well as non-mammalian vertebrates and possesses low sequence identity with PRL, but is 
capable of activating prolactin receptor alpha (PRLRα) (Huang et al., 2009). The retention of 
PRL2 in non-mammalian vertebrates but not in mammals was hypothesized to have occurred as 
a result of divergent functions that do not overlap with PRL1 (Huang et al., 2009). Further 
research should aim to provide an understanding of whether teleost PRLs exhibit a degree of 
genetic heterogeneity similar to their mammalian orthologs and to examine the physiological 
significance of the newly identified divergent form of PRL2 in relation to PRL1.  
 Traditionally, production and secretion of PRL in the anterior pituitary was considered 
the most important and physiologically relevant property of this hormone. However, ample 
evidence now exists for extra-pituitary production of PRL (Ben-Jonathan et al., 1996 for review), 
which suggests that PRL may have non-canonical functions. Precursor cells from the zebrafish 
pituitary gland begin to migrate from the anterior neural ridge at 10-12 hours post-fertilization 
(hpf) and PRL precursor cells initiate terminal differentiation at 22 hpf (Herzog et al., 2003; 
Pogoda and Hammerschmidt, 2007), which suggests that PRL may be active during this stage of 
embryogenesis. The development of the pituitary gland in zebrafish is not complete until 72 hpf 
when all cells of the anterior pituitary have completed terminal differentiation (Herzog et al., 
2003). Using sensitive reverse transcriptase polymerase chain reaction (RT-PCR) and 
quantitative real-time PCR (qRT-PCR), we showed the presence of PRL transcripts in zygotic 
cells at the earliest stages of embryogenesis and much earlier than the appearance of the pituitary 
precursor cells (Fig. 1-1). Importantly, the circulatory system of the zebrafish does not begin to 
be established until 24-26 hpf (Isogai et al., 2001), which is indicative that these hormones, while 
present, cannot function in a canonical endocrine manner; but instead may act as short-range 
diffusible signals in an autocrine or paracrine fashion at least during this early stage of 
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embryogenesis (Fig. 1-2). It is worthwhile considering that post-zygotic embryos are physically 
quite small and that molecules capable of diffusing over distances of a few hundred microns can 
exert their effects over relatively broad domains. In support of this idea, the recently identified 
PRL2 in zebrafish was demonstrated to be expressed at 4 hpf and locally within the eye, brain, 
and kidney (Huang et al., 2009).   
Extra-pituitary expression of PRL is not unique to zebrafish nor is the idea of endocrine 
hormones acting through an autocrine or paracrine mechanism (Ben-Jonathan et al., 1996; Ben-
Jonathan et al., 2008). Using in situ hybridization, immunohistochemistry, and the sensitive 
detection technique of RT-PCR, PRL has been detected in a variety of tissues (Bole-Feysot et al., 
1998). The distribution of PRL ranges from specific tissues or cells that synthesize PRL to fluid 
compartments that contain PRL. Some sources of PRL include the mammary gland, 
myometrium, neurons, myocytes, amniotic fluid, and bone marrow (Bole-Feysot et al., 1998). 
Furthermore, evidence has shown the presence of transcripts and proteins for the PRL/GH gene 
family prior to the ontogenesis of a functional pituitary in diverse vertebrates, including: 
zebrafish (Herzog et al., 2003; Sbrogna et al., 2003; Liu et al., 2006), seabream (Santos et al., 
2003), rainbow trout (Yang et al., 1999), chicken (Harvey et al., 2000), mouse (Pantaleon et al., 
1997), rat (Garcia-Aragon et al., 1992; Zhang et al., 1997), cow (Joudrey et al., 2003), and 
human (D’Alfonso et al, 1992; Freemark et al., 1997). The importance of extra-pituitary PRL 
was first suggested by Nagy and Berczi, who showed that hypophysectomized rats required 
residual PRL for survival (Nagy and Berczi, 1978, 1991) as demonstrated by the observation that 
immunoneutralization of PRL decreased lactogenic activity and ultimately resulted in death. 
Further studies are required to better understand the physiological relevance of extra-pituitary 
expression of PRL and the non-classical actions of these endocrine hormones. It has been known 
8 
 
for some time that extra-pituitary PRL in the amniotic fluid or transferred from the deciduas 
(Riddick and Daly, 1982) provides a rich source of PRL important for the developing fetus. 
More recently, local production of PRL in the mammary gland has been implicated to induce 
mammary tumor growth through either an autocrine or a paracrine mechanism (Wennbo and 
Tornell, 2000; Fig. 1-2). 
Prolactin Receptor (PRLR) 
 It is generally accepted that classical PRL action is mediated through a membrane-bound 
receptor (PRLR), whether the action is endocrine, paracrine, or autocrine. The initial step in PRL 
signaling requires hormone binding, which induces PRLR homodimerization and produces an 
active trimeric complex of one ligand and two receptor molecules (Goffin and Kelly, 1997). The 
same mechanism was demonstrated for trout PRLR (Le Rouzic et al., 2001), indicating that the 
ligand-receptor mechanism of PRLR activation is conserved in fish. Improper or defective 
formation of the trimeric complex has been shown to be detrimental to PRLR signaling (Bazan, 
1990; Goffin and Kelly, 1997).  
The PRLR is divided into an extracellular domain (ECD), transmembrane domain (TD), 
and intracellular domain (ICD). The PRLR ECD is composed of two pairs of disulfide bonds and 
a WS motif (Tpr-Ser-X-Trp-Ser), both of which are important for correct folding and cellular 
trafficking (Rozakis-Adcock and Kelly, 1991; Miyazaki et al., 1991) and ligand-receptor 
interactions (Rozakis-Adcock and Kelly, 1992; Baumgartner et al., 1994). Unlike the ECD, the 
ICD is less conserved but contains a region known as Box I (proline-rich motif that is membrane 
proximal) that is essential for the constitutive association of JAK, an upstream kinase of PRLR 
(Lebrun et al., 1995). Different forms of the PRLR (long, intermediate, and short) have been 
suggested to result from differential transcription at alternative initiation sites and from 
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alternative splicing of non-coding and coding exon transcripts (Hu et al., 1991, 1996). Despite 
differences in the overall length of each PRLR isoform, each variant is composed of an identical 
extracellular domain (ECD) (Postel-Vinay et al., 1991; Bole-Feysot et al., 1998). So far only one 
PRLR, including isoforms with identical ECD but varying ICD, has been reported in vertebrates 
(Fukada et al., 2005).  
 Extensive studies have demonstrated the wide distribution of the classical PRLR in both 
fetal and adult vertebrates. The PRLR is expressed in a wide variety of fetal tissues in 
mammalian species (Freemark et al., 1993, 1995). PRLR transcripts and proteins were detected 
in almost all tissues including classic lactogenic tissues (liver, adrenal, pancreas, thymus, lung, 
intestine, and kidney) and non-lactogenic tissues (ganglia, cochlea, adipose tissue, whisker 
follicles, facial cartilage, and olfactory epithelium) in mammals (Freemark et al., 1997). In fact, 
it is nearly impossible to find a tissue that does not express PRLR in mammals (Bole-Feysot et 
al., 1998). The situation in zebrafish appears to reflect that of the mammalian models. Both 
PRLRα and PRLRβ transcripts are expressed throughout zebrafish development, from the 
zygotic up to the adult stage (Fig. 1-1; see Chapter 2.1). Moreover, embryonic expression of 
PRLRα was detected using whole mount in situ hybridization in the primordial adenohypohysis 
at the anterior neural ridge, pancreas, and pronephric tubules at 24 hpf (Liu et al., 2006), 
consistent with previous findings indicating roles of PRL in murine pancreas and kidney 
development (Bole-Feysot et al., 1998; Freemark et al., 2002). It remains to be determined if 
PRLRs are expressed in other tissues throughout zebrafish embryogenesis in addition to those 
characterized so far.  
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Downstream Molecules and Pathways for PRL and PRLR Signaling 
 The PRLRs are associated characteristically with cytoplasmic kinases, termed Janus 
kinases (JAKs) (Campbell et al., 1994; Ihle et al., 1994; Lebrun et al., 1995). PRLR dimerization 
resulting from PRL binding causes the activation of the associated JAK by auto-phosphorylation. 
The phosphorylation of JAK leads to phosphorylation of PRLR and several other downstream 
signaling molecules. The major downstream signaling molecules of JAK are a series of signal 
transducers and activators of transcription (STAT) molecules that serve as transcription factors to 
promote cell survival, differentiation, and proliferation during zebrafish embryogenesis (Hou et 
al., 2002). In zebrafish, three JAKs (JAK1, JAK2a, and JAK2b) and four STATs (STAT1, 
STAT3, STAT5.1, and STAT5.2) have been identified (Conway et al., 1997; Oates et al., 1999a, 
b; Yamashita et al., 2002; Lewis et al., 2004). Zebrafish JAKs and STATs have a relatively high 
degree of amino acid sequence similarity to each other and to their mammalian counterparts, 
with conservation ranging from about 65% to nearly 90% (Conway et al., 1997; Oates et al., 
1999a, b; Yamashita et al., 2002; Lewis et al., 2004).  
 Distinct from its role in the JAK/STAT signal transduction pathway, PRLR signaling can 
also function through PI3K, the Src family of kinases (SFK; c-Src and Fyn), and other pathways 
(1. PI3K: Al-Sakkaf et al., 1997; Berlanga et al., 1997; 2. Src: Berlanga et al., 1995; 3. Fyn: Al-
Sakkaf et al., 1997; Clevenger and Medaglia, 1994; 4. MAPK: Buckley et al., 1994; Piccoletti et 
al., 1994; Das and Vonderhaar, 1997; Nohara et al., 1997; 5. IRS: Berlanga et al., 1997, 
Yamauchi et al., 1998; or novel pathways). However, all of the PRL signaling studies have been 
performed in mammalian cell lines and the precise nature of the PRLR signaling pathway 
(JAK/STAT, PI3K/AKT, Src/AKT and/or MEK/ERK) has not been demonstrated in any 
vertebrate embryo in vivo. It is essential to define the PRLR signaling pathways in embryonic 
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development in vivo, especially in major target organs. Most likely, many of the mechanisms 
mediated in mammals by PRLR are also conserved in zebrafish.  The reasons for the likely 
conservation are: (1) activation of PRLR requires a trimeric complex (Bazan, 1990; Goffin and 
Kelly, 1997; Le Rouzic et al., 2001), (2) many of the components of the PRLR signaling 
pathways found in zebrafish have relatively high sequence relatedness with mammalian genes 
(Conway et al., 1997; Oates et al., 1999a, b; Chan et al., 2002), (3) many of the antibodies 
specific for mammalian molecules involved in JAK/STAT, Src/AKT, PI3K/AKT, and 
MAPK/Erk pathways have been successfully used in zebrafish studies (Conway et al., 1997; Wu 
and Kinsey, 2000; Yamashita et al., 2002; Cha et al., 2006), and (4) inhibitors for these pathways 
have also been shown to inhibit the same pathways in zebrafish (Montero et al., 2003; Hong et 
al., 2006). 
Embryonic Function of PRL and Growth Hormone (GH) 
 The functions of PRL can be organized into six categories: 1) water and electrolyte 
balance, 2) growth and development, 3) endocrine and metabolic regulation, 4) brain function 
and behavior changes, 5) reproduction, and 6) immunoregulation and protection (Bole-Feysot et 
al., 1998); many of these functions are shared in all vertebrates. The properties or characteristics 
that define a function for PRL during embryonic development in any of these categories require 
the active secretion of PRL and a functional PRLR. It is now generally accepted that PRL is 
expressed in a wide range of tissues in diverse vertebrate species during early development. In 
addition, PRLRs are also found during embryogenesis and have been detected in nearly all 
tissues examined. Intuitively, the presence of hormone and receptor localized in the same 
tissues/cells of embryos and adults would be expected to function in a similar manner provided 
that the other components of the pathway required for activity are present. Alternatively, sites of 
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receptor expression in embryos may have unique functions during development that are 
independent of their functions in adults. Nonetheless, the presence of both hormone and receptor 
during embryogenesis strongly suggests functional roles for PRL at a stage prior to the 
development of a functional pituitary gland.  These functions could be mediated either through 
autocrine, paracrine or even classical endocrine mechanisms provided that the appropriate 
biological structures or targets are present. While there is evidence that the PRL/GH gene family 
members and their respective receptors are transcribed and translated in early development, 
much less is known about the roles of the PRL/GH family in embryonic, larval, or juvenile 
stages of development. A limited number of studies suggest that GH functions to stimulate 
glucose transport and protein synthesis in mouse blastocysts (Pantaleon et al., 1997) and that it is 
involved in various stages in mammalian development (Waters and Kaye, 2002; Markham and 
Kaye, 2003). Despite these studies, the evidence for a role of PRL during vertebrate development 
is limited. One explanation for the paucity of information concerning a role of PRL during 
development involves a dominant paradigm for PRL that has emerged in endocrinology based on 
the absence of developmental defects in anencephalic fetuses, decapitated mammalian fetuses, 
hypophysectomized fetuses, fetuses treated with dopamine D2 receptor agonists (repressor of 
PRL secretion), mutant dwarf mouse strains lacking pituitary lactotrophs, and PRL knockout 
mice. In all these cases, the absence of gross developmental defects has been interpreted to mean 
that PRL and the PRL/GH family of hormones do not play a role in embryogenesis (Zhou et al., 
1997; Goffin et al., 1999; Kelly et al., 2001).    
However, each of these methods has flaws that compromise the interpretation of the 
results and leave open the possibility that PRL and its related peptides play a role in 
embryogenesis. The absence of an observed phenotypic effect related to treatments that purport 
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to inactivate PRL have arisen from various sources, including: 1) the inability to inhibit 
completely extra-pituitary expression of the pituitary hormones in anencephalic models; 2) the 
maternal expression of many members of the mammalian PRL/GH gene family at the placental 
uterine interface (often with overlapping functional roles), such that maternally derived hormone 
masks the defects induced by physical or pharmacological treatments; 3) cross-talk between 
multiple ligands and their common receptors; both PL and PRL binds to the PRLR with high 
affinity (Golos et al., 1993; Freemark et al., 1996; Soares et al., 1998; Herman et al., 2000; 
Biener et al., 2003; Li et al., 2005);  and 4) genetic and biochemical redundancy of PRL and 
PRL-related hormone effects that have the potential to mask deficiencies in individual genes. 
 In the following sections, we focus the discussion on potential roles of PRL/GH in early 
development of representative model organisms. 
Mammals 
In humans, fetal development consists of early, mid-, and late gestational periods that are 
characterized by rapid transformations in tissue composition, cellular organization, and 
biological functions. Maternal serum levels for PRL and PL begin to increase around 10 weeks 
of gestation and peak near term (Freemark et al., 1999). Similarly, fetal levels for PRL increase 
at 10 weeks and maintain relatively constant levels until the third trimester where PRL increases 
dramatically and peaks at term (Freemark et al., 1999; Ben-Jonathan et al., 2008). By 
comparison, PRL levels in amniotic fluids are 10- to 50-fold higher than those in the maternal or 
fetal blood and peak at 20-24 weeks of gestation (Ben-Jonathan et al., 1996, 2008). Extremely 
high levels of PRL in amniotic fluids beginning at early gestation, a period of rapid tissue 
differentiation and organ development, implicate a role for PRL in organogenesis. Studies on the 
ontogenesis of the PRLR in human fetuses indicate diverse tissue expression by 7.5 weeks of 
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gestation (Freemark, 2001). Many of the PRLR immunoreactive sites include derivatives of 
embryonic mesoderm, the periadrenal and pronephric mesenchyme, the pulmonary and duodenal 
mesenchyme, the cardiac and skeletal myocytes, and the mesenchymal precartilage and maturing 
chondrocytes (Freemark et al., 1997). Interestingly, many of these tissues exhibited changes in 
cellular distribution and the magnitude of PRLR expression throughout development (Freemark 
et al., 1997). In the fetal bone, adrenal gland, and lung, the receptor is expressed initially in 
mesenchymal cells and subsequently in maturing chondrocytes, adrenocortical cells, and 
bronchiolar epithelial cells. In the central nervous system, the PRLR is first detected in the 
periventricular neuroepithelium and later in mature neurons of the hypothalamus and olfactory 
bulb. In the pancreas, the PRLR is detected first in the exocrine tissue and ductal epithelium; 
subsequently, PRLR is predominantly expressed in the pancreatic β-cells in the islet of 
Langerhans. Changes in PRLR expression in different cell types or regions within the same 
tissue during development imply developmentally dependent changes in lactogenic functions 
(PRL or PL actions mediated through the PRLR). Cellular distribution of PRLR expression at 
mid-gestation is localized in acinar tissue and ductal epithelial cells, suggesting a role for 
lactogens in the growth and function of the exocrine pancreas (Freemark et al., 1997). However, 
during late gestation and in postnatal life, PRLR is expressed preferentially in islet cells, 
consistent with the insulin tropic effects of lactogenic hormones in pancreatic islets of adult 
humans (Brelje et al., 1993; Sekine et al., 1996; and Weinhaus et al., 1996). Similarly, initial 
expression of PRLRs in surface mesenchymal cells and neocortical cells suggests a role of 
lactogens in adrenocortical maturation or growth during fetal development (Freemark et al., 
1997); while subsequent expression of PRLRs in differentiated adrenocortical cells suggest a role 
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in modulating the production of fetal adrenal androgens and glucocorticoids (Ogle et al., 1979; 
Eldridge et al., 1984; Pepe and Albrecht, 1990; Glasow et al., 1996). 
The tissue distribution of PRLR in rodents appears to mirror those observed in human 
fetuses. PRLR has also been detected in a number of fetal tissues, both in rat and mouse, 
including derivatives from all three germ layers, although the absolute levels may differ among 
tissues (Royster et al., 1995; Freemark et al., 1996; Freemark et al., 1997; Tzeng and Linzer, 
1997). Rodent PRLR is strictly lactogenic and typically interacts with PRL, PL-I, or PL-II 
(Ogren and Talamantes, 1988), which is different than human PRLR that binds prolactin as well 
as growth hormone. The predominant lactogen-mediating PRLR function in rodents during the 
first half of pregnancy is the daily surges of PRL, while mid- to late gestational stages involve 
PL as both maternal and fetal PRLs are suppressed (Reusens et al., 1979; Slabaugh et al., 1982; 
Khorram et al., 1984; Soares et al., 1991; Soares et al., 2004). In fetal rats, the functions of PRLR 
that mediate tissue differentiation and/or organ development and function correlate closely with 
its observed effects in humans (Freemark et al., 1997). The fetal mouse shows similar tissue 
distribution of PRLR and also suggested potential differences in functional roles of PRLR 
between the fetus and postnatal animals in specific tissues (Tzeng and Linzer, 1997). The results 
from mouse PRLR knockouts are difficult to reconcile in the context of information about levels 
of PRL, PRL-related hormones and functional PRLR activities in humans, mice and rats. Results 
from mouse PRLR knockouts failed to demonstrate fetal lethality or gross morphological defects 
(Ormandy et al., 1997) but removal of low molecular weight molecules (including PRL and PL) 
in serum used to incubate rat fetuses significantly reduced embryonic growth and development, 
which were partially restored by supplementation with either PL or PRL (Karabulut and Pratten, 
1998; Karabulut et al., 1999; 2001). While it is difficult to compare the results from knockouts 
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with small molecule depletion experiments, the restoration of growth and development by PL 
and PRL supplementation argues for a role of PL and PRL in mouse embryogenesis. The 
mechanism of PRL and PL-dependent growth promotion has been suggested to involve insulin-
like growth factors (IGFs) (Karabulut et al, 1999; 2001), which is essential for fetal survival in 
rodents (Powell-Braxton et al., 1993). The effects of PL, PRL and PRLR and their interactions 
with other growth factors will require a detailed analysis of the distribution and activities in each 
tissue of the PRLR-deficient mouse and would benefit from an examination of their 
characteristics in an alternative model organism like the zebrafish.   
  Information concerning the activity of GH in mammalian development is also very 
limited. GH transcripts or proteins were detected in the rat from ED 12 (Garcia-Aragon et al., 
1992; Zhang et al., 1997), in human at 9-16 weeks (D’Alfonso et al., 1992); in mouse at the 
blastula stage (Pantaleon et al., 1997); and in the cow at the 2-4 cell stage (Joudrey et al., 2003).  
It is unclear at this time whether the significant discrepancies in stage of embryogenesis at which 
GH transcripts or products were first identified is the result of improved sensitivity in the 
detection methods employed or whether they represent authentic species-specific differences in 
the timing of initial expression. GHR transcripts or proteins were also detected during the early 
cleavage stage of mouse embryogenesis (Pantaleon et al., 1997; Terada et al., 1996), and in cows 
from ED 2 onwards (Izadyar et al., 2000; Kolle et al., 2001). These GHRs continued to be 
expressed in these two species even at later stages of development (Garcia-Aragon et al., 1992; 
Hill et al., 1992; Scott et al., 1992; Ymer and Herington, 1992; and Werther et al., 1993). The 
presence of these functional hormones and receptors has been demonstrated to act directly on the 
early embryo (Waters and Kaye, 2002) by improving the reliability of cleavage and blastocyst 
formation in the cow (Izadyar et al., 1998) and mouse (Fukaya et al., 1998). One physiological 
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role of GH at the blastocyst stage may be involved in the stimulation of glucose transport and 
protein synthesis in the blastocyst (Pantaleon et al., 1997), which suggests that GH activity at this 
stage of embryonic development, is probably important for successful implantation. 
Aves 
Historically, the chicken has served as an important model for studies of development 
because of the size of the embryos and the ease with which they can be manipulated in ovo and it 
is one of a handful of model organisms in which the PRL/GH gene families have been shown to 
play a critical role during embryogenesis.  In chick embryos, GH protein was initially detected at 
embryonic day (ED) 1-2 (Wang, 1989) while the transcripts were first observed as early as ED 2 
(Harvey et al., 2000). Subsequently, GH immunoreactive cells were detected in a host of tissues 
and in specific cell populations between ED 3-5, particularly within the neural tube, notochord, 
somites, limb buds, heart, liver, mesonephros, Wolffian duct, and amnion (Harvey et al., 2000). 
At later stages of embryonic development, between ED 7-8, GH expression was observed to be 
more restricted and was detected in the chondrocytes of the limb buds, the brain, and the neural 
retina (Murphy and Harvey, 2001; Harvey et al., 2001, 2004). Interestingly, GH in the embryonic 
neural retina and the vitreous chamber was shown to be associated primarily with 15-16 kDa 
proteins although the typically monomeric 22-26 kDa GH was also present in small amounts 
(Baudet et al., 2003; Sanders et al., 2003). A number of other protein structural variants gave rise 
to a spectrum of sizes from 15 kDa to >110 kDa during chick development but the functional 
roles for these various forms, similar to PRL isoforms, are not yet understood (Aramburo et al., 
2000). Complementary to the hormones, GHR was also detected beginning at ED 3 and was 
present in most tissues and cells up to ED 8 in chick embryos (Harvey at al., 2000). Both 
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hormone and receptor were also present prior to the formation of the pituitary (ED 16) and 
circulatory system (ED 2-3) during chick development (Kansaku et al., 1994; Porter et al., 1995).         
 A number of studies have been conducted to understand the physiological roles of GH 
during development. Deletion of the GHR gene in chickens appeared to be related to dwarfism 
(Goddard et al., 1996), despite the observation that body weight at hatching was not significantly 
affected (Decuypere et al., 1991), which was indicative that the effect of GHR gene deletion had 
a latent effect on growth that may have occurred after hatching. The hypothesis was further 
supported by lack of hepatic IGF-I in GHR deleted chicken compared to abundant expression of 
IGF-I in wild-type chicken at 4-weeks after hatching (Tanaka et al., 1996). In addition, growth 
hormone has been implicated in a variety of embryonic functions, including growth, 
differentiation, neurogenesis, gliogenesis, adipogenesis, chondrogenesis, angiogenesis, cell 
proliferation, cell survival, and eye development (Sanders and Harvey, 2004).  While results 
from GH and GHR suggest that these genes have diverse functions during embryogenesis, the 
absence of information on PRL activity in chickens precludes comparisons to other vertebrates 
and represents an important area for future comparative molecular physiological research. 
Amphibians 
 In amphibians, PRL is widely known for its anti-metamorphic effects. Numerous in vivo 
(Clemons and Nicoll, 1977; Kikuyama et al., 1980; Eddy and Lipner, 1975) and tissue culture 
(Derby and Etkin, 1968; Tata et al., 1991) studies have demonstrated the ability of PRL to inhibit 
endogenous or exogenous thyroid hormone that stimulates tail re-absorption resulting from 
extensive cell apoptosis and the dismantling of largely collagen-based extracellular matrix. In a 
seemingly paradoxical series of results it has been demonstrated that PRL is able to stimulate 
collagen synthesis in tadpole tail fins (Yoshizato and Yasumasu, 1970) and to stimulate the 
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activity of two Xenopus collagenases, XCL3 and XCL4 (Jung et al., 2004). Further, the over-
expression of PRL or a combination of PRL and PRLR in transgenic Xenopus laevis prevented 
tail re-absorption (Huang and Brown, 2000a). These seemingly opposing roles of PRL during 
amphibian development suggest a complex function of PRL involving multiple factors regulating 
metamorphosis and tissue remodeling. The preservation of the tail in tadpoles of PRL transgenic 
frogs is consistent with its ability to stimulate fibroblast growth factor to counter the activation of 
proteolytic enzymes by thyroid hormone during metamorphosis (Yoshizato and Yasumasu, 
1970; Berry et al., 1998; Huang and Brown, 2000a). Thyroid hormone has been demonstrated to 
induce XCL3, XCL4, or other collagenases in the metamorphic tadpole tail when massive 
collagen degradation is occurring (Patterton et al., 1995; Stolow et al., 1996; Berry et al., 1998; 
Damjanovski et al., 2000; Jung et al., 2002). In addition to the expression of XCL3 and XCL4 
during thyroid hormone-dependent metamorphosis, these collagenases have also been detected at 
early developmental stages during Xenopus embryogenesis (Stolow et al., 1996; Damjanovski et 
al., 2000). Both expression of PRL (Buckbinder and Brown, 1993) and PRLR (Yamamoto et al., 
2000) coincide with collagenase expression in vivo, and have been suggested to regulate the 
thyroid hormone-independent phase of Xenopus organogenesis and metamorphosis (Jung et al., 
2004). Studies in various mammalian cell lines have recently reported that PRL also stimulates 
collagenase activity and is likely to be mediated by PKC and PKA, which suggests the 
possibility that PRL is involved in tissue remodeling in mammals as well as in amphibians (Jung 
et al., 2004). 
 Unlike PRL, the primary activity of GH during amphibian development is to stimulate 
tadpole and frog growth rather than metamorphosis (Bern et al., 1967; Clemons and Nicoll, 
1977). Although the expression pattern of GH (Buckbinder and Brown, 1993) during Xenopus 
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development would be consistent with a juvenilizing hormone that inhibits metamorphosis, 
recent establishment of transgenic frogs over-expressing Xenopus GH (xGH) clearly 
demonstrated no alteration in the developmental programs involved in metamorphosis (Huang 
and Brown, 2000b). These transgenic frogs grew at an accelerated rate with typical skeletal 
abnormalities reminiscent of acromegaly in mammalian models. Furthermore, over-expression of 
Xenopus PRL (xPRL) failed to affect their normal weight (Huang and Brown, 2000a). 
Transgenic frogs over-expressing ovine PRL (oPRL) did, however, increase the tadpole weight 
by 30-50% but it was due to the ability of oPRL, but not xPRL, to cross-react with and activate 
the xGHR (Huang and Brown, 2000b).                              
Teleosts           
Fish provide particularly useful model organisms for investigating the functional roles of 
the PRL/GH superfamily during embryonic development. We have established the zebrafish as a 
model to study PRL functions during embryogenesis because of the various advantages over 
other fish species and mammalian models mentioned previously. In addition to these advantages, 
PRL and PRLR have been detected throughout embryogenesis in many species of teleosts, which 
suggests that the expression of these hormones and their receptors during early embryogenesis 
has a deep evolutionary history and that they likely play a functional role prior to their synthesis 
by the pituitary gland.  
PRL has been detected in larval stages after hatching, particularly in the pituitary, in a 
number of teleost species, including sea bass (Dicentrarchus labrax), coho salmon 
(Onchorynchus kisutch), chum salmon, sea bream, ayu (Plecoglossus altivelis) and Japanese eels 
(Anguilla japonica) (Arakawa et al., 1992; Cambre et al., 1990; Leatherland and Lin, 1975; 
Naito et al., 1993; Power and Canario, 1992; Saga et al., 1999). PRL transcripts have also been 
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detected in rainbow trout (Yang et al., 1999), Mozambique tilapia (Ayson et al, 1994), seabream 
(Santos et al., 2003; Power, 2005), and zebrafish (Herzog et al., 2003) during early teleost 
development and as early as 22 hpf in zebrafish. Studies showed PRL proteins are expressed by 
30 hpf using immunohistochemical methods (Sbrogna et al., 2003) and 18 hpf using a PRL 
promoter-driven green fluorescent protein in zebrafish (Liu et al., 2006). Interestingly, PRL in 
both seabream (Santos et al., 2003) and zebrafish are expressed during somitogenesis and levels 
gradually increase at gastrulation (Song et al., unpublished data). Seabream and Mozambique 
tilapia PRLR transcripts were present after fertilization and mRNA levels also increased at 
gastrulation, suggesting roles for PRL in subsequent organogenesis (Santos et al., 2003; Shiraishi 
et al., 1999).  Although levels of PRLR during zebrafish embryogenesis do not appear to increase 
dramatically, likely due to analysis of whole embryos rather than specific tissues, both the 
classical PRLR and the recently identified PRLRβ transcripts are detected soon after fertilization 
and throughout embryogenesis (Fig. 1-1). Furthermore, immunocytochemistry of 1 dpf seabream 
embryos indicate PRLR immunoreactive cells are present in the developing brain, eye 
primordium, and olfactory lobe (Santos et al., 2003). The combined results from various teleosts 
that possess both PRL and PRLR during early development, show changes in expression patterns 
at certain developmental stages, and the expression of functional PRLR in multiple organ 
placodes strongly suggest functional roles for PRL in regulating various aspects of development 
in teleosts.      
Using zebrafish and antisense morpholino (MO) gene knockdown, we have circumvented 
many of the obstacles present in mammalian models and provide data to suggest a functional role 
for PRL during embryogenesis. Morpholino knockdown of PRL (PRL-MO) yielded several 
significant phenotypes in larvae including the lack of a gas bladder, short body length, fewer 
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proliferating cells, and reduced head, brain ventricle, and eye sizes (Zhu et al., 2007; unpublished 
data). These morphological changes were dependent on the dosage of PRL-MO injected, with 
increasing concentrations of PRL-MO resulting in greater effects (Zhu et al., 2007). The 
morphological defects observed in multiple tissues/cells in PRL-knockdown (PRL-KD) embryos 
are not surprising as the wide distribution of PRLR contributes to the functional diversity of 
PRL. The specific effects of PRL-KD on the development of zebrafish embryos have been 
verified by rescue using in vitro transcribed prl mRNA (Zhu et al., 2007) and with two additional 
morpholinos targeted to different regions of the prl gene that resulted in similar phenotypic 
abnormalities (Zhu et al., 2007; unpublished observation). 
 These are only some of the phenotypes examined thus far. With the generation of PRLRα 
antibody, new sites of receptor expression have been identified (see Chapter 2.1). The abundant 
expression of PRLRα in the olfactory system, as recently determined, suggests either structural 
or functional defects in the olfactory system in these PRL-KD embryos. Detection of PRLR in 
osmoregulatory organs such as the kidneys, gills, and intestine in zebrafish is consistent with 
other fish species (Shiraishi et al., 1999; Santos et al., 2003; Liu et al., 2006); and PRL probably 
regulates osmoregulation as described in these fish (Power, 2005). Similarly, PRL effects on 
calcium balance, metamorphosis, and possibly immunoregulation suggested in other fish during 
early development is also expected in zebrafish (Power, 2005). Further studies on the 
morphological defects of other tissues/organs and the physiological consequences of PRL 
depletion in PRL-KD embryos require more detailed analysis of each phenotype. In addition, 
knockdown of PRLRα and PRLRβ should be complemented with other approaches such as 
dominant negative receptors and mutants to further verify the specificity of PRL functions during 
zebrafish embryogenesis.        
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Rationale and Objectives of the Study 
Despite a wide spectrum of physiological functions of prolactin in adults and postnatal 
growth effects of growth hormone, the effects of the PRL/GH family in embryonic development 
and organogenesis remain controversial (Bole-Feysot et al., 1998). The results from PRL or GH 
knockout mouse models suggested non-essential functions of members of PRL/GH during early 
development. However, the redundancy of PRL/GH/PL genes, ligand binding capacities, and 
biochemical pathways complicated the investigation of the true functions of these hormones in 
embryonic development. In our previous studies, we used antisense oligonucleotides morpholino 
to disrupt targeted in vivo mRNA translation to investigate the involvement of PRL, GH, SLα, 
and SLβ in zebrafish development. We found that the members of the PRL/GH family, 
especially PRL, affect the normal development and growth of the gas bladder, head, body, and 
eyes (Zhu et al, 2007). Our research provided the first evidence that a PRL family member plays 
a role in vertebrate embryogenesis, and suggests that redundant effects of the PRL/GH family 
observed in mammalian models poses fewer complications to identify functions of these 
hormones in zebrafish development than comparable research in mammals. Nevertheless, the 
mechanisms of PRL leading to these morphological defects are unknown. Characterization of the 
entire cognate receptor set for the PRL/GH family that mediate the biological effects of these 
hormones and target tissues of PRLRs throughout zebrafish embryogenesis is lacking. Although 
it was demonstrated that PRLRα was expressed in the pancreas and kidney at 24 hpf (Liu et al., 
2006), there is no illustration of their target sites prior to and after 24 hpf,  the cell-specific 
expression of PRLRα within the pancreas, or the expression profile of PRLRβ. Analysis of 
tissue-specific expression of PRLRs would allow the differentiation between direct and indirect 
actions of PRL and possibly assign different functions of PRL that are likely dependent on the 
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receptor type-mediated signaling. Furthermore, the biological or developmental events leading to 
the morphological defects associated with PRL-KD have not been investigated. Identifying a 
biological process disrupted in PRL-KD embryos with a characterized function of PRL would 
strengthen support for the PRL morphant phenotypes. Lastly, using an alternative method to 
complement the morpholino technology would help distinguish potential non-specific or off-
target effects often seen with MOs and would greatly help define PRL function(s) in zebrafish 
embryogenesis.         
In the subsequent chapters, we establish zebrafish as a useful model to explore the role of 
PRL by 1.) identifying the members of the PRL/GH receptor family, 2.) demonstrating that PRL 
acts as an anti-apoptotic factor during embryogenesis, and 3.) establishing the first stable 
transgenic line expressing a non-functional prolactin receptor α (nPrlrα) within the pancreas to 
examine its role during pancreatic development.     
Fig. 1-1. Reverse-transcriptase PCR analysis for expression of hormone and receptors of the
PRL/GH superfamily throughout early zebrafish development. Primers were directed towards
two different exons to eliminate amplification of genomic DNA. β-actin was used as a loading
control. Abbreviations at the end of each row are as follows: cell (c), hour (h), day (d), ovary
(ov), prolactin receptors (PRLRα, PRLRβ), growth hormone receptors (GHR-I, GHR-II),
prolactin (PRL), growth hormone (GH), somatolactin alpha (SLα), and somatolactin beta (SLβ).
PRLRα
PRLRβ
GHR-II
GHR-I
PRL
GH
SLα
SLβ
β-actin
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Fig. 1-2. Proposed mechanism of PRL actions during development. Two different populations of
cells are illustrated by two different colors, representing cells capable of producing local PRL
and those that are responsive to PRL (presence of PRLRs on the cell membrane). Prior to the
development of the circulatory system, PRL functions through either an autocrine or paracrine
mode of action. Establishment of the circulatory system by 24-26 hours post-fertilization (hpf)
enables PRL to function through an endocrine mechanism by releasing PRL into the blood
stream. Local production and central secretion of PRL by the pituitary gland may exhibit
functions including but not limited to cell migration, survival, proliferation, and growth.
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CHAPTER 2.1: CLONING, STRUCTURAL CHARACTERIZATION AND EXPRESSION OF 
THE PRL/GH RECEPTOR FAMILY 
Chapter Summary 
  Functional roles for the pituitary-derived hormones prolactin (PRL), growth hormone 
(GH), and somatolactins (SLs) during early embryogenesis are limited and controversial. 
Pituitary hormones mediate specific functions through membrane bound receptors on target 
tissues, indicating the need to identify cognate receptors for these hormones in order to gain 
insight into the potential roles for the PRL/GH superfamily in development. In zebrafish, we 
identified two genes that closely resemble growth hormone receptors (GHR), namely GHR-I and 
GHR-II, and two distinct subtypes of prolactin receptors (PRLR; PRLRα and PRLRβ). It appears 
that GHR-I is more structurally similar to the characterized fish somatolactin receptors (SLRs) 
and GHR-II is likely the ortholog of human GHRs, which are more divergent in teleost species. 
The duplication of zebrafish GHRs and PRLRs seems to have arisen through the fish-specific 
whole genome duplication event. Quantitative real-time PCR demonstrated that all four receptors 
(GHR-I, GHR-II, PRLRα, and PRLRβ) were expressed throughout early zebrafish 
embryogenesis. In situ hybridization analyses of PRLRs illustrated both overlapping and unique 
expression patterns for the two different forms. PRLRα appears to have acquired a novel 
function in pancreas development while PRLRβ maintains the ancestral role in osmoregulation. 
Expression of PRLRs within the kidney and pancreas suggest that these two tissues are prime 
targets for PRL action during embryogenesis. Taken together, the existence of both hormones 
and receptors for the PRL/GH family suggests functional roles for pituitary hormones during 
zebrafish embryogenesis.  
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Introduction 
 
The prolactin (PRL) and growth hormone (GH) superfamily, including the teleost-
specific somatolactin alpha (SLα) and somatolactin beta (SLβ), regulate a diverse range of 
biological activities. GH regulates growth (Wood et al., 2005), PRL controls osmotic equilibrium 
(Sakamoto and McCormick, 2006), SLα regulates fat metabolism (Fukamachi et al., 2005), and 
SLβ has been proposed to control melanophore aggregation (Nguyen et al., 2006). The functions 
of these pituitary-derived hormones are mediated by initially binding to their cognate membrane 
bound receptors (growth hormone receptor, GHR; prolactin receptor, PRLR; and somatolactin 
receptor, SLR, respectively) that subsequently triggers a phosphorylation cascade leading to a 
multitude of signaling events.   
  The identities and structures of these hormone-specific receptors have been extensively 
studied.  Since the initial discovery of GHR in humans (Leung et al., 1987), cDNA sequences for 
GHRs have been described for a variety of vertebrate species (Edens and Talamantes, 1998; 
Huang and Brown, 2000b; Calduch-Giner et al., 2001; Lee et al., 2001; Tse et al., 2003; 
Kajimura et al., 2004; Fukada et al., 2004; Very et al., 2005; Benedet et al. 2005). Orthologs of 
the human PRLR has also been identified in numerous species (Bole-Feysot et al., 1998). 
However, SLRs have only been cloned recently in a limited subset of teleost species: masu 
salmon (Fukada et al., 2005), Atlantic salmon (Benedet et al., 2008), Japanese medaka and 
Takifugu rubripes (Fukamachi et al., 2005). Due to a lack of studies comparing the binding 
affinities of a complete homologous set of hormone-receptor members and limited SLR 
sequences, classification of GHRs and SLRs remains controversial. Nonetheless, current 
information on the functional and structural similarities between these receptors places the 
PRLRs, GHRs, and SLRs among the class I cytokine receptor family (Huising et al., 2006). 
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We hypothesized that in parallel with the existence of PRL/GH family of hormones, their 
cognate receptors were also expressed during zebrafish embryogenesis. We further hypothesized 
that, the actions of these pituitary hormones would be mediated by their specific cognate 
receptors and would be expressed in specific target tissues important for hormone function. The 
objective of this study was to identify all the members of the PRL/GH receptor family, and 
examine the target tissues of each receptor during embryogenesis. In our experiments, we 
developed molecular tools for the quantitation of receptor levels (transcripts and protein). 
Investigating the differential distribution of these hormone receptors will provide a better 
understanding of target tissues and define potential roles of the PRL/GH family during early 
development and in adult zebrafish.  
Methods and Materials 
 
Fish Maintenance and Staging 
 
  Zebrafish, Danio rerio, were maintained according to standard protocols (Westerfield et 
al., 1993). Zebrafish were purchased from a local pet store and maintained at 28.5°C on a 14-
hour light and 10-hour dark cycle.  Embryos were staged in hours post-fertilization (hpf) and 
days post-fertilization (dpf) with reference to morphological features as previously described 
(Kimmel et al., 1995). 
Cloning of the Zebrafish PRLRβ Gene 
 
 Zebrafish embryos at 24 hpf were collected and immediately placed in 1 ml TRIzol 
reagent (Gibco). Following homogenization by sonication, 200 μl of chloroform was added and 
the solution was vortexed vigorously. The mixture was centrifuged, and the aqueous layer was 
transferred to a clean RNase-free microcentrifuge tube. Total RNA was precipitated and 
redissolved in 100 μl of water. First-strand cDNA was synthesized from 1 μg total RNA using 
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the GeneRacer kit (Invitrogen), in accordance with the manufacturer’s instructions. Nested PCR 
was performed using zfPRLR2nestedF2, 5’-CCGTTCCCTTTGCTGCTTTCTG-3’, and 
zfPRLR2nested R2, 5’-ACCTGTGATTCTCCCATAAACCGC-3’, designed from sequences 
similar to known zebrafish PRLRα identified from the zebrafish genome (Ensemble Zv 7). The 
first PCR was performed in 50 μl aliquots using a gradient Eppendorf Mastercycler with a 2 min 
denaturation at 94°C for 30 sec, annealing at 40-55°C for 30 sec and elongation at 72°C for 1 
min. The product of the first PCR reaction was diluted 1:10 with sterilized deionized water and 1 
μl was used as the template for the second round of PCR. Using the nested primers 
zfPRLR2gspF2, 5’-TCTTTGGTTCTGGAACTGGTGGCA-3’, and zfPRLR2gspR2, 5’-
TCTCTCATTGTGTCCTGGATCC-3’, a 20 μl reaction was prepared. The reaction conditions 
for the second PCR were a 2 min denaturation at 94°C, the PCR cycle was repeated 25 times 
with the following conditions: 94°C for 30 sec, 55°C for 30 sec and 72°C for 1 min. 
 Gene-specific primers were designed from the partial PRLRβ sequences. 5’ and 3’ RACE 
were performed using the GeneRacer kit following the manufacturer’s instructions, for both 
PRLRα and PRLRβ. The products were separated on a 2% agarose gel by electrophoresis at 
150V for 15 min, ligated into the TOPO TA vector (Invitrogen) and sequenced with vector-
specific primers using the Big Dye Terminator kit and ABI Prism DNA sequencer 377 (Perkin-
Elmer, Willesleg, MA, USA). Sequence data were compiled using Sequence Navigator (ABI, 
Foster City, CA, USA). Gene-specific primers were designed from the compiled sequences and 
the purified full-length sequence of PRLRβ and PRLRα PCR products were subcloned into 
pGEM-T Easy vector (Promega, Madison, WI) using T4 DNA ligase (Promega, Madison, WI) 
with the reaction incubated overnight at 4°C.    
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Whole Mount In Situ Hybridization (WISH) and Sectioning 
 
Whole mount in situ hybridization (WISH) using digoxigenin (DIG)-labeled riboprobes 
were carried out as previously described (Korzh et al., 1998). PRLRα and PRLRβ in the pGEM-
T Easy vector were linearized with Not I and Sac II respectively, followed by in vitro 
transcription reaction with T7 or SP6 RNA polymerase (Ambion, TX, USA) for synthesis of the 
DIG-labeled anti-sense RNA probes. The embryos were fixed with 4% paraformaldehyde (PFA) 
for 24 hpf at room temperature (RT), hybridized with the DIG-labeled probe in hybridization 
buffer [50% formamide, 5X standard saline citrate (0.75 M NaCl, 0.075 M sodium citrate), 50 
μg/ml heparin, 500 μg/ml yeast tRNA, and 0.1% Tween-20] at 68°C, followed by incubation 
with 1:2000 anti-DIG antibody conjugated with alkaline phosphatase at 4°C overnight. 
Hybridization of the probe was detected by incubating with NBT (nitroblue tetrazolium; 0.03%) 
and BCIP (5-bromo, 4-chloro, 3-indolyl phosphate; 0.02%) in 0.1 M TBS at pH 9.5 until desired 
color development occurred (30 min to 1 hr) at RT. For sectioning, the stained embryos were 
embedded in 1.5% bacto-agar and incubated in 30% sucrose at 4°C overnight. The embedded 
embryos were sectioned with a cryostat microtome (Microm HM 505E, Zeiss) in cross section 
orientation at 12 μm thickness and collected on polysine microscope slides (Thermo Scientific). 
Sections were fixed with 4% PFA in phosphate buffered saline (PBS) for 10 min, washed with 
PBS, and mounted in 1:1 PBS:glycerol under a glass cover slip and sealed with nail polish to 
prevent drying. Photographs were taken using a camera mounted to an Olympus AX-70 
microscope (Olympus, Japan) using bright field illumination.  
 Reverse Transcriptase PCR and Quantitative Real-Time PCR (qRT-PCR) 
 
 Total RNA isolation was performed as described above for all tissues and larvae. First-
strand cDNA synthesis was conducted as described previously, but gene-specific primers were 
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used to synthesize the templates for PCR (Table 2.1-1). PCR amplification of PRLRα cDNA 
from these samples were achieved with a 2 min denaturation at 94°C, 35 cycles of 30 sec at 
94°C, 30 sec at 58°C and 1 min at 72°C; PRLRβ conditions were the same as PRLRα except 
with an annealing temperature of 54°C; for GHR-I, a 2 min denaturation at 94°C, then 35 cycles 
of 30 sec at 94°C, 30 sec at 63°C and 1 min at 72°C. GHR-II cDNA was amplified with a 2 min 
denaturation at 94°C, then 35 cycles of 30 sec at 94°C, 30 sec at 63°C and 1 min at 72°C. All 
conditions ended with a 10 min extension at 72°C and primers (Table 2.1-1) for each gene were 
produced on two different exons to prevent amplification of genomic DNA. Water was used in 
place of cDNA to serve as a negative control and β-actin was used as a positive and loading 
control. 
 For qRT-PCR, the same primers (Table 2.1-1) were used with shorter program times and 
slight changes to annealing temperature. Briefly, plasmid DNAs containing the full-length gene 
of interest were quantified by using a Pharmacia DNA/RNA calculator to set up the standard 
curve. Each plasmid was serially-diluted (103 to 109
 Candidate cDNAs from the different developmental stages and ovarian tissues were 
measured using qRT-PCR with SYBR green dye (Stragtagene, La Jolla, CA) in a Cepheid Smart 
Cycler MX4000 (Cepheid, Sunnyvale, CA). The PCR mixture (25 μl) consisted of a 1X Cepheid 
). SmartCycler software created a growth 
curve based on the amount of fluorescence detected at each cycle number. The critical threshold 
(Ct) was empirically determined and calculated from this growth curve. The Ct value and the 
Log concentrations of a serially-diluted plasmid standard were used to create a standard curve. 
The cDNA standards were measured by quantitative real-time polymerase chain reaction (qRT-
PCR) with three independent experiments to check reproducibility, and to determine the linear 
range of the standard curve. 
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enhancer additive (1 mM Tris, pH 8.0; 0.1 mg/ml bovine serum albumin, non-acetylated; 0.75 M 
trehalose; 1% tween-20), 10 μl Master Mix (2.5X) (Eppendorf), 500 nM forward and reverse 
primers and 0.25X SYBR green dye. Primers for PCR were produced to yield between 200-400 
base pair amplification products. 
 Sample Ct values were determined by the Smart-Cycler program. The initial 
concentrations of candidate cDNAs were interpolated from the standard curve. Then these 
concentrations of the sample cDNAs, which should be equal to the concentrations of the sample 
candidate mRNAs, were converted to fmol/μg total RNA. 
Construction of Recombinant Expression Vector for the Extracellular Domain of Zebrafish  
 
GHR-I, GHR-II, and PRLRα 
 
The extracellular domain (ECD) including the transmembrane domain of PRLRα, 
PRLRβ, GHR, and SLR were amplified by polymerase chain reaction (PCR) from the full-length 
cDNA sequence for each receptor in the pGEM-T Easy vector. The PCR reaction was carried out 
in a 50 µl volume, which included 5 µl of 10X PCR buffer, 1.5 µl of 10 mM dNTP, 1 µl (10 μg) 
of cDNA template, 2.5 units of Pfu DNA polymerase, and 0.3 µM of forward and reverse 
primers (Table 2.1-2). The PCR conditions were as follows: a 2 min denaturation at 94°C, 25 
cycles of 30 sec at 94°C, 30 sec at 55°C, and 1 min at 68°C followed by a 15 min extension at 
68°C. The PCR products were subcloned into pET-100 expression vector (Invitrogen, Carlsbad, 
California) and transformed into TOP 10 competent E. coli cells by heat shock at 42°C. Clones 
were verified for correct ligation by sequencing with forward and reverse universal primers using 
the Big-Dye Terminator kit and an ABI Prism 377 DNA Sequencer (Perkin-Elmer, Willesleg, 
MA, USA). The plasmid constructs were amplified and purified using Qiagen Plasmid 
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Purification kit (Qiagen, USA), then transformed into BL21 Star (DE3) competent cells for the 
production of the recombinant proteins.  
Expression and Solubilization of Recombinant Zebrafish GHR-I, GHR-II, and PRLRα 
 
Proteins 
 
Production of recombinant protein for GHR-I-ECD, GHR-II-ECD, and PRLRα-ECD 
were initiated by inoculating BL21 Star (DE3) cells containing the appropriate expressing 
vectors into 10 ml Luria Broth (LB). The cells were grown overnight at 37°C in a C24 incubator 
shaker (New Brunswick Scientific, Edison, NJ). Then, the entire 10 ml of the bacteria cells were 
inoculated into 500ml LB and incubated at 37°C shaker for 2 to 4 h. A 500 µl 1M IPTG was 
added when the O.D600 of the bacterial suspension reached between 0.5 and 0.8 to induce the 
production of the recombinant protein. The culture was incubated further for an additional 24-28 
h to accumulate recombinant protein. The recombinant proteins were isolated and purified from 
inclusion bodies using a procedure modified from the protocol described previously (Nguyen et 
al., 2006). Briefly, bacterial cells were collected from the culture suspension by centrifugation at 
4°C for 10 min at 7974 x g using a Sorvall RC-5B Refrigerated Superspeed centrifuge (DuPont 
Instruments, USA). The supernatant was discarded and cell pellets were collected and washed in 
a suspension buffer (1 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4). 
Then, the bacterial cells were disrupted by sonication in a homogenizing buffer (20 mM Tris-
HCl, 5 mM EDTA, 1 mM PMSF, 1% Triton X-100, pH 8.0). Inclusion bodies with cell 
membranes were collected in pellets by centrifuging the mixture for 15 min at 3645 x g. Partial 
removal of  cell membranes and bacterial proteins was carried out by stirring the suspension 
overnight at 4°C in 20 ml stirring solution (20 mM Tris-HCl, 5 mM EDTA, 4% Triton X-100, 
pH 8.0). Then, the suspension was centrifuged as described previously and the pellets were 
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collected and sonicated (at power 3) for 3 secs on ice in the stirring buffer. The bacterial pellets 
were collected again by centrifugation and washed with three 20 ml washes using the suspension 
buffer. Finally, the inclusion bodies were solubilized by stirring the pellets for 2 days in 10 ml 
solubilization buffer (8 M urea, 20 mM NaPO4
Metal Affinity Column Purification of Recombinant Zebrafish GHR-I, GHR-II, and  
, 500 mM NaCl, pH 7.8).  
 
PRLRα Proteins 
 
The recombinant proteins were purified using ProBond purification system (Invitrogen) 
at RT. Briefly, 10 ml of solubilized proteins were added to the purification column containing 5 
ml ProBondTM resin.  The recombinant proteins containing a His-tag were allowed to bind to the 
resin by gently stirring the suspension for 30 min on a shaker. The resin was pelleted by 
centrifuging for 1 min at 180 x g or by gravity. The supernatant was discarded. The resin was 
washed twice with 5 ml of a denaturing binding buffer (8 M urea, 20 mM NaPO4, 500 mM 
NaCl, pH 7.8) for 5 min. Subsequently, the resin was washed five times with 5 ml of a 
denaturing wash buffer with the same composition as the binding buffer but with pH 5.0, for 5 
min each time by gently inverting the column. Finally, the protein was recovered with two 
washes using 4 ml elution buffer (8 M urea, 20 mM NaPO4
 
, 500 mM NaCl, pH 4.0). The 
recovered recombinant protein elution was transferred to a dialysis tubing (Spectrum 
Laboratories, Rancho Dominguez, CA), suspended in 1 L of ammonium bicarbonate buffer (0.05 
M), and stirred overnight at 4°C. The next morning, the protein solution was transferred to a new 
1 L ammonium bicarbonate buffer and stirred for an additional 4-6 h at 4°C. The protein solution 
was subsequently added to a clean 15 ml centrifuge tube, solidified by storage at -20°C and 
lyophilized using Freezone6 (Labconco) at -20°C.  
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Production of Antibodies for the Extracellular Domain of Zebrafish GHR-I, GHR-II and  
 
PRLRα 
 
Antisera to recombinant zebrafish GHR-I, GHR-II, and PRLRα were produced in three 
female rabbits. Each rabbit received injections subcutaneously at multiple locations on the back. 
For the initial immunization, each rabbit received 0.5 ml of emulsion containing 50-100 μg 
recombinant extracellular domains of GHR-I, GHR-II, or PRLRα proteins and complete 
Freund’s adjuvant to elicit a rapid immuno-response to the antigens. At 38 days, each rabbit was 
boosted with 0.5 ml of emulsion containing 50 μg of the respective receptor recombinant 
proteins and incomplete Freund’s adjuvant. Booster injections were repeated at a 2-week interval 
and test bleeds were conducted prior to the final bleeding. After the final bleed, the serum was 
allowed to coagulate overnight at 4°C, followed by centrifugation at 10,000 x g for 10 min. The 
coagulated particles were removed with a glass Pasteur pipette and the anti-sera was stored at -
20°C. Specificity and affinity of antibodies were determined by Western blotting and 
immunohistochemistry. 
Western Blot Analysis using Zebrafish Specific GHR-I, GHR-II and PRLRα Antibodies 
Western blot analysis was performed as previously described (Nguyen et al., 2006) with a 
few modifications. Tissue samples were collected from anesthetized adults (MS-222; 200 mg/L 
in buffered solution) and immediately transferred to ice cold PBS. Samples were sonicated with 
10 short bursts (2 sec each) with a sonicator (Sonic Dismembrator, Fisher Scientific) at power 3, 
followed by centrifugation for 10 min at 20,000 x g. The resulting pellet was resuspended in 1X 
SDS buffer (0.0625 M Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol), boiled 
for 10 min and then cooled on ice. Each sample was loaded with 40 µg of total protein, estimated 
by the Bradford assay, onto a 12% SDS/PAGE gel in a Bio-Rad apparatus (Bio-Rad 
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Laboratories, CA) and electrophoresed at 200V for 1 h on ice. The protein was transferred to a 
nitrocellulose membrane (Whatman) in transfer buffer (25 mM Tris-base, 192 mM Glycine, 20% 
v/v Methanol, pH 8.3) at 100V for 1 h. The membrane was blocked with 5% nonfat milk in 
TBST (50 mM Tris, 100 mM NaCl, 0.1% Tween 20, pH 7.4) for 30 min at RT and incubated 
with primary antibody against the respective receptors (1:2000) in 10 ml of 5% nonfat milk in 
TBST overnight at 4°C. Subsequently, the membrane was washed with 15 ml of TBST five 
times for 5 min at RT, incubated for 1 h with horseradish peroxidase conjugated to goat anti-
rabbit antibody (1:5000; Cell Signaling, Beverly, MA) at RT, and finally washed five times for 5 
min each with 15 ml of TBST at RT. The Western blots were then treated with a 
chemiluminescent substrate (Super Signal West Extended Dura Substrate, Pierce, Rockford, IL, 
USA) at RT for 5 mins. The signals were digitally recorded using a chemiluminescence image 
system (FluorChemTM
Immunohistochemistry (IHC) using Zebrafish Specific PRLRα Antibodies 
 8800, Alpha Innotech, San Leandro, CA). Protein size was determined by 
comparing blotted protein size to a biotinylated protein ladder (Cell Signaling, Beverly, MA) 
following the manufacturer’s instructions. The specificity of each antibody was assessed using 
the same recombinant extracellular domain for the respective receptors used to inject the rabbits 
for antibody production to serve as a positive control.  
  
Twenty zebrafish larvae and twenty 1-month old juveniles were fixed overnight or for 
one week, respectively, in 20 ml of 10% Bouin’s fixative (Fisher Scientific). Three 1-month old 
juveniles were fixed per 20 ml of 10% Bouin’s and twenty larvae were fixed in 20 ml. Samples 
were then dehydrated using 10 ml of the following solutions for 30 mins unless indicated 
otherwise: washing 2X with 70% ethanol (EtOH), 1X with 95% EtOH, 1X with 100% EtOH, 1X 
with Xylene, 1X with Xylene:Methyl Salicylate (1:1), and finally 1X with Methyl Salicylate for 
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1 h. Then samples were mounted in paraffin using cassettes, sectioned at 8 μm thickness, and 
collected onto a pre-frosted glass microscope slide (Fisher Scientific, Pittsburgh, PA). The 
sections were then deparaffinized by washing 2X for 5 min with Xylene and rehydrated by 
washing the sections 1X with 100% ethanol (EtOH), 1X with 95% EtOH, and 1X with 70% 
EtOH for 5 min each and finally washed 3X with PBS for 5 min. Then, the sections were 
incubated in blocking solution (PBS with 3% BSA, and 1% Normal goat serum) for 1 h at room 
temperature. Finally the sections were incubated with anti-zebrafish PRLRα antibody (1:1000 
diluted in blocking solution) overnight at 4°C. Next, the primary antibody was washed away 
with PBS for 4X for 5 min and incubated with horseradish peroxidase conjugated to goat anti-
rabbit (1:2000; Cell Signaling, Beverly, MA). The secondary antibody was detected using 
Vectastain ABC kit (Vector Laboratories, Burlingame, CA) according to the manufacturer’s 
protocol.  
Statistical analysis 
 
 The significance of the mean differences between various experimental groups was 
determined by one-way ANOVA followed by Tukey test analysis. A P value <0.05 was 
considered statistically significant. 
Results 
 
Identification of Zebrafish GHR-I and GHR-II Genes 
 
  In an attempt to identify the cognate receptors for the PRL/GH family of hormones, 
known PRLR, GHR, and SLR cDNAs from selected fish species were used to conduct a BLAST 
search (Basic Local Alignment Search Tool) against the zebrafish genome (Ensembl genome 
browser: http://www.ensembl.org/index.html and NCBI database: http://www.ncbi.nlm.nih.gov). 
Two expressed sequence tag (EST) clones were identified to be similar to GHRs, one located on 
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chromosome 8 (zfGHR8; Image:6896869) and the second on chromosome 21 (zfGHR21; 
Image:7428125). Complete sequencing and assembly of the full-length EST clones, indicated 
that zfGHR8 was more similar to the well established goldfish GHR, and was re-named zfGHR-
I; while we designated zfGHR21 as zfGHR-II. Both zfGHR-I and zfGHR-II possess conserved 
functional domains with the class 1 cytokine receptor family and other vertebrate GHRs: a signal 
peptide (predicted by SignalP 3.0, http://www.cbs.dtu.dk/services/SignalP), an FGEFS motif in 
the extracellular domain, a single transmembrane domain (predicted by using TMHMM Server 
v2.0, http://www.cbs.dtu.dk/services/TMHMM), Box 1 and Box 2 in the intracellular domain 
(Fig. 2.1-1; Fig. 2.1-2). zfGHR-I is composed of 571 aa consisting of 9 exons, 7 cysteine 
residues in the ECD, and 9 tyrosine residues. zfGHR-II is shorter in overall length, with 8 exons 
spanning 555 aa. zfGHR-II only possesses 5 cysteine residues for two potential disulfide bridges 
compared to zfGHR-I and retains 5 tyrosine residues in the intracellular domain. Another key 
difference between the two receptors is the B site; zfGHR-I maintains the typical TVEN 
sequence observed in classical GHRs across vertebrate species, while there is a modification of 
the first two amino acids in zfGHR-II, NIEN.          
 Comparison of amino acid similarities of zfGHR-I with other GHR cDNAs reveals a high 
level of conservation within the cyprinids (Table 2.1-3). zfGHR-I shares an approximate 88.2% 
amino acid similarity with flathead minnow GHR and between 81.1-83.3% similarity with other 
members of the carp family. In contrast, sequence comparison between zfGHR-I with more 
distantly-related fish species or higher order vertebrates indicated fewer similarities, 53.5-61.1% 
and 39-42% respectively. Despite low sequence similarities with non-teleost GHRs, all 
characteristic landmarks of GHRs were present. Phylogenetic analysis groups zfGHR-I with 
SLRs and zfGHR-II in the GHR clade with other known teleost GHRs and SLRs (Fig. 2.1-3). 
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Zebrafish Prolactin Receptor (zfPRLR) Genes 
 
  The zebrafish PRLRα (zfPRLRα) sequence was previously identified (NCBI accession 
no. NM_001128677.1) but only the coding region was presented. RNA ligase-mediated rapid 
amplification of cDNA ends (RLM-RACE) was employed to identify the complete sequence for 
zfPRLRα. The results indicated that zfPRLRα possesses two distinct 5’ UTR. The different 5’ 
UTR consisted of 186 and 199 bases, representing type-I and type-II, respectively (Fig. 2.1-4). 
The two types of 5’ UTR were distinct but 31 bases immediately upstream of the start codon 
were identical. In contrast, only one 3’ UTR was present, consisting of a short sequence of 51 nt 
that included the poly-A tail sequence. The zfPRLRα cDNA demonstrates the presence of 8 
exons, 5 cysteine residues for two potential disulfide linkages, and 14 tyrosine residues in the 
intracellular domain with two located within Box 2. 
  The complete zfPRLRα cDNA encodes a receptor protein of 605 amino acids. Similar to 
all class I cytokine receptor superfamily members, zfPRLRα is divided into three domains, an 
extracellular, transmembrane, and intracellular domain. The extracellular domain consists of 230 
amino acids with a putative signal peptide represented by the first 22 aa of the coding sequence 
and a WSEWT motif in the membrane proximal region. The transmembrane domain spans 
amino acid 230-253 with a sequence, RSLWIMITIFSVFIVFILTWMLK. The intracellular 
domain contains 352 aa and possesses the conserved functional domains common to GHR-I and 
GHR-II: a proline rich region Box 1 (PPVPGPKI) and Box 2 (DLLVEYLEVY). All conserved 
functional domains for zfPRLRα are shown in Fig. 2.1-4.      
  Interestingly, while data mining for all the potential hormone receptors of the PRL/GH 
superfamily, one genomic contig had low homologies with all other receptors, but possessed 
features of zfPRLRα, and was named zfPRLRβ. Further data mining using the BLAST search 
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algorithm to examine the zebrafish genome at the Ensemble genome browser with PRLR 
sequences from similar fish species provided evidence for a full-length gene. Subsequent PCR-
based cloning of cDNAs obtained from 24 hours post-fertilization (hpf) zebrafish embryos 
generated full-length clones (Fig. 2.1-5A-B), indicating that the zfPRLRβ sequence was actively 
transcribed and not a pseudogene. The full-length sequence of zfPRLRβ was later obtained from 
RLM-RACE and identified to be a single distinct gene located on chromosome 5.  
  Analysis of the full-length cDNA for zfPRLRβ shows a sequence of 1544 bp 
encompassing a 5’ UTR of 190 nt, a coding region of 1341 bp, and a short sequence of 13 
adenines following the stop codon (Fig. 2.1-5A). The coding region is composed of 447 aa with 
a putative signal peptide of 22 aa and a single transmembrane domain, 
QNTVVICAVTLTVVIFMLTAGVMT. The extracellular domain contains five cysteine residues 
and the conserved WSDWS motif. Within the intracellular domain, Box 1 and five potential sites 
for tyrosine phosphorylation were identified, but Box 2 appeared not to be conserved. All 
conserved functional domains for zfPRLRβ are represented in Fig. 2.1-5A.      
  Both PRLRα and PRLRβ share conserved functional domains with human PRLR 
(hPRLR) including the two disulfide bonds within the extracellular domain, the WS motif, and 
Box 1 (Fig. 2.1-6). PRLRβ did not maintain a conserved Box 2 with hPRLR.   
Distribution of GHR-I and GHR-II Proteins in Zebrafish 
 
  The temporal distribution of zfGHR-I and zfGHR-II during development was analyzed to 
gain a better understanding of hormone functions in zebrafish. Both zfGHR-I and -II were 
expressed throughout early zebrafish embryogenesis (Fig. 2.1-7A and Fig. 2.1-7C). Levels of 
either of the receptor types were not significantly different among any developmental stages or 
times from one-cell to 14 days post-fertilization (dpf). In contrast, transcripts for both receptors 
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were abundant in the ovaries.   
  In adult zebrafish, both zfGHR-I and zfGHR-II were co-expressed in most tissues, albeit 
at different levels (Fig. 2.1-8A). zfGHR-II expression was highest in the eyes, brain, liver, 
spleen, and gills. On the other hand, zfGHR-I was expressed most abundantly in the ovary, eye, 
muscle, heart, liver, and spleen. Although these receptors share common target tissues, zfGHR-I 
was more abundant in the ovaries, muscle, and intestine, while zfGHR-II levels were higher in 
the brain, kidney, and gills. At the protein level, both zfGHR-I and zfGHR-II were confirmed in 
all tissues examined, with the addition of the olfactory tissue (Fig. 2.1-8B). The specificity of the 
antibodies was verified using the recombinant extracellular domain of either zfGHR-I or zfGHR-
II as a positive control, demonstrating the detection of the respective receptors in native zebrafish 
tissues.  
Developmental Expression of PRLRα and PRLRβ Transcripts and Proteins 
 
 Similar to the zfGHRs, both zfPRLRα and zfPRLRβ transcripts were expressed 
throughout zebrafish development, from the zygote to juvenile stages (Fig. 2.1-7B, Fig. 2.1-7D). 
Embryonic expression of PRLRα was detected using whole mount in situ hybridization (WISH) 
as early as 15 hpf in the pronephric ducts and tissues undergoing morphogenetic events (Fig 2.1-
9A-C). By 17 hpf, PRLRα was detected in multiple clusters of cells located between the bilateral 
rows of pronephric ducts (Fig. 2.1-9E). The location of these cell clusters suggest that some are 
insulin-positive while the other cells may be β-cell progenitors or other endocrine precursor cells 
that have not completed differentiation. At 20 hpf, PRLRα expressing cells migrate to the 
midline and form a single layer of clustered cells (Fig. 2.1-9I). By 24 hpf, the cluster of PRLRα 
positive cells expands and is expressed in β-cells (Fig. 2.1-9M; Fig. 4-2D-F). The expression of 
PRLRα is maintained in pancreatic β-cells up to 5 dpf and follows the same migratory and 
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expansion pattern of insulin-producing cells (Argenton et al., 1999; Biemar et al., 2001). Unlike 
the pancreas, the expression of PRLRα in the kidney is restricted to particular regions of the 
kidney as development proceeds. PRLRα is initially expressed during early somitogenesis, 
throughout the entire pronephric tubule (Fig. 2.1-9C, F-G, J) but never fused to the cloaca (Fig. 
2.1-9F). By 24 hpf, PRLRα is expressed strongly in all segments of the primitive kidney: 
proximal convoluted tubule (PCT), proximal straight tubule (PST), distal early (DE), distal late 
(DL), and pronephric duct (PD) (Fig. 2.1-9K). At 48 hpf, PRLRα expression is restricted to PCT 
and the anterior region of the PCT (Fig 2.1-10A-B). Expression of PRLRα is further restricted to 
the region that defines the onset of PCT coiling at 72 hpf, and by 5 dpf PRLRα is only detected 
in the PCT coils of the zebrafish pronephric tubule (Fig. 2.1-10E, I). PRLRα was also expressed 
in various regions of the eye (Fig. 2.1-10K), ionocytes, optic vesicle (Fig. 2.1-10F), and intestine 
(Fig 2.1-10D, H).       
 In contrast, PRLRβ was expressed most strongly in the kidney and the expression was 
maintained throughout embryogenesis (Fig. 2.1-11B, D, F-J). PRLRβ expression was initially 
observed at 17 hpf in both tissues undergoing morphogenesis around the eyes and within the 
pronephric ducts (Fig 2.1-11A-C). At 19 hpf, PRLRβ was expressed throughout the entire 
kidney, from the PCT to the distal PD (Fig. 2.1-11D).  The expression pattern persisted even at 3 
dpf in all regions (Fig. 2.1-11I-J). Additionally, PRLRβ was observed in the optic vesicle, heart, 
and within different parts of the brain, though staining was weak (Fig. 2.1-11E, G; data not 
shown).   
 Immunohistochemistry using a zebrafish-specific PRLRα antibody demonstrated 
abundant expression of PRLRα in olfactory epithelium and bulbs by 48 hpf  and in 1 month post-
fertilization zebrafish (Fig. 2.1-12A-B); as well as in the levator arcus palatine (Fig. 2.1-12C), 
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intermandibularis anterior and posterior, and the kidneys of one month old zebrafish (Pereira et 
al., unpublished data). In addition, Western blotting showed PRLRα expression in the olfactory 
organs, brain, eye, intestine, ovaries, and spleen of adult tissues (Fig. 2.1-8B). The recently 
identified PRLRβ transcript was also demonstrated to be expressed in a number of adult tissues, 
including the gills, kidneys, testes, ovaries, intestines, liver, scales, heart, lipids, brain, muscles, 
eyes, and spleen (Fig. 2.1-8A). 
Discussion 
 
In this study, we identified four cognate receptors for the PRL/GH family in zebrafish 
and examined the potential targets of hormone receptor action during zebrafish embryogenesis. 
Analysis of the zebrafish genome revealed the existence of two growth hormone receptors 
(GHRs; GHR-I and GHR-II) and two distinct prolactin receptors (PRLRs; PRLRα and PRLRβ) 
that share multiple conserved functional domains with known vertebrate GHRs and PRLRs. The 
GHRs were expressed most abundantly in the brain, liver and muscles as expected for their well 
characterized function in postnatal growth and metabolism (Rousseau and Dufour, 2007). 
Transcripts for the PRLRs were highest in the gills, kidney, brain and eyes, consistent with their 
reported roles in regulating ion balance and development (Manzon, 2002; Nguyen et al., 2008). 
Furthermore, all four receptors were expressed within the ovaries and the overall receptor levels 
were maintained from the one-cell stage throughout the first 14 days post-fertilization (dpf). At 
the cellular level, PRLRs were expressed predominantly in the pancreas and pronephric tubule 
during early zebrafish embryogenesis.  
In previous studies, it was initially observed that fish exhibited two divergent GHRs that 
represented two distinct lineages of GHRs in fish evolution (Tse et al., 2003). The two groups of 
GHRs were divided into the salmonid GHRs (GHR type I) and the non-salmonid GHRs (GHR 
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type II) based primarily on the number of conserved extracellular cysteine residues. However, 
this view was subsequently challenged by the identification of both GHR types within a single 
species in several teleosts: gilthead seabream, black seabream, southern catfish, Nile tilapia, and 
eel (Saera-Vila et al., 2005; Jiao et al., 2006; Ozaki et al., 2006). Furthermore, the two GHR-like 
genes in masu salmon were characterized as a GHR and a SLR based on their preference for 
binding to GH and SL, respectively (Fukada et al., 2004, 2005). Phylogenetic analysis revealed 
that masu salmon SLR is orthologous to GHR-I of non-salmonids along with medaka and fugu 
SLRs, suggesting that non-salmonid GHR-I are potentially SLRs rather than GHRs (Fukamachi 
et al., 2005).   
Two genomic contigs representing both putative GHR subtypes were recently identified 
in the zebrafish genome database. Our physical sequencing of EST clones and real-time PCR 
analysis demonstrated that both genes are functionally expressed in zebrafish. Consistent with 
other fish possessing two distinct genes similar to tetrapod GHRs, the zebrafish GHR-like genes 
can also be classified based on amino acid (aa) sequence comparison into zfGHR-I and zfGHR-
II. Examination of the zfGHR-I and zfGHR-II demonstrated distinct amino acid sequence and 
structural differences of the two GHR-like genes similar to other teleost (Saera-Vila et al., 2005; 
Jiao et al., 2006). Zebrafish GHR-I, like all vertebrate GHRs except for the salmonids (Very et 
al., 2005), possesses 7 conserved cysteine residues. Biochemical analysis of the human GHR 
demonstrates that disulfides are paired sequentially to produce short loops, 10-15 residues long, 
with one cysteine residue un-paired (Fuh et al., 1990). Applying the same conceptual framework 
suggests that in zfGHR-I, Cys at position 44 (Cys44) likely forms a disulfide bond with Cys54, 
Cys86 links with Cys97, and a third disulfide linkage between Cys111 and Cys127. In contrast, 
zfGHR-II only possesses two of the conserved N-terminal disulfide bonds (Cys37 with Cys47 and 
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Cys83 with Cys93) and lacks a third intramolecular disulfide bond. Although zfGHR-II lacks a 
third disulfide cross bridge, both zfGHRs retain the conserved second disulfide bond that has 
been demonstrated to be important for GH ligand binding (Van den Eijnden, 2006). Another key 
difference is the position of the unpaired cysteine residues between the two zfGHRs. In zfGHR-I, 
Cys219
  The masu salmon GHR (msGHR), which is structurally similar to zfGHR-II, has strict 
binding capacity for GH and not SL or PRL (Fukada et al., 2004). On the other hand, masu 
salmon SLR (msSLR), which is structurally similar to zfGHR-I, has a preference for SL but GH 
also has the capacity to bind to msSLR (Fukada et al., 2005). Based on the residual and structural 
similarities and phylogenetic position of zfGHR-I with other known teleost SLRs while zfGHR-
II belongs to the teleost GHR clade (Fig. 2.1-3), it is speculated that zfGHR-I is the ortholog of 
teleost SLRs; and zfGHR-II represents the teleost-specific GHR. In this scenario, zfGHR-I and 
zfGHR-II are likely to show a similar binding capacity to zebrafish GH and SL as observed in 
the masu salmon. Although our binding assays failed, it was recently demonstrated that zebrafish 
PRLs did not bind to either zfGHR-I or zfGHR-II (Huang et al., 2009) consistent with the 
inability of sPRL to bind to masu salmon GHRs, leaving GH and SLs as the remaining ligands 
for these receptors. The identity of the zebrafish SLR awaits future binding studies for the two 
 is positioned 8 aa upstream of the conserved FGEFS motif compared to the free cysteine 
residue located 73 aa upstream in zfGHR-II. The unpaired cysteine residue has been suggested to 
be involved in intermolecular disulfide bonds with a dimerizing GHR (Zhang et al., 1999), and 
the membrane proximal cysteine in zfGHR-I may provide more structural flexibility of the 
receptor for ligand binding compared to zfGHR-II which may possess strict affinity for GH. 
Together, these characteristic may provide important clues into the potential ligands that may 
bind to the zfGHRs.  
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GHR-like genes using a homologous system encompassing the entire hormone-receptor set.    
   Recently, zfGHR-I and zfGHR-II were demonstrated to possess conserved synteny with 
the human GHR loci, indicating that zfGHR-I and zfGHR-II are true orthologs to human GHR 
(Fukamachi and Meyer, 2007). Thus, the emergence of zfGHR-I in the zebrafish lineage is likely 
due to duplication and divergence from the ancestral GHR gene during the fish-specific genome 
duplication (FSGD) event in the stem lineage of actinopterygians (ray-finned) leading to the 
modern day teleosts. The lack of a second GHR-like gene in lungfish and sturgeon, lineages that 
did not experience FSGD, further supports the duplication of fish GHR through the FSGD event 
(Fukamachi and Meyer, 2007), possibly giving rise to the teleost SLR. However, lungfish and 
sturgeon GHRs show higher amino acid similarity with teleost SLRs then GHRs of mammals, 
birds, and teleosts. It is possible that the ancestral GHR gene duplicated and underwent 
functional switching in fish to account for the emergence of a second SL, SLβ, present in some 
teleosts (Zhu et al., 2004). Nonetheless, further studies to identify additional SLRs across teleost 
species complemented with competitive binding studies would greatly facilitate the proper 
nomenclature of the GHR isoforms as either a SLR or GHR in teleosts. The identities of the GH 
family of peptide hormones and receptors in the lamprey (Petromyzon marinus) would be 
particularly useful in determining the timing of events that led to the expansion of this hormone-
receptor family because it did not experience the FSGD (3R) or 2R (Daza et al., 2009; 
Panopoulou and Poustka, 2005). Currently, only GH has been found to exist in the sea lamprey 
and possibly represents the most ancient gene of this hormone family, but no evidence for the 
receptors are available (Kawauchi et al., 2002; Moriyama et al., 2006).  
  Similarly, the prolactin receptor (PRLR) also appears to have undergone gene duplication 
during the FSGD event. Although less studied, two distinct genes for PRLR have been isolated 
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or described by in silico data mining in several teleost species, but only a single PRLR gene have 
been found in non-teleost species, suggesting a unique phenomenon found only in fish (Huang et 
al., 2007; Fiol et al., 2009). Unlike mammalian species where extensive heterogeneity of the 
PRLR is observed (Freeman et al., 2000; Nguyen et al., 2008), the zebrafish complement 
consists of two PRLR genes that have been designated as PRLRα and PRLRβ or the equivalent 
PRLR1 and PRLR2 in other teleosts. Compared to PRLRα, PRLRβ shares relatively low overall 
sequence homologies with non-teleost PRLRs. Furthermore, PRLRβ differs with respect to the 
length and composition of their intracellular domain (ICD). PRLRβ lacks several tyrosine 
residues conserved in the ICD of the classical PRLRα and the conserved Box 2 domain found in 
most class 1 cytokine receptor families, suggesting differences in the activation of post-receptor 
signaling pathways.  
  It appears that the retention of the duplicated PRLR genes in zebrafish was a consequence 
of both sub- and neo-functionalization. Developmental expression profiles indicate that both 
PRLRα and PRLRβ are expressed during early somitogenesis throughout the primitive 
pronephric tubule. However, as the kidney develops, PRLRα expression becomes restricted to 
the proximal convoluted tubules (PCT), while PRLRβ maintains expression in all regions of the 
pronephric tubule. This suggests that initially, the overlapping of both PRLRα and PRLRβ 
signaling are important for the regulation of osmotic equilibrium, as is expected for the well 
defined role of PRL as a freshwater adapting hormone (Sakamoto and McCormick, 2006). The 
subsequent differential expression of zebrafish PRLRs within the pronephric tubules is possibly 
an example of sub-functionalization of the ancestral function as an osmoregulating hormone 
(Manzon, 2002). While PRLRβ continues to maintain general hydromineral balance throughout 
zebrafish embryogenesis, PRLRα acquired more specific functions related to the anterior 
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structure of the kidneys, such as blood filtration or tubular resorption. The expression pattern of 
PRLRα and PRLRβ also appears to be different in the anterior region of kidney (Fig. 2.1-10E 
and 2.1-11J), possibly indicating the regulation of different cell types. In contrast, PRLRα may 
have acquired novel functions, possibly involved in developmental aspects related to the onset of 
coiling within the PCT region as suggested by its restricted expression. In addition, only PRLRα 
was transcribed in the endocrine pancreas during embryogenesis, suggesting a unique role of 
PRLRα in regulating pancreas development and indicating a new function acquired by PRLRα to 
secure its existence in the zebrafish genome.       
Intriguingly, PRLR was expressed abundantly in the olfactory system in the rat fetus 
(possibly for regulation of food intake), despite its low expression in adult rat olfactory bulbs 
(Freemark et al., 1996). Although PRLR transcripts and proteins were localized in olfactory 
sensory neurons (OSN), the specific cell types have not been identified (Freemark et al., 1996). 
We found PRLRα expressed abundantly in the olfactory system of zebrafish (Fig. 2.1-12A-B). 
Using immunohistochemical methods, PRLRα was detected as early as 36 hpf and sustained up 
to the juvenile stage in both the olfactory epithelium and olfactory bulb in zebrafish (Fig. 2.1-
12A-B). Similar results reporting persistent high level expression of PRLR throughout larval 
development in the olfactory nerve and neurons in the sea bream have been reported (Santos et 
al., 2003). To date, not a single study has demonstrated a role for PRLR during embryogenesis, 
even within the olfactory system in vertebrates, despite the extremely important role of olfaction 
for social and environmental interaction, as well as for survival. Future studies should be 
conducted to analyze the consequences of PRLR expression on development of the olfactory 
system and its physiological relevance during development.    
 Here, it is important to note the discrepancies between PRLRα expression between 
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immunohistochemistry (ISH) and whole mount in situ hybridization (WISH). At first glance, the 
differences in PRLRα expression may reflect the detection of two fundamentally different 
aspects of cellular biology, protein and transcripts respectively. Due to the fact that our WISH 
data is consistent with an independent study (Liu et al., 2006), it is likely that our IHC results 
may require additional validation. Our lab produced polyclonal anti-sera against the PRLRα 
using recombinant protein of the zebrafish extracellular domain of PRLRα. As with all novel 
antibodies, we tried several types of fixatives, time of fixations, antibody dilutions, among other 
factors to optimize the staining conditions for the PRLRα antibody. However, only 10% bouins 
fixative produced staining at a dilution factor of 1:1000 without producing severe background. 
The anti-PRLRα antibody was expected to detect the ECD of PRLRα without complication due 
to the fact that the ECD is exposed on the cellular membrane. However, the requirement of a 
relatively low antibody dilution to detect the antigen when the anti-sera was produced against 
zebrafish PRLRα suggests that our antibody titer was not optimal, and may have reduced 
antibody stability and affinity for the antigen. The PRLRα antibody detected PRLRα in various 
adult tissues under a denatured state by Western blot analysis. IHC may have failed to detect 
PRLRα in the pancreas and kidney due to the native conformation of the PRLRα extracellular 
domain which masks PRLRα antibody-specific epitopes. Alternatively, our PRLRα antibody 
may have cross-reacted with other structurally similar receptors. This is suggested by the fact 
that strong expression of GHR-I was also detected by IHC in the olfactory epithelium and bulb 
(Pereira et al., unpublished data) which would be consistent with an absence in olfactory 
epithelium staining in our WISH data. Consequently, additional work will be required to 
optimize the efficiency and specificity of the PRLRα antibody.  
In summary, we demonstrated that the zebrafish PRL/GH receptor family is composed of 
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zfGHR-I, zfGHR-II, zfPRLRα, and zfPRLRβ. All four receptors are expressed throughout 
zebrafish embryogenesis, providing targets for hormone action and supportive role for these 
proteins in early development as we previously suggested (Zhu et al., 2007). Expression of 
PRLRs within the endocrine pancreas and embryonic kidney indicates that PRL has direct 
physiological or developmental functions on these organs during development. Future studies 
will aim to identify the role of PRLRs in these tissues and explore the molecular mechanisms 
leading to embryonic functions of PRL and PRLRs.  
Table 2.1-1. Primers used for quantitative real-time PCR (qRT-PCR) of ghr-I, ghr-II, prlrα,  
prlrβ, ins, and ef1α.
Gene 
Name
Primer Name Direction Target Sequence
ghr-I zfGHR cDNA 
Synthesis
Reverse 5’ AGGAAGGAGGATTTGGAG 3’
zfGHRRealTF1 Forward 5’ GGTGACTTTTCGTTGCTG 3’
zfGHRRealTR1 Reverse 5’ TGTAAAGCAGGCCTCATC 3’
ghr-II 21Ests cDNA 
Synthesis
Reverse 5’ GGCTGTTGGTGTATTAGG 3’
21EstsRealTF1 Forward 5’ TTCAACACGGCCTCATCT 3’
21EstsRealTR1 Reverse 5’ GCAGCTGGATCACATAAG 3’
prlrα zfPRLR cDNA 
Synthesis
Reverse 5’ GGCATTTGGACTGTTGTG 3’
zfPRLRRealTF1 Forward 5’ TCTGCCCACTACATATGC 3’
zfPRLRRealTR1 Reverse 5’ ACCGCTTTGACGTTTTCC 3’
prlrβ zfPRLR5 Coding R1 Reverse 5’ GACCTCTTTGTGTTCCTGTA3’
PRLR5 RT R1 Forward 5’ GTGCTCTGGGATATTTGC 3’
PRLR5 RT F1 Reverse 5’ GCCTGTGGAAGTTGATGT 3’
ins Insa RT F1 Forward 5’ TAAGCACTAACCCAGGCACA 3’
Insa RT R1 Reverse 5’ GATTTAGGAGGAAGGAAACC 3’
elf1α Ef1a RT F1 Forward 5’ AGACTGGTGTCCTCAAGCCT 3’
Ef1a RT R1 Reverse 5’ TGAAGTTGGCAGCCTCCATG 3’
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Gene 
Name
Primer Name Direction Target Sequence
ghr-I zfGHRpET100R1 Reverse 5’ TCACGCCATCGGAGACTG 3’
zfGHRpET100F1 Forward 5’ CACCCAAGGATCTGAGCTGTTT 3’
ghr-II 21EstspET100R1 Reverse 5’ TCATTTGTTAGGTATAAGTATAAA 3’
21EstspET100F1 Forward 5’ CACCACACAAAATGTGCTT 3’
prlrα zfPRLRpET100R1 Reverse 5’ TCATCTGGGAATATAGTTGGG 3’
zfPRLRpET100F1 Forward 5’ CACCGTCAGTCCTCCA 3’
prlrβ PRLR5 pET100 R1 Reverse 5’ TCAATTCTGCATGACAGTCATATTG 3’
PRLR5 pET100F1 Forward 5’ CACCGAGGAGTGTGATCCCCCAATA 3’
prlrα dnPRLRaF2 Forward 5’ AGAGACCGCGGGAACAACAGATC
TGAGGAGTTTGG 3’
dnPRLRaR2 Reverse 5’ CTCTCCGCGGCAGCAAACAAAGC
TTCACACTGTTGTG 3’
Table 2.1-2. Primers used for construction of recombinant expression vectors of ghr-I, ghr-II,
prlrα, and prlrβ.   
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Fig. 2.1-1. Organization of zebrafish growth hormone receptor type I (zfGHR-I) with respect to
functional domains. The full-length cDNA was determined by sequencing EST clone
Image:6896869. The conserved cysteine residues in the extracellular domain are represented by
green bars. The FGEFS motif is represented by a red bar, transmembrane domain by a black
box, Box 1 by a purple bar, and Box 2 by a blue bar. Specific to GHR is the B site highlighted
with a grey bar. Potential tyrosine phosphorylation sites are indicated by a bolded letter Y
highlighted in red. Sequences that are not highlighted represent the 5’ and 3’ untranslated
regions; while those that are either highlighted by yellow and sky blue represent exons.
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Fig. 2.1-2. Organization of zebrafish growth hormone receptor type II (zfGHR-II) with respect
to functional domains. The full-length cDNA was determined by sequencing of an EST clone
Image:7428125. The conserved cysteine residues in the extracellular domain are represented by
green bars. The FGEFS motif is represented by a red bar, transmembrane domain by a black
box, Box 1 by a purple bar, and Box 2 by a blue bar. Potential tyrosine phosphorylation sites are
indicated by a bolded letter Y highlighted in red. Sequences that are not highlighted represent
the 5’ and 3’ untranslated regions; while those that are either highlighted by yellow and sky blue
represent exons.
55
Species                         zfGHR-I                      zfGHR-II                
Zebrafish GHR-I - 52.9
Zebrafish GHR-II 52.9 -
Fathead minnow GHR (AAY63802) 88.2 65.9
Catla GHR (AAU93896) 83.1 52.6
Common carp GHR (AAU95675) 83.3 53.6
Grass carp GHR (AAP37033) 82.7 53.5
Goldfish GHR (AAK60495) 81.5 52.9
Turbot GHR (AAK72952) 61.1 49.5
Rainbow trout GHR1 (AAW56611) 56.7 55.1
Rainbow trout GHR2 (AAT76435) 56.0 55.3
Black seabream GHR (AAN77286) 60.5 50.1
Black seabream GHR2 (AAV83932) 53.5 53.5
Human GHR (NP000154) 39.0 29.0
Sheep GHR (AAP49814) 41.0 29.0
Frog GHR (AF193799) 40.0 29.0
Turtle GHR (AAF05775) 42.0 30.0
Chicken GHR (AAA48781) 41.0 30.0
Rabbit GHR (AAB67613) 40.0 30.0
Mouse GHR (NP034414) 39.0 29.0
Rat GHR (NP058790) 42.0 30.0
Table 2.1-3. Amino acid similarity of zfGHR-I and zfGHR-II to other vertebrate GHRs.
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Fig. 2.1-3. Phylogenetic analysis of zfGHR-I and zfGHR-II sequences. Multiple sequence
alignment and construction of the phylogenetic tree was performed with ClustalW using the
mature proteins of four teleost species possessing a single GHR and SLR; frog PRLR was used
as an out group. All nodes are supported by bootstrap values of 1000. Branch lengths indicate
proportionality to amino acid changes on the branch. GenBank accession numbers: masu SLR
(BAD51998); medaka SLR (DQ002886); zebrafish GHR-I (zfGHR-I, BC134903); masu GHR
(BAB64911); medaka GHR (DQ010539); zebrafish GHR-II (zfGHR-II, EU649775); and frog
PRLR (AF193801). Fugu SLR and GHR sequences were obtained as described by Fukamachi
and Meyer (2007).
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Fig. 2.1-4. Organization of zebrafish prolactin receptor α (PRLRα) with respect to functional
domains. The full-length cDNA was determined by rapid amplification of cDNA ends (RACE).
The five conserved cysteine residues are represented by bolded C’s highlighted in green. The
WS motif is represented by a red bar, the transmembrane domain by a black box, the Box 1
sequence by a purple bar, and the Box 2 sequence by a blue bar. Potential tyrosine
phosphorylation sites are indicated by a bolded letter Y highlighted in red. Sequences that are
not highlighted represent the 5’ and 3’ untranslated regions (UTR). The two different 5’ UTR
are labeled. Sequences highlighted in yellow and sky blue represent exons.
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Fig. 2.1-5. Organization of zebrafish prolactin receptor β (PRLRβ) with respect to functional
domains. (A) The full-length cDNA was determined by RACE. The five conserved cysteine
residues are represented by bolded C’s highlighted in green. The WS motif is represented by a
red bar, transmembrane domain by a black box, the box 1 sequence by a purple bar, and the box
2 sequence by a blue bar. Potential tyrosine phosphorylation sites are indicated by a bolded
letter Y highlighted in red. Sequences that are not highlighted represent the 5’ and 3’
untranslated regions; while those that are either highlighted in yellow and sky blue represent
exons. (B) The diagram shows corresponding PCR products from different sets of primers
produced to target different regions of the PRLRβ gene, (C) amplified by reverse-transcriptase
PCR using cDNAs obtained from embryos at 24 hours post-fertilization.
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Fig. 2.1-6. Comparison of human prolactin receptor (hPRLR), and the two zebrafish prolactin
receptor subtypes (zfPRLRα and zfPRLRβ). The full-length sequence of PRLRα and PRLRβ
were obtained by rapid amplification of cDNA ends (RACE) from 24 hpf zebrafish embryos,
and the hPRLR sequence was obtained from NCBI (NP_000940). The two conserved disulfide
bridges in the extracellular domain are represented by red bars. The WS motif is represented by
a purple bar, transmembrane domain by a black bar, the Box 1 sequence by a yellow bar, and the
Box 2 sequence by a green bar. Sequence alignments of each conserved domain are shown. N-
terminal (NH2), C-terminal (COOH), and the total number of amino acids in the mature
hormone are indicated.
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Fig. 2.1-7. Quantitative real-time PCR analyses of zebrafish GHR-I, GHR-II, PRLRα and
PRLRβ at different developmental stages and times. (A) growth hormone receptor type I
(GHR-I); (B) prolactin receptor alpha (PRLRα); (C) growth hormone receptor type II (GHR-II);
and (D) prolactin receptor beta (PRLRβ) throughout early zebrafish development. Cell number
(c), hour (h), day (d), ovary (ov). For each given gene, different letters denoted above the bars
indicate statistically significant difference (P<0.05) between developmental stage, time, or from
ovaries of the gene being measured.
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GHR-I
GHR-II
PRLRα
GHR-I
GHR-II
PRLRα
PRLRβ
β-actin
Fig. 2.1-8. Transcript and protein expression of GHR-I, GHR-II, PRLRα, and PRLRβ. (A)
Detection of transcripts by means of reverse transcriptase PCR in selected adult zebrafish
tissues. (B) Western blot detection of proteins for GHR-I, GHR-II and PRLRα in tissues isolated
from adult zebrafish.
A.
B.
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60 kDa
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Fig. 2.1-9. Expression of PRLRα in 15 hpf to 24 hpf embryos. Expression of PRLRα was
obtained by whole mount in situ hybridization using an antisense PRLRα riboprobe. Anterior is
to the left (B, E, I, K-M); for all others anterior is up. The expression of PRLRα in the pancreas
was indicated by arrowheads; in the kidney by arrows; and * indicates pituitary gland . Scale
bar, 50 μm: A, C, D, E, K. Scale bar, 100μm: B, E-G, I-J, L-M. e: eye.
15hpf Lateral                 Flat-mount                  Dorsal
17hpf Lateral          Dorsal Ventral                Lateral
20hpf Lateral             Dorsal                     Lateral
24hpf Lateral Lateral Flat-mount
A B C
D E F G
H I J
K L M
e e
e
e
e
e *
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Fig. 2.1-10. Expression of PRLRα in 72 hpf to 5 dpf embryos. Expression of PRLRα was
obtained by whole mount in situ hybridization using an antisense PRLRα riboprobe. Anterior is
to the left. The expression of PRLRα in the pancreas was indicated by arrowheads; in the kidney
by arrows; and * indicates expression in the eyes. Scale bar, 50 μm: C, G, J. Scale bar, 100 μm:
A-B, D-G, H-I.
72hpf Lateral                              Ventral                   Lateral
Ventral         5dpf Lateral                            Ventral            
Ex Ex
A B C
D E F
G H I J
Ventral         5dpf Lateral                            Ventral            
Ex
* *
48hpf Lateral Ventral Ventral
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Fig. 2.1-11. Expression of PRLRβ in 17 hpf to 72 hpf embryos. The expression of PRLRβ was
obtained by whole mount in situ hybridization using an antisense PRLRβ riboprobe. Anterior is
to the left. The expression of PRLRβ in the kidney indicates by arrows and * represents
expression along developing anterior structures. Scale bar, 100 μm. e: eye.
24hpf Lateral 48hpf Lateral                            Ventral  
17hpf Lateral           Dorsal 19hpf Lateral
e
e
e
e
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Fig. 2.1-12. Protein expression of PRLRα in the olfactory placode, olfactory bulb and levator
arcus palatine. (A) and (B) show strong immunostaining with PRLRα antibody in 48-72 hpf
embryos, and 1-month post-fertilization (mpf) juveniles within the olfactory placode and
olfactory bulb, respectively. The pictures in (B) are high magnification (20X) of the boxed area
of the inserts. (C) Immunohistochemical staining of the levator arcus palatine in 1 mpf
juveniles. PRLRα: tissues were incubated with a zebrafish specific PRLRα antibody (anti-
zfPRLRα, 1:1000); Pre-serum: control serum lacking anti-zfPRLRα antibody. Arrowheads
indicate PRLRα protein positive regions detected by the presence of anti-zfPRLRα binding. Bar:
50 µm.
C.
48 hpf 72 hpf
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CHAPTER 2.2: FUNCTIONAL ANALYSIS OF PROLACTIN RECEPTORS 
Chapter Summary 
We recently demonstrated that in vivo inhibition of prolactin (PRL) translation produced 
embryos with multiple morphological abnormalities, but the molecular mechanisms responsible 
for these phenotypes are unknown. Zebrafish PRL appears to regulate its function through both 
prolactin receptor (PRLR) subtypes, PRLRα and PRLRβ, which are also expressed throughout 
zebrafish development. Our functional knockdown of PRLRα resulting from treatment with 
antisense morpholino (MO) failed to produce similar morphological defects to the previously 
described PRL morphant (Zhu et al., 2007), but two independent laboratories using different 
MOs indicated that the knockdown of PRLRα in zebrafish embryos exhibited many 
characteristics of PRL morphants. Knockdown of PRLRβ produced different effects on the eye 
size, but simultaneous knockdown of PRLRβ with PRL produced complementary effects on both 
eye size and body length, suggesting that PRL may function through PRLRβ. Furthermore, 
morphological abnormalities associated with PRL morphants were determined to be specific by: 
1.) the observation of reduced PRL peptide hormone levels in PRL knockdown, 2.) phenotypes 
of PRL knockdown were independent of the off-target effect by activation of the p53 pathway, 
and 3.) multiple constitutively active signaling molecules of the PRLR signaling pathways 
rescued phenotypes of PRL morphants. We suggest that the JAK2/STAT5 and PI3K/AKT are 
important signaling pathways responsible for normal anterior structure development and body 
length during zebrafish embryogenesis.   
Introduction 
 
  Prolactin (PRL) is a pleiotropic hormone produced and secreted by the anterior pituitary 
gland and in a variety of extra-pituitary tissues (Ben-Jonathan et al., 1996). The actions of PRL 
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can be mediated by an autocrine, paracrine or endocrine mechanism (Clevenger et al., 2003, 
2009; Grattan and Kokay 2008). These diverse modes of action and sources of PRL contribute to 
the multifunctional nature of this hormone. PRL has been identified to modulate over three 
hundred different physiological processes, including effects on water and salt balance, growth 
and development, brain and behavior, and a critical role in reproduction (Bole-Feysot et al., 
1998; Ben-Jonathan et al., 2008).   
  The biological effects of PRL are mediated by interaction with a membrane bound 
prolactin receptor (PRLR) belonging to the class 1 cytokine receptor superfamily (Huising et al., 
2006). PRL signaling is initiated by hormone binding to two cell surface PRLR monomers, 
leading to their dimerization and subsequent activation of post-receptor signaling molecules (Rui 
et al., 1994). PRLR signaling can activate a diverse set of signaling transducers, including the 
JAK2 tyrosine kinase and the signaling transducers of transcription (STAT), phosphoinositol-3-
kinase (PI3K), and AKT (Bole-Feysot et al., 1998). Mammalian PRLRs exists in multiple 
isoforms with identical extracellular domains (ECD) and varying composition of the intracellular 
domain (ICD) (Hu et al., 1991, 1996, 2001). Differences in the ICD have been found to mediate 
divergent signaling pathways (Hu et al., 2001).   
  Teleosts appear to also have a conserved mechanism of PRLR activation and signaling. 
The activation of PRLR in fish follows the same mechanism of PRL inducing PRLR 
dimerization (Le Rouzic et al., 2001). Zebrafish also possess multiple JAKs and STATs that 
share a high degree of amino acid similarity with their mammalian orthologs (Conway, et al., 
1997; Oates et al., 1999a, b; Yamashita et al., 2002). Furthermore, inhibitors of PI3K and AKT 
in mammalian cell lines were similarly shown to inhibit the PI3K/AKT pathway in zebrafish 
embryos (Montero et al., 2003; Hong et al., 2006). In fish, the PRLR heterogeneity is a result of 
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PRLR duplication producing two distinct PRLR isoforms with several differences in the ICD 
that have been shown to regulate different signaling mechanisms (Huang et al., 2007). These 
data suggest that zebrafish may serve as a useful model to study the role of PRL and PRLR 
signaling in vivo. 
Recently, we demonstrated that PRL is an important regulator for normal development of 
the eyes, brain, melanophores and body size in zebrafish (Zhu et al., 2007). Our studies also 
suggest that PRL functions in embryos by acting as an anti-apoptotic factor during zebrafish 
embryogenesis (Nguyen and Zhu, 2009) and probably holds many functions yet to be 
discovered. For the first time, PRL was demonstrated to be functional and important for the 
development of several organs/tissues during vertebrate embryogenesis. These novel results 
highlight the need to understand the mechanisms that may be responsible for the observed 
morphological defects due to the reduction of PRL. The focus of this study was to determine the 
biological significance of PRLRα and PRLRβ using antisense oligonucleotide-mediated 
knockdown and to examine the signal transducers that may be involved in PRLR signaling 
during zebrafish development.    
Methods and Materials 
 
Experimental Animal and Conditions 
 
  Zebrafish, Danio rerio, were maintained according to standard protocols (Westerfield et 
al., 1993). Zebrafish were purchased from a local pet store and maintained at 28.5°C on a 14-
hour light and 10-hour dark cycle.  Embryos were staged in hours post-fertilization (hpf) and 
days post-fertilization (dpf) with reference to morphological features as previously described 
(Kimmel et al., 1995). 
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 Eight females and four males were placed into a 38-l spawning tank for 2 days before 
collecting the embryos. To prevent the fish from eating the embryos, two layers of marbles were 
placed in the bottom of the spawning tank the night before embryo collection. Approximately 
15-20 min after the beginning of the light cycle, embryos were siphoned from the bottom of the 
tank. 
Microinjection of Antisense Morpholino (MO) 
 Antisense morpholino (MO) oligomers specific for PRLATGMO, PRLRαATGMO, 
PRLRαSpliceMO, PRLRβATGMO, and p53ATGMO
Rescuing PRL Knockdown using Modified Prl mRNA and Constitutively Active JAK2a, 
STAT5.1, PI3K and AKT  
 were purchased from Gene Tools, LLC (Philomath, 
OR) and were microinjected as previously described (Zhu et al., 2007; Nguyen and Zhu, 2009). 
Sequences for MOs used in this study are listed in Table 2.2-1 and Fig. 2.2-1A. 
Constitutively active JAK2a (CA-JAK2a) and STAT5.1 (CA-STAT5.1) constructs were 
kindly provided by Dr. Alister Ward while CA PI3K (CA-PI3K) and AKT (CA-AKT) constructs 
were a gift from Dr. Juan-Antonio Montero and Dr. Charles Hong, respectively. Capped mRNA 
for CA-JAK2a, CA-PI3K, CA-AKT were generated by transcription of XhoI (Invitrogen) 
linearized plasmid DNA (1μg/μl; pA301.CMV.Tel-Jak2a, pCS2-p110CAAX, and 
pAdTrack.CMV-myr-AKT) using the SP6 and T7 mMessage mMachine kit (Ambion, TX). CA-
STAT5.1 (pBK.CMV-Stat5.1) was linearized with BamHI (Invitrogen) and transcribed with T3 
mMessage mMachine kit (Ambion, TX). The mRNAs were diluted with nuclease-free water and 
phenol red dye to a concentration of 50 ng/nl for CA-JAK2a, CA-PI3K, and CA-AKT; and CA-
STAT5.1 was diluted to 100 ng/nl. One nanoliter was microinjected into one- or two-cell stage 
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embryos independently or simultaneously with PRL-MO by the methods described previously 
(Zhu et al., 2007).    
Immunohistochemistry (IHC) and Western Blotting 
 
Three whole zebrafish brains were dissected and immediately fixed in 30 ml of 10% 
Bouin’s fixative (Fisher Scientific). Zebrafish brains were then dehydrated using 10 ml of the 
following solutions for 30 min unless indicated otherwise at room temperature: washing 2X with 
70% ethanol (EtOH), 1X with 95% EtOH, 1X with 100% EtOH, 1X with Xylene, 1X with 
Xylene:Methyl Salicylate (1:1), and finally 1X with Methyl Salicylate for 1 h. Then samples 
were mounted in paraffin using cassettes, sectioned at 8 μm thickness, and collected onto a pre-
frosted glass microscope slide (Fisher Scientific, Pittsburgh, PA). The sections were then 
deparaffinized by washing 2X for 5 min with Xylene and rehydrated by washing the sections 1X 
with 100% ethanol (EtOH), 1X with 95% EtOH, and 1X with 70% EtOH for 5 min each and 
finally washed 3X with PBS for 5 min. Then, the sections were incubated in blocking solution 
(PBS with 3% BSA, and 1% Normal goat serum) for 1 h at room temperature. Finally the 
sections were incubated with anti-salmon PRL (1:10000 diluted in blocking solution) overnight 
at 4°C. Next, the primary antibody was washed away with PBS for 4X for 5 min and incubated 
with horseradish peroxidase conjugated to goat anti-rabbit (1:2000; Cell Signaling, Beverly, 
MA). The secondary antibody was detected using Vectastain ABC kit (Vector Laboratories, 
Burlingame, CA) according to the manufacturer’s protocol.   
Embryos at 24 hpf were dechorionated using 23-gauge needles (BD Biosciences) and 
transferred to cold Ringer’s solution (116 mM NaCl, 2.9mM KCl, 1.8 mM CaCl2, and 5 mM 
HEPES) with EDTA (final conc. 1mM) and PMSF (final conc. 0.3mM; general protease 
inhibitor) (Westerfield et al., 2000). Embryos were de-yolked in deyolking buffer without 
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calcium (55mM NaCl, 1.8mM KCl, 1.25mM NaHCO3) (Link et al., 2006) by repeated pipetting 
with a 200 μl pipette tip until the majority of the yolk cells dissolved into the solution. The extent 
of yolk removal with minimal disruption to the embryo tissue was monitored under a 
stereomicroscope. The embryos were shaken for 5 min at 1100 rpm (Thermomixer, Eppendorf) 
followed by centrifugation at 300 x g for 30 sec to pellet and collect the tissues. The supernatant 
was discarded and 1 µl of lysis buffer was added per embryo along with 20% 5X SDS loading 
buffer. An extract equivalent to approximately 10 embryos was loaded per lane i.e. 10 μl. 
Proteins were resolved on a 12% SDS/PAGE gel in a Bio-Rad apparatus (Bio-Rad Laboratories, 
CA) and electrophoresed at 200V for 1 h on ice. The protein was transferred to a nitrocellulose 
membrane (Whatman) in transfer buffer (25 mM Tris-base, 192 mM Glycine, 20% v/v 
Methanol, pH 8.3) at 100V for 1 hour. The membrane was blocked with 5% nonfat milk in 
TBST (50 mM Tris, 100 mM NaCl, 0.1% Tween 20, pH 7.4) for 30 min at RT and incubated 
with anti-salmon PRL at a dilution of 1:2000 in 10 ml of 5% nonfat milk in TBST overnight at 
4°C. Subsequently, the membrane was washed with 15 ml of TBST five times for 5 min at RT, 
incubated for 1 h with horseradish peroxidase conjugated to goat anti-rabbit antibody (1:5000; 
Cell Signaling, Beverly, MA) at RT, and finally washed five times for 5 min each with 15 ml of 
TBST at RT to remove excess secondary antibody. The Western blots were then treated with a 
chemiluminescent substrate (Super Signal West Extended Dura Substrate, Pierce, Rockford, IL, 
USA) at room temperature for 5 min. The signals were digitally recorded using a 
chemiluminescence image system (FluorChemTM 8800, Alpha Innotech, San Leandro, CA). 
Protein size was determined by comparing blotted protein size to a biotinylated protein ladder 
(Cell Signaling, Beverly, MA) following the manufacturer’s instructions and β-actin served as 
the loading control. 
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Statistical analysis 
 
 The significance of the mean differences between various experimental groups was 
determined by one-way ANOVA followed by Tukey test analysis. A P value <0.05 was 
considered statistically significant. 
Results 
 
Functional Analysis of PRLRα and PRLRβ Gene Knockdown 
 
 Unexpectedly, microinjection of antisense morpholino (MO) into zebrafish zygotes with 
either PRLRαspliceMO or PRLRαATG-MO did not phenocopy our previous PRL knockdown (PRL-
KD) results. Although, RT-PCR indicated an absence of PRLRα transcripts likely due to 
nonsense-mediated decay (NMD) within PRLRαspliceMO 
Verification of Off-Target Effects 
(Fig. 2.2-1B), no morphological defects 
were observed in PRLRα morphants. Consistently, no complementary effect was observed when 
PRLRα-MO was co-injected with PRL-MO (Fig. 2.2-3). However, two independent research 
groups demonstrated that PRLRα knockdown produced several phenotypes similar to PRL-KD 
(Liu et al., 2006; Lewis et al., unpublished). In contrast, morpholino-mediated gene knockdown 
of PRLRβ increased eye size at 2.5 ng injection while administration of 1.25 ng or 5 ng of 
PRLRβ-MO did not affect eye size (Fig. 2.2-2). PRLRβ morphants also displayed shorter body 
length (Fig. 2.2-2). In addition, co-injection of PRL-MO with PRLRβ-MO produced a 
complementary reduction of both eye size and body length (Fig. 2.2-3).  
To provide further support that the observed phenotypes in PRL-KD embryos were not 
an off-target effect caused by activation of p53, embryos were co-injected with PRL-MO and a 
morpholino against p53 (p53-MO). The eye size, head area, and body length were significantly 
smaller/shorter compared to the controls; and were similar to microinjection of PRL-MO alone 
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(Fig. 2.2-4A). The embryos also lacked a swim bladder at 5 dpf (Fig. 2.2-4B). Furthermore, PRL 
protein was reduced in PRL knockdown embryos (Fig. 2.2-5).      
Involvement of JAK2a, STAT5.1, PI3K and AKT in PRL Signaling during Zebrafish  
 
Embryonic Development 
 
The involvement of the signaling pathways disrupted within PRL-KD embryos was 
examined using constitutively active (CA) signaling molecules known to be activated by PRLR, 
including JAK2a, STAT5.1, PI3K, and AKT. Under the scenario of PRL-KD, it is assumed that 
PRLR signaling would be reduced, thus leading to defective signal transduction for normal organ 
development. Co-injection of CA-JAK2a or CA-STAT5.1 with PRL-MO partially rescued eye 
size, head area, and body length (Fig. 2.2-6A-F). In contrast, injection of CA-JAK2a or CA-
STAT5.1 alone did not induce additional defects independently of those shown following PRL-
KD alone. Relatively normal development of these structures (i.e. eye size) in single injection of 
CA molecules indicated that co-injection with PRL-MO partially rescued PRLR signaling 
through the JAK2/STAT5 pathway. Furthermore, both JAK2a and STAT5.1 partially rescued 
swim bladder development (Fig. 2.2-6G).  
The role of PI3K and AKT were also examined in PRL-KD embryos. Co-injection of 
CA-AKT with PRL-MO partially rescued body length of PRL-KD embryos, but PI3K did not 
show a significant rescue (Fig. 2.2-7B, D). In contrast, both PI3K and AKT partially rescued eye 
size (Fig. 2.2-7A, C). It is interesting to note that eye size was partially rescued to a similar 
degree when injected independently with either CA-PI3K or CA-AKT along with PRL-MO, 
suggesting the possibility that the PI3K/AKT pathway is one possible mechanism that operates 
to maintain normal eye size. PI3K was further shown to rescue head area (Fig. 2.2-7E). 
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Discussion 
 
  Contradictory results obtained for PRL function based on phenotypes induced by PRL-
KD (Zhu et al., 2007) relative to those obtained from PRL and PRLR knockout mice (Horseman 
et al., 1997; Ormandy et al., 1997) has led us to explore the involvement of PRLRα and PRLRβ 
in early zebrafish development. Functional knockdown of both PRLR subtypes failed to 
phenocopy PRL morphants, probably due to the incomplete action of MOs used in this study. 
However, all of the morphological defects associated with PRL morphants were partially 
reversed by constitutively active signaling molecules known to mediate PRLR function, 
suggesting that the PRL/PRLR signal transduction is involved in regulating the normal 
development of the observed morphological abnormalities in PRL-KD embryos. 
   The failure of our two morpholinos targeted against different regions of the PRLRα gene 
to produce any phenotype would typically suggest that it is not functional during early 
development. This would render our previous observation of developmental defects in PRL 
morphants non-specific. Along the same line, many morpholinos exhibit off-target effects that 
are not displayed by characterized mutant genes and are represented by common neural cell 
death with a reduction in both eye and head size (Robu et al., 2007), consistent with our 
observation in PRL morphants (Zhu et al., 2007; Nguyen and Zhu, 2009). However, two 
independent groups have previously demonstrated that functional knockdown of PRLRα resulted 
in reduced eye and head size (Liu et al., 2006) with additional defects such as shortened fins, 
severe hydrocephaly, and neural mast abnormalities (Lewis et al., unpublished). It is interesting 
to note that the antisense morpholino used by Liu and colleagues overlapped with our translation 
blocking morpholino, yet we did not observe any phenotypes. In addition, verification of the 
effectiveness of our splice blocking morpholino targeted against the PRLRα gene showed a 
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complete absence of PRLRα transcripts (Fig. 2.2-1B) but no mistarget, off-target, or toxicity 
related phenotypes were observed. These differences may result from the use of wild-type strains 
with dissimilar genetic backgrounds. One notable example is the difference in MO activity 
against the one-eyed pinhead (oep) gene with a characterized mutant. In one wild-type strain, 
approximately 50% exhibited the expected loss-of-function phenotype following treatment with 
oep-MO, while a different wild-type strain failed to respond to the oep-MO (Nasevicius and 
Ekker, 2000). MOs directed against nagie oko glass onion and the CXCR4 genes were also 
observed to possess different MO activities due to strain-specific DNA polymorphism of 
different wild-type strains (Malicki et al., 2002). 
  Variation in MO activity resulting from differences in genetic background represents one 
limitation of the antisense morpholino technology and exemplifies the importance of multiple 
controls to determine the specificity of the morpholino or use of well established inbred lines, 
particularly if the gene function has not been characterized (Bill et al., 2009). We have 
previously demonstrated that in vitro transcribed prl mRNA with mutations in the PRL-MO 
binding site partially ameliorated the effects of PRL knockdown (Zhu et al., 2007). In addition, a 
second translation blocking morpholino and a splice blocking morpholino against the PRL gene 
produced the same phenotype described for the original PRL morphant (Table 2.2-1; Zhu et al., 
2007; unpublished observation). One disadvantage of the translation blocking morpholino is the 
requirement of a specific antibody to verify the knockdown of the targeted gene. Using an anti-
PRL antibody produced against salmon PRL (anti-sPRL), we demonstrated that anti-sPRL 
antibody specifically recognized the zebrafish PRL-producing lactotrophs of the anterior 
pituitary (Fig. 2.2-5A), and subsequently the knockdown of PRL proteins in PRL morphants (Fig 
2.2-5B). Our PRL morphants exhibited phenotypes similar to those described for off-target 
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effects with other MOs that have been suggested to result from the activation of p53 (Robu et al., 
2007). In this case, we verified the specificity of the PRL knockdown phenotypes by 
simultaneously co-injecting PRL-MO with a p53-MO (Fig. 2.2-4A-B). The results illustrated that 
the PRL-MO effects are p53-independent. Together, reduction in anterior structures (eyes and 
head), shorter body length, and absence of the swim bladder inflation are most likely specific 
phenotypes of PRL morphants.             
      The PRLR signal transduction mechanisms mediating various biological activities 
associated with PRL have been well characterized (Ben-Jonathan et al., 2008). To shed light on 
the importance of PRLRα and PRLRβ during embryonic development, we examined the 
JAK2a/STAT5.1 and PI3K/AKT signaling transduction pathways that are mediated by PRLR in 
various tissues (Freeman et al., 2000). By using constitutively active (CA) signaling molecules, 
we were able to bypass the requirement of PRLR activation by PRL binding, which is expected 
to be reduced in PRL knockdown embryos. The ability of CA-JAK2a and CA-STAT5.1 to 
partially rescue developmental defects in PRL morphants suggest that the JAK2/STAT5 pathway 
is also important in maintaining normal morphological development of anterior structures and 
overall body length in zebrafish. Moreover, knockdown of STAT5.1 in zebrafish recapitulates 
many of the phenotypes observed in PRL morphants (Lewis et al., unpublished), suggesting that 
STAT5.1 is an important downstream mediator of PRLR function. Although the JAK2/STAT5 
mechanism is not unique to PRLRs, delivery of either CA-JAK2a or CA-STAT5.1 molecules 
alone did not interfere with normal zebrafish development. It is likely that the JAK2a/STAT5.1 
pathway is involved in PRLR action during zebrafish development but is restricted to specific 
cell types. For example, we recently demonstrated that JAK2a rescued apoptosis in the eye and 
central nervous system of PRL knockdown embryos (Nguyen and Zhu, 2009); suggesting 
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JAK2a/STAT5.1 pathway potentially mediates the anti-apoptotic function of PRL during early 
zebrafish development. In fact, PRL has been found to activate JAK2/STAT5 signaling to induce 
the expression of the pro-survival regulator Bcl-xl (Fujinaka et al., 2007). In addition, 
JAK2/STAT5 signaling also targets the transcription of the cell cycle regulator c-Myc (Blakely 
et al., 2005) and cyclin D1 (Brockman et al., 2002; Brockman and Schuler 2005) which if 
disrupted in PRL-KD embryos could cause the reduction in growth seen in many tissues/organs. 
Similarly, since both the CA-PI3K and CA-AKT partially rescued eye size, they may also be 
activated by PRLR in zebrafish. PRL treated lymphoid cells were shown to induce c-Myc 
expression and promoted cell proliferation and survival by activation of a PI3K/AKT-dependent 
mechanism (Dominguez-Caceres et al., 2004). In contrast, CA-PI3K rescued head area but not 
AKT, while the reverse was true for body length in PRL-KD embryos. This observation may 
reflect the ability of PI3K and AKT to mediate functions independent of each other by activating 
other downstream signaling molecules. We hypothesize from these results that cell growth, 
proliferation, and/or apoptosis are general biological processes disrupted in PRL knockdown 
embryos, leading to the observed phenotypes.     
  The JAK2a/STAT5.1 and PI3K/AKT signaling pathways appears to be important 
mechanisms regulated by PRLR in zebrafish development, but our model does not allow us to 
distinguish which PRLR subtype is mediating these signaling pathways. The teleosts have been 
proposed to experience a fish-specific whole genome duplication event, resulting in the co-
existence of two distinct PRLR subtypes (see Chapter2.1). The two PRLR isoforms in seabream 
were shown to differ in tissue distribution patterns, post-receptor signaling pathways, and 
different hormonal responses (Huang et al., 2007). In addition, stably transfected cell lines 
expressing tilapia PRLR1 and PRLR2 induced different gene expression patterns for c-Fos, Bcl-
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xl, c-Myc, and Spi2.1 (Fiol et al., 2009). In zebrafish, PRLR functions also appear to be 
controlled by two PRLR subtypes, PRLRα and PRLRβ. The PRLRβ subtype is distinct from 
PRLRα because of a lack of the conserved Box 2 functional domain and the absence of many 
tyrosine residues within the intracellular domain (ICD). The differences within the ICD of 
zebrafish PRLRβ compared to PRLRα likely reduces potential sites for signaling molecule 
phosphorylation that may lead to activation of different signaling pathways as previously 
observed in fish species possessing two PRLRs (Huang et al., 2007; Fiol et al., 2009). Recently, 
it was demonstrated that PRL, had the capacity to trigger downstream post-receptor events by 
interacting with both PRLRα and PRLRβ in zebrafish, and not with the two GHR-like receptors, 
confirming that PRL can mediate its specific function though both PRLRα and PRLRβ (Huang et 
al., 2009). In addition, simultaneous functional knockdown of PRL and PRLRβ resulted in a 
complementary reduction of eye size and body length, providing support for the notion that 
PRLRβ is a functional receptor for PRL during zebrafish embryogenesis (Fig. 2.2-3). However, 
these results do not provide information on the specific signaling molecules responsible for the 
observed phenotype in PRL and PRLRβ knockdown embryos. On the other hand, Lewis and 
colleagues demonstrated that PRLRα possessed conserved STAT5 binding sites, suggesting that 
at least PRLRα is capable of inducing the JAK2/STAT5 pathway. Recently, a new PRL isoform, 
PRL2, was shown to have a strict binding affinity for PRLRα (Huang et al., 2009). Analysis of 
PRL2 indicated that it was expressed in extra-pituitary tissues including the eyes and brain and 
knockdown of PRL2 affected neuron differentiation in retina development (Huang et al., 2009), 
further complicating the distinction between PRLRα and PRLRβ signaling in our model.  
Whether PRL and PRL2 have overlapping or unique signaling pathways mediated by PRLRα 
and PRLRβ, and the significance of potential divergent signaling mechanisms between the two 
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PRLR subtypes awaits further experimentation. 
Although we have proposed that PRLRs likely regulate the normal development of 
several organs/tissues during zebrafish development, we could not demonstrate a direct function 
of PRLRs on eye and brain development with our current data. Whole mount in situ 
hybridization (WISH) failed to detect transcripts for either PRLRα or PRLRβ within the eyes or 
the central nervous system. This may reflect the detection limitation with WISH compared to 
real-time PCR which is more sensitive at detecting transcripts for PRLRα and PRLRβ (Fig. 2.1-
7). The detection limitations between the two techniques may also explain why Huang et al 
(2009) did not provide evidence for local expression of PRL2 by in situ hybridization in 
zebrafish embryos, but instead used reverse transcriptase PCR to demonstrate the existence of 
PRL2 during embryonic stages. Alternatively, PRL could mediate an indirect function on eye 
and brain development by regulating other growth factors. The insulin-like growth factors (IGFs) 
and their cognate receptors, insulin-like growth factor receptors (IGFRs), have been 
demonstrated to be essential for normal growth and development, particularly within the central 
nervous system (Anlar et al., 1999; Russo et al., 2005). Several lines of evidence indicate that 
lactogenic hormones increase IGFs serum levels both in vitro and in vivo (Murphy et al., 1988; 
Hill et al., 1989; Lassare et al., et al., 1991; Karabulut and Pratten, 1998; Karabulut et al., 1999, 
2000). More recently, it was demonstrated that PRL increased IGF-2 mRNA in mammary 
epithelial cells (Brisken et al., 2002). Both IGFs and IGF-1R are expressed in pancreatic β-cells 
(Fehmann et al., 1996; Hill et al., 1999). The existence of PRLRα within the pancreatic β-cells 
provides a plausible target for PRL signaling to stimulate production and secretion of IGFs into 
the circulatory system where they can interact with IGFRs in the brain and eyes. This idea is in 
line with a previous report indicating that newborn PRLR KO mice had a 70% reduction in IGF-
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2 mRNA in brown adipocyte tissues (BAT) and a 35% reduction in plasma IGF-2 levels 
(Viengchareun et al., 2008). Furthermore, Viengchareun et al (2008) also suggested that the 
mechanism by which PRLR induced IGF-2 transcription in BAT was mediated by the 
JAK2/STAT5 pathway. It is possible that in zebrafish, PRL may also activate the JAK2/STAT5 
pathway via PRLRα to stimulate the production of IGF-2 that would be secreted and affect other 
target tissues such as the head and eyes. Knockdown of the IGFRs with antisense morpholino or 
dominant negative IGFRs in zebrafish resulted in severe developmental retardation with shorter 
body length and defects in the eyes, head, other parts of the central nervous system (Eivers et al., 
2004; Schlueter et al., 2006). Analysis of the IGFs and IGFRs expression level in PRL 
morphants would lend support for an indirect function of PRL on anterior structure development. 
In summary, we provide additional support for the specificity of the previously identified 
phenotypes for PRL morphants. Although antisense morpholinos against PRLRα appears to be 
ineffective in our wild-type strain, other laboratories demonstrate phenotypic abnormalities 
consistent with our PRL morphants (Liu et al., 2006; Lewis et al., unpublished). We further show 
that PRL proteins are decreased in PRL morphants and that the effects observed in PRL 
knockdown embryos are independent of the off-target effects activated by p53. Successful rescue 
of PRL morphants by constitutively active JAK2a, STAT5.1, PI3K, and AKT in vivo indicate 
they are important mediators of PRLR signaling for regulating normal development of the eyes, 
head, body length and swim bladder. Furthermore, the involvement of these signaling molecules 
also provide plausible mechanisms (JAK2/STAT5.1 and the PI3K/AKT) that may explain for the 
observed morphological abnormalities observed in PRL-KD embryos. Finally, we have 
established the zebrafish as an appropriate model to study PRL functions in vivo. Although the 
PRLRα MOs used in this study were not functional in our pet store bought zebrafish, it 
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highlights the importance of using properly maintained inbred wild-type zebrafish strains. The 
combined results from this study provide support for the specificity of the previous phenotypes 
found in PRL morphants. With the additional confidence that phenotypes of the PRL morphants 
are specific and the effective use of CA signaling molecules in vivo, the zebrafish will be a useful 
model to identify tissue- and cell-specific actions of these molecules in PRLR targets to further 
our understanding of PRL/PRLR signaling in zebrafish embryogenesis in the future. 
Gene 
Name
MO Name Target Sequence Target 
Region
prl ATG-prl-MO1 TAGACCCTTGAGCCATTACTAGAAC ATG
prl ATG-prl-MO2 TATTTTCTTGCGTGAATCTGTGTGG 5’ UTR
prl Spl-prl-MO GCCGGtaagagtgtactttattacat Exon 3
prlrα ATG-prlrα-MO CATTAGGTGATGATGAGGATTTCCG ATG
prlrα Spl-prlrα-MO GTGGtgggttcaaaataaatacgat Exon 4
prlrβ ATG-prlrβ-MO TCCAGGACACAATGAGAGATGCAGA 5’ UTR
Table 2.2-1. Sequences of antisense oligonucleotide morpholinos used in the study to 
target prl, prlrα, prlrβ.
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Fig. 2.2-1. Positions of morpholinos within the PRLRα gene and verification of PRLRα
knockdown. A: Two types of morpholinos are indicated: ATG MO and Splice MO. Bolded and
underlined sequences represent primers used for RT-PCR to verify efficiency of PRLRα splice
morpholino knockdown. Sequences highlighted in yellow and green represent different exons.
B: RT-PCR products using primers specific for PRLRα. Open arrowheads indicate expected size
of PRLRα transcripts in the absence of Splice MO and closed arrowheads represent expected
truncated PRLRα transcripts in the presence of effective Splice MO.
A.
B.
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Fig. 2.2-2. Effects of PRLRβ knockdown on body length and eye size at 3 days post-fertilization
(dpf) in zebrafish larvae. Results shown as average (mean±SEM) of twenty individuals from one
representative experiment. Each experiment consists of a non-injected control group (non-
injected), a standard morpholino control group (MO-control, 2.5ng per embryos), a PRL-MO
group and three PRLRβ−ΜΟ groups (1.25, 2.5 and 5 ng per embryo). Means with different
letters indicated statistically significant differences between each treatment group P<0.05.
Similar results were obtained at least three times from independent experiments.
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Fig. 2.2-3. Complementary knockdown effects of prolactin and its receptors on body length and
eye size at 3 days post-fertilization (dpf) in zebrafish larvae. Results are shown as average
(mean±SEM) of twenty individuals from one representative experiment. Each experiment
consists of a non-injected control group (non-injected), a standard morpholino control group
(MO-control, 2.5ng per embryos), a PRL-MO group and a combination of PRL-MO with either
PRLRα-MO or PRLRβ-MO group (2.5 ng per embryo). Means with different letters indicate
statistically significant differences between each treatment group with P< 0.05. Similar results
were obtained at least three times from independent experiments.
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Fig. 2.2-4. Effects of co-injection of p53 morpholino (p53-MO, 2.5 ng/embryo) and prolactin
antisense morpholino (PRL-MO, 2.5 ng/embryo) on the eye size, head size, body length and
gas bladder of 3 days post-fertilization (dpf) zebrafish larvae. A: Approximately 100 embryos
for each treatment group were microinjected at the one-cell stage, and the data were collected at
3 dpf. Similar results were obtained from at 3 independent experiments. (*): show statistically
significant differences (P<0.05). from non-injected and morpholino controls (MO-control). B:
Representative images of 3 dpf zebrafish co-injected with PRL-MO and p53-MO effect on eye
size (lateral) and head size (dorsal). The third panel to the far right represents a lateral view of
the gas bladder of zebrafish larvae at 5 dpf.
A.
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Hypothalamus
RPD
PPD PI
Fig. 2.2-5. PRL morphant effects on PRL protein in zebrafish embryos at 24 hpf. A: Section
immunohistochemistry on an adult zebrafish gland using an anti-salmon PRL (sPRL) antibody
(1:10000). Closed arrowheads indicate PRL-producing cells. RPD, rostal pars distalis; PPD,
proximal pars distalis; PI, pars intermedia. B: Western blot analysis of 24 hpf zebrafish embryos
using an anti-sPRL antibody (1:2000) comparing the levels of PRL between non-injected (NI),
morpholino control (MO-control), and prolactin morpholino (PRL-MO) embryos. Anti-β-actin
was used as a loading control.
A.
B. PRL-MO                 NI              MO-control 
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Fig. 2.2-6. The effects of constitutively active JAK2a and STAT5.1 on the eye size, body length,
head area, and gas bladder development in PRL-MO embryos. Each bar represents average data
of approximately 80 individuals (mean±SEM). Different letters denoted above the bars indicate
statistically significant difference (P<0.05) between the treatment groups. Similar results were
obtained from 3 independent experiments.
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Fig. 2.2-7. The effects of constitutively active PI3K and AKT on the eye size, body length, and
head area on PRL-MO embryos. Each bar represents average data of approximately 80
individuals (mean±SEM). Different letters denoted above the bars indicate statistically
significant difference (P<0.05) between the treatment groups. Similar results were obtained
from 3 independent experiments.
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CHAPTER 3: PROLACTIN FUNCTIONS AS AN ANTI-APOPTOTIC FACTOR DURING 
ZEBRAFISH EMBRYOGENESIS 
Chapter Summary 
            Prolactin (PRL) is a multifaceted hormone that is capable of modulating hundreds of 
physiological processes in adult vertebrates. However, the physiological functions of PRL in 
embryonic development are still controversial. One of the biological actions of PRL is to 
promote survival of cells. Almost all studies on the anti-apoptotic action of PRL have involved 
the use of mammalian cell lines and tissues, rather than in vivo. In order to determine whether 
PRL acts as a survival factor for embryonic cells during development, PRL protein was knocked-
down in zebrafish embryo by the microinjection of PRL antisense morpholino (PRL-MO) to 
inhibit the translation of the PRL transcript. A significant increase in the number of apoptotic 
cells was observed in embryos treated with PRL-MO compared to control embryos injected with 
control morpholino or non-injected controls. The number of apoptotic cells increased more 
significantly between 15 and 35 hours post-fertilization (hpf). Interestingly, apoptotic cells were 
restricted to the central nervous system, particularly in the eyes and brain. Apoptosis of these 
cells was further demonstrated using the Neutral Comet assay to detect DNA damage, a hallmark 
of apoptosis. It was found that the level of DNA damage was dependent on the dose of PRL-MO 
injected and consistent with higher levels of nick ends detected by the TUNEL assay in PRL-MO 
embryos. An examination of genes linked to the apoptotic pathway indicated the transcript of 
caspase-8, a representative caspase gene of the extrinsic pathway, was significantly higher in 
PRL knockdown embryos than the non-injected control or control morpholino. Together, these 
results suggest that PRL acts as a survival factor during zebrafish embryogenesis.  
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Introduction 
 Apoptosis or programmed cell death (PCD) is an important biological process involved in 
the maintenance of tissue homeostasis in adult multicellular organisms and during normal 
development of vertebrates that eliminates extraneous or damaged cells (Ellis et al., 1991; 
Jacobson et al., 1997). In adult animals, the primary role of PCD is to restrain the proliferation of 
abnormal cells. The mechanism by which PCD is induced or inhibited is dependent on cell types 
and their capacity for self-renewal (Solary et al., 1996), but the common function of PCD is to 
prevent the progression of disease resulting from proliferation of damaged or abnormal cells.  
One of the major roles of apoptosis during early embryonic development is to sculpt and shape 
organ and tissue development (Milligan and Schwartz, 1997). In mammals, PCD has been 
observed throughout embryogenesis, during the blastocyst stage for cavitation and formation of 
the inner cell mass (Hardy et al., 1989). PCD has also been demonstrated during gastrulation in 
mouse, chick, and frogs (Coucouvanis and Martin, 1995; Alnemri et al., 1996; Plosazj et al., 
1998,). Similarly, apoptosis is a normal process throughout zebrafish embryogenesis after the 
mid-blastula transition state and affecting all tissues (Cole and Ross, 2001; Negron and 
Lockshin, 2004). Despite the different onset of apoptosis among different species of vertebrates, 
the biochemical and molecular mechanisms of apoptosis appears to be conserved between 
zebrafish and other vertebrates. A number of zebrafish apoptotic apoptotic regulators such as the 
bcl-2 family and a variety of caspases are highly homologous to mammalian apoptotic related 
genes (Inohara and Nunez, 2000). Characterization of the zebrafish bcl-2 gene family with the 
mammalian bcl-2 family indicates a substantial functional similarity between these vertebrate 
species (Kratz et al., 2006). Furthermore, examination of the major effector caspase, caspase-3, 
in zebrafish demonstrates similar characteristics in structure, functions, and substrate specificity 
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to that of human caspase-3 (Yabu et al., 2001a, 2001b; Yamashita, 2003), indicating functional 
conservation of the apoptotic pathway.   
Recently, we demonstrated that prolactin (PRL) is an important hormone responsible for 
the proper development of several tissues/cells in zebrafish (Zhu et al., 2007). The temporary 
knockdown of PRL protein resulted in abnormal development of several tissues resulting in 
smaller head, absence of swim bladder, smaller eyes, and reduced melanophore differentiation. 
Some of the physiological processes deviating from normal functioning as a result of PRL 
knockdown (PRL-KD) may include growth (Shepard et al., 1997), cell proliferation (Bole-Feysot 
et al., 1998) and neurogenesis (Shingo et al., 2003). All three biological processes may be 
affected by programmed cell death as a result of abnormal cell growth, inhibition of 
proliferation, and improper connections among the neuron cells in PRL-KD embryos. 
Experimental studies over the past decade have provided evidence to support the role of PRL in 
the suppression of PCD. The anti-apoptotic effect of PRL was first suggested in amphibians as 
PRL was demonstrated to inhibit thyroid hormone-induced metamorphosis, a process 
characterized by extensive apoptosis (White and Nicoll, 1981; Ray and Dent, 1986). 
Subsequently, numerous studies in the Nb2 lymphoma cell lines suggested an anti-apoptotic role 
for PRL (Buckley et al., 1995; Leff et al., 1996; Krishan et al., 2001).   
Since nearly all studies on anti-apoptotic role of prolactin have been conducted in vitro 
by using cell lines, we examined the role of prolactin on cell death in vivo in zebrafish embryos 
in the current study. Furthermore, we investigated the effect of prolactin knockdown on the 
transcriptional activity of embryonic cells during embryogenesis. These results provide the first 
functional study on PRL’s role in suppressing apoptosis in an in vivo system and provide insight 
into potential physiological roles of prolactin during early embryonic development in vertebrates. 
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Methods and Materials 
Maintenance of Fish, Embryo Collection and Staging 
Zebrafish, Danio rerio, were bred and reared in multiple 38-l holding tanks. The water 
temperature was maintained at 28-29°C. The photoperiod was 14 hours light (8:00 am-10:00 pm) 
and 10 hours dark (10:00 pm-8:00 am). Fish were fed with a high protein food (Fry feed Kyowa 
B, Kyowa Hakko Kogyo Co., Ltd, Tokyo, Japan), three times daily. The ratio of female fish to 
male fish was kept at 2:1 in 38-l spawning tanks. Two layers of marbles were laid across the 
bottom of the spawning tanks to prevent fish from eating their embryos the night before embryo 
collection. Embryos were siphoned from the bottom of the marbles within 15 minutes of 
spawning after the start of the light cycle in the following morning. Embryos were washed 
several times with 10% Hank’s solution (0.137 M NaCl, 5.4 mM KCl, 0.25 mM Na2HPO4, 0.44 
mM KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 4.2 mM NaHCO3
Microinjection of Zebrafish Embryos 
) prior to being subjected to 
various treatments including microinjection. Then, embryos were transferred to 100 X 15 mm 
Petri dishes and incubated at 28.5°C. Embryos were staged according to the time post-
fertilization and morphological criteria described previously (Kimmel et al., 1995).  
 All chemicals and reagents were purchased from Sigma unless indicated otherwise. 
Morpholino antisense oligomers for prolactin were purchased from Gene Tools (Philomath, 
Oregon) and microinjected as described previously (Zhu et al., 2007). Briefly, prolactin 
morpholino (PRL-MO) was resuspended  in nuclease-free sterile water to a concentration  of 10 
ng/nl (1.25 mM), which was then further diluted to a series of working concentrations of 1.25, 
2.5 and 5 ng/nl immediately before the injection using nuclease-free sterile water and phenol red 
dye. These concentrations of PRL-MO showed specific effect of prolactin knockdown and did 
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not show any non-specific effect of morpholino (Zhu et al., 2007). The survival rates of 
morpholino injected zebrafish embryos were generally above 85%, which were comparable to 
control morpholino and non-injected embryos. The prolactin antisense morpholino was 
microinjected into embryos at the 1-2 cell stages using glass microcapillary pipettes attached to a 
micro-manipulator, under a Leica MZ6 microscope (Leica, Germany). Injection was driven by 
compressed N2
Neutral Comet Assay for Detection of DNA Damage 
 gas, under the control of a PV820 Pneumatic PicoPump (World Precision 1 
Instruments, Sarasota, FL, USA). Microinjection volume was estimated at 1 nl/embryo. Non-
injected (NI, physiological state) and morpholino control (Cntrl-MO) injected embryos with no 
known target transcript in the zebrafish (which takes into consideration the effects of injection) 
served as control groups for the comparison of PRL-MO injected embryos. 
 For analyses of DNA damage, neutral comet assay rather than Alkaline Comet assay was 
used since the latter typically detects single strand breaks compared to Neutral Comet assay that 
detect double stranded breaks. Apoptosis is commonly associated with double stranded DNA 
fragmentation. Furthermore, alkaline conditions can also detect AP labile sites and 
excision/repair or single stranded DNA damage in the process of the repair mechanism that does 
not represent DNA damage associated with apoptosis. Dechorionated embryos were macerated 
and suspended in 50 μl of phosphate buffered saline by repeated pippetting. Low melting agarose 
(0.8%, 250 μl) was added to the mixture (Sigma-Aldrich). The entire mixture was then spread on 
a microscope slide pre-frosted with a thin layer of low melting agarose (GibcoBRL, San 
Francisco, CA, USA) and incubated at 4°C for 15 min. Solidified slides were then incubated in 
lysis buffer (10 mM Tris HCl (pH 10), 2.5 M NaCl, 100 mM EDTA, 1% Triton X-100, 1% 
sarcosyl) for 1 h at 4°C, followed by equilibration in 50 ml of 1X TBE for 45 min (using fresh 
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1X TBE every 15 min). Next, slides were placed on the base of an electrophoresis apparatus and 
electrophoresed at 0.7 V/cm and 300 mA for 15 min. Slides were then neutralized by washing 
three times (5 min each wash) with 0.4 M Tris-HCl (pH 7.5), followed by fixation for 5 min in 
100% methanol. Each slide was re-hydrated in ultrapure water for 10 min and stained with 
ethidium bromide (20 μg/ml). Pictures of “comets” (damaged DNA migrates out from the 
condensed nucleus, forming structure that resembles a comet) were taken with a fluorescent 
microscope (Olympus BX-40) and a spot digital camera at 510-560 nm in a horizontal sweep to 
prevent analysis of the same comets. Three slides were produced for each time point, and fifty 
individual comets were randomly photographed per slide. Comets were analyzed using Comet 
Score (AutoComet.com) for the tail moment, taking into consideration both the tail length and 
tail intensity migrating away from the condensed nucleus. Each treated or control group 
consisted of three zebrafish embryos with fifty individual comets assessed from each embryo. A 
mean value of tail moment was obtained for each embryo, and the average of these mean values 
for all embryos in a group was obtained (Jarvis and Knowles, 2003). 
Quantitative Real-Time PCR (qRT-PCR) of RNA for Caspase-8 Gene 
 Total RNA was obtained from approximately 100 embryos by adding 1 ml TRIzol 
reagent (Invitrogen), then homogenized using a sonicator (Sonic Dismembrator Model 100, 
Fisher), and purified following the manufacturer’s instructions. Following the manufacturer’s 
(Invitrogen) instructions, first-strand cDNA was synthesized in a 10 μl reaction including 4 μl 
total RNA (1 μg), 0.5 μl oligo dT primer (0.5 g/L), 0.5 μl 10 mM dNTP, 1 μl 10X RT buffer, 2 μl 
25 mM MgCl2, 1 μl 0.1 M DTT, 0.5 μl RNase out and 0.5 μL (25 units) Superscript III reverse 
transcriptase. Quantitative real-time PCR (qRT-PCR) was performed with SYBR green dye 
(Stragtagene, La Jolla, CA, USA) in a Cepheid Smart Cycler MX4000 (Cepheid, Sunnyvale, CA, 
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USA). The PCR mixture (25 μl) consisted of a 1X Cepeid enhancer additive (1 mM Tris, pH 8.0; 
0.1 mg/ml bovine serum albumin, non-acetylated; 0.75 M trehalose; 1% Tween-20), 10 μl 
Master Mix (2.5X) (Eppendorf), 500 nM forward and reverse primers, and 0.25X SYBR green 
dye. The amplification protocol consisted of an initial denaturation of 95˚C for 2 m in, followed 
by 40 cycles of 95°C denaturation for 15 sec, 60°C annealing for 30 sec, and 72°C extension for 
30 sec using zfcaspase 8 F3 and zfcaspase 8R3 (Table 3-1). 
 The same cDNA was used for reverse transcriptase PCR and performed according to the 
protocol outlined in Chapter 2.1 with the appropriate primers for the candidate apoptosis-related 
genes in Table 3-1. 
Apoptotic Assays 
 Apoptotic cells of the embryos were determined by TUNEL assay, caspase-3 
immunostaining, or acridine orange staining. Embryos were collected at 24 hours post-
fertilization (hpf), dechorionated using watchmaker forceps, and fixed in fresh 4% 
paraformaldehyde at 4°C. After 24 h fixation, the embryos were dehydrated through a series of 
methanol solutions (30%, 50%, 70%, 90%, 5 min in each solution) and finally preserved in 
100% methanol at -20°C for at least overnight. Embryos were then rehydrated in phosphate 
buffered saline containing 0.1% Triton X-100 (PBST). Following rehydration, embryos were 
permeabilized with pre-cooled acetone for 15 min at -20°C and washed twice in PBST for 5 min 
each wash at room temperature (RT). Embryos were then blocked in 1 ml of 2% goat serum for 3 
h at RT. Goat serum was removed with two 1 ml washes for 5 min with PBST. PBST was 
removed and embryos were then incubated in 50 μl of terminal deoxnucleotidyl transferase 
dUTP nick end labeling (TUNEL) reaction mixture, 25 μl of Enzyme solution and 225 ul of 
Labeling solution according to the manufacturer’s instructions (Roche Applied Science 
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Cat#2156792), for 1.5 h in the dark at 37°C. After 5X washes with PBST for 5 min each, 
embryos were incubated in horseradish peroxidase converter (identifies dUTP) for 30 min at 
37°C in a water bath. Excess converter-POD was removed by rinsing 4X for 5 min with 1 ml 
PBS. Embryos were then developed in 1 ml of metal enhanced diaminobenzidine (for 5 ml 
solution: used 100 μl of 40 mg/ml DAB in 50 mM Tris, 25 μl NiCl, 5 ml 100 mM Tris, 1.5 μl of 
30% hydrogen peroxide).    
 An anti-active caspase-3 antibody (BD Biosciences #559565, San Jose, CA, USA) 
generated against conserved region of the active form of human caspase-3 (aa 163-175, 
CRGTELDCGIETD) shared 85% identity with zebrafish caspase-3 at amino acid 166-177 
(CRGTELDPGVETD). Several groups have used the antibody to determine apoptosis in 
zebrafish (Kratz et al., 2006). Embryos were processed using the same protocol described in the 
previous paragraph and blocked in 5% goat serum and 2 mg/ml bovine serum albumin for 2 h 
before addition of anti-active caspase-3 (1:500). Embryos were incubated in primary antibody at 
4°C overnight on a shaker. Following three 20 min washes with PBST, embryos were incubated 
with 1:1000 biotinylated antibody (ABC Vectastain Kit) for 2 h at room temperature. Embryos 
were washed again with PBST to remove excess biotinylated antibody and incubated with AB 
reagent (5  μL reagen t A+5  μL reagen t B/mL in  PBST) fo r 45  min . After several washes with 
PBST, embryos containing cells possessing active caspase-3 were visualized using 
diaminobenzidine (20 mg/mL in 50 mM Tris). 
 Acridine orange is a nucleic acid selective metachromatic vital dye that is a useful and 
cost effective method for measuring apoptosis. For acridine orange staining, live embryos were 
dechorionated and submerged in a 1.5 ml microcentrifuge tube containing a final concentration 
of 5 μg/ml of acridine orange in 10% Hanks’ solution. Embryos were incubated at 28.5°C for 30 
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min in the dark. Prior to fluorescent microscopic image acquisition, 20 embryos were washed 5X 
with 1 ml of 10% Hanks’ solution and mounted in low melting agarose for positioning.  
Rescuing PRL Knockdown using Modified Prl mRNA and Constitutively Active JAK2a  
 Construction of modified PRL cDNA for rescue was described previously (Zhu et al., 
2007). Capped mRNA from the mutated prl cDNA was generated by transcription of Not I 
(Invitrogen) linearized plasmid DNA (1μg/μl; pCS2+
Statistical Analysis 
.EGFP-MutatedPRL) using the SP6 
mMessage mMachine kit (Ambion, TX). Constitutively active JAK2a (CA-JAK2a) construct 
was kindly provided by Dr. Alister Ward. Capped mRNA for CA-JAK2a was generated by 
transcription of Xho I (Invitrogen) linearized plasmid DNA (1μg/μl; pA301.CMV.Tel-Jak2a) 
using the SP6 mMessage mMachine kit (Ambion, TX). Both mRNAs were diluted with 
nuclease-free water and phenol red dye to a concentration of 0.3-0.45 ng/ml for prl mRNA and 
50 ng/nl for CA-JAK2a. One nanoliter was microinjected into one or two-cell stage embryos by 
the methods described previously (Zhu et al., 2007).    
  The significance of the mean differences between various experimental groups was 
determined by one-way ANOVA followed by Tukey test analyses. A P value <0.05 was 
considered statistical significant.  
Results 
Inhibition of PRL Translation Results in Increased Apoptosis in the Central Nervous 
System 
A dose-dependent increase in DNA damage, assessed by the Neutral Comet assay, was 
observed in embryos treated with increasing concentrations of prolactin morpholino. 
Significantly higher levels of DNA damage were observed in the prolactin knockdown embryos 
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treated with 2.5 ng or 5 ng prolactin morpholino compared to both the non-injected and control 
morpholino-injected embryos at all time points examined (Fig. 3-1). Although there was an 
apparent increase in DNA damage between 16 to 20 hours post-fertilization (hpf) in control 
embryos, the changes were not statistically significant (Fig. 3-1). 
 There were a larger number of apoptotic cells observed in prolactin knockdown embryos 
than in control morpholino injected embryos during embryonic development (Fig. 3-2). Most of 
the apoptotic cells were localized within the eyes and throughout the brain. The result was 
further confirmed by the TUNEL assay (Fig. 3-3). The effect of prolactin knockdown on 
apoptotic cells was reduced by co-injection of prolactin morpholino with either mutated prl 
mRNA that has low binding affinity with prolactin morpholino or constitutively active JAK2a 
(Fig. 3-3). Similar results were obtained using TUNEL assay, whole mount immunostaining with 
anti-active caspase-3 (Fig. 3-3A), or acridine orange staining (3-4).  
Increased apoptosis in PRL-KD embryos involves caspase-8 and caspase-3 
Several apoptotic-related genes, Bax, bad, caspy, caspy-2, caspase-3, and p53, were all 
present between 14 and 30 hpf, but the levels of these transcripts between the controls and 
prolactin knockdown embryos were not significantly different (Fig. 3-5). Interestingly, caspase-8 
transcript, an essential component of the extrinsic apoptotic pathway, increased significantly in 
prolactin knockdown embryos compared to control morpholino or non-injected controls (Fig. 3-
6). 
Discussion 
In this study, we were the first to demonstrate an anti-apoptotic role of prolactin in 
zebrafish embryos in vivo, although the anti-apoptotic role of prolactin has already been reported 
in cell lines and carcinoma tissues.  Our results suggest that prolactin suppresses cell death in 
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zebrafish embryos at least partly by inhibiting DNA damage and the expression of the initiator 
caspase-8. In addition, prolactin-dependent apoptosis in the central nervous system in prolactin 
knockdown embryos provides a plausible explanation for the observed reduction in the eye size, 
head size, and melanophore differentiation of prolactin knockdown embryos reported previously 
(Zhu et al., 2007).  
During segmentation at 10-24 hpf in zebrafish, many organs begin to form, including the 
brain, eyes, and melanophores. This period coincides with a progressive increase in programmed 
cell death associated with normal development (Furutani-Seiki et al., 1996; Cole and Ross, 
2001). The reduction in the size of the brain and eyes or in the number of melanophores in 
prolactin knockdown embryos may be partially attributed to increased cell death as a result of 
decreasing prolactin levels. We have recently shown that both the transcripts for prolactin and its 
associated prolactin receptor (PRLR) are present throughout zebrafish development (Nguyen et 
al., 2008). Knocking down the levels of both the prolactin hormone and the receptor increased 
apoptosis during early zebrafish embryogenesis (unpublished data). In fact, prolactin has been 
implicated to function as an anti-apoptotic factor in a number of cell lines and/or tissues derived 
from the mammary gland, prostate, and ovaries (Ahonen et al., 1999; Tessier et al., 2001; 
Ruffion et al., 2003; Asai-Sato et al., 2005) along with other specific cell types. These results 
suggest that the anti-apoptotic role of prolactin is conserved in vertebrates and that prolactin 
plays an important role in not only survival of carcinogenic tissues or cells in adults (Yamashita, 
2003) but also in normal development of vertebrates.   
Apoptosis during normal zebrafish development is initially observed at the onset of the 
tail bud stage (Yabu et al., 2001b). As embryogenesis progresses, there is an increase in 
apoptosis until the formation of the neural tube (~24 hpf). Knockdown of prolactin further 
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increased apoptosis between 14-24 hpf compared to controls. Consistent with the increase in the 
level of apoptosis, embryos treated with prolactin morpholino also suffered from increased DNA 
damage which is an indication of apoptosis. Prolactin has been demonstrated to suppress DNA 
fragmentation in Nb2 lymphoma cells (LaVoie and Witorsch, 1995). Increased DNA degradation 
was also reported in mammary glands with a deficiency in growth hormone and prolactin 
(Travers et al., 1996). However, further studies are required to delineate the specific mechanism 
responsible for the inhibitory effects of prolactin on DNA fragmentation leading to apoptosis. 
Interestingly, these PRL-KD-induced apoptotic cells appear to be localized mainly in the 
central nervous system, around the eyes, surrounding the ventricles, and the optic tectum. 
Apoptotic cells restricted to the central nervous system suggests that the majority of the dying 
cells are neuronal derived, including the melanophore cells which are neural crest derivatives. 
Shingo and colleagues recently demonstrated that prolactin stimulates neurogenesis in the 
maternal brain during pregnancy (Shingo et al., 2003). Reduced prolactin may be accompanied 
by insufficient growth factors that would eventually lead to apoptosis of these neuron cells.  The 
rescue effect resulting from using constitutively active JAK2a mRNA or mutated prl mRNA 
further supports the anti-apoptotic role of prolactin in zebrafish embryos. 
Prolactin-treated cells have been found to promote cell survival by mediating the up-
regulation of a number of pro-survival members of the bcl-2 family in mouse mammary 
epithelial cells, human breast cancer cells, and rat prostate (Leff et al., 1996; Coppenolle et al., 
2001; Peirce and Chen, 2003). However, we found that none of the bcl-2 family of genes 
examined was differentially expressed during early zebrafish development. One of the reasons 
for the discrepancy may be due to the use of whole zebrafish embryos for cDNA synthesis. The 
apoptotic cells were restricted to specific regions of the eyes and central nervous system. First 
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strand cDNA synthesis using whole embryos that include the yolk and other regions that do not 
harbor apoptotic cells could greatly dilute the actual levels of transcripts being detected. 
Alternatively, the levels of these transcripts may not differ, but the functional protein 
concentrations may be altered.  
 We have demonstrated for the first time, a physiological role of prolactin during 
embryonic development and provided further evidence for the anti-apoptotic role of prolactin, 
indicating another functional conservation between zebrafish and mammalian models. It is 
known that more than half of neuronal cells undergo programmed cell death during the formation 
of the central nervous system. Although prolactin knockdown embryos appear to have a 
proportionate reduction in some physical structures, continued cell death in the central nervous 
system in prolactin knockdown embryos can potentially cause neurodegenerative diseases or 
decrease the cognitive ability of the embryo in the long term.  One of the future goals is to 
determine the long-term effects of the morphological abnormalities (Zhu et al., 2007) and 
apoptosis (current study) in prolactin knockdown fish. In addition, it will be interesting to 
determine the relationship between prolactin and the apoptotic signaling pathway in zebrafish 
embryogenesis and the possible cross-talk between the two disparate signaling pathways.  
Gene Name Primer Name Direction Target Sequence
Caspase-8 zfcaspase 8 F3 Forward GCCTCTTGGATACTGTCT
zfcaspase 8 R3 Reverse CCAAAACTGTGCCCTTCT
Bad zfbad F1 Forward GACTTGCTGGAAACTGGA
zfbad R1 Reverse AGAAATGCCAACCAGCTG
Bax zfbax F1 Forward GCTGCACTTCTCAACAAC
zfbaxR1 Reverse GTCGGCTGAAGATTAGAG
Caspase-3 zfcaspase 3 F1 Forward AATGACCAGACAGTTGCG
zfcaspase 3 R1 Reverse GAGCCGGTCATTGTGTTT
Caspy-2 zfcaspy2 F1 Forward CTGGAGAATAAGGACCGT
zfcaspy2 R1 Reverse TTTCCTTTGAGTCCCGCT
Caspy zfcaspy F1 Forward CGCGTCCGAAAATCTACA
zfcaspyR1 Reverse AGCAAGGCCAGTCGTTTT
p53 zfp53 F1 Forward GATGGAGATAACTTGGCG
zfp53 R1 Reverse GGTTTTGGTCTCTTGGTC
β-actin zfβ-actin Forward TTCGAGACCTTCAACACCC
zfβ-actin Reverse TGGTGGTGAAGCTGTAGCC
Table 3-1 Primers used for RT-PCR of genes involved in the apoptotic pathways.
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Fig. 3-1. Neutral comet assay for DNA damage. The insert pictures are representative of no
DNA damage (left) vs. a cell undergoing DNA damage (right). Migration of damaged DNA
proceeds to the right toward the anode in the electrophoretic field, while non-damaged but
loosely compacted DNA surrounds the “head” (nucleus). Three embryos were analyzed per
treatment and fifty individual comets were examined for each embryo. The parameter used to
measure the extent of DNA damage in each treatment was the tail moment, which is the product
of the tail length and tail intensity migrating away from the condensed nucleus. (*) indicates
statistically significant difference (P<0.05) between treatments in a given time point.
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Fig. 3-2. Whole-mount immunostaining of PRL-MO-treated embryos using an anti-active
caspase-3 antibody. Knockdown embryos were sampled from four time points between 18 hours
and 24 hours post-fertilization (hpf). Control embryos were injected with morpholino control
(MO-control) with no known sequence specificity to any zebrafish gene. Arrows represent sites
of apoptosis; arrowheads point to regions undergoing apoptosis off the body axis of the embryo.
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Fig. 3-3. Comparison of apoptotic cells in zebrafish embryos at 24 hpf with different treatments.
Embryos were treated with prolactin morpholino (PRL-MO), PRL-MO co-injected with either
mutated prolactin transcript (PRL mRNA) or constitutively active JAK2a transcript (CA-
JAK2a), and controls (growth hormone morpholino, GH-MO; non-injected; or MO-control). A).
Representative images of zebrafish embryos analyzed by anti-active caspase-3 immunostaining
(top panel) and TUNEL assay (bottom panel). Apoptotic regions are indicated by arrows in both
panels. B). Results shown as average number (mean±SEM) of apoptotic cells in individual
larvae (n=3) stained with TUNEL assay from a representative experiment. (*) indicated
statistically significant differences from control. The experiment was repeated at least three
times.
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Fig. 3-4. Comparison of AO staining between non-injected embryos, PRL morphants, and PRL
mRNA rescued embryos. Embryos were treated with prolactin morpholino (PRL-MO) or PRL-
MO co-injected with PRL mRNA at 24 hours post-fertilization (hpf). Fluorescent microscopic
images of representative were larvae viewed from three different positions (lateral,
dorsal/lateral, dorsal) stained with acridine orange (AO) with superimposed white dots
representing apoptotic cells. The experiment was repeated at least 3 times. (e, eye; n, notochord;
Y, yolk; F, forebrain ventricle; M, midbrain ventricle; H, hindbrain ventricle.
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Fig. 3-5. Differential expression of apoptotic related genes analyzed by RT-PCR in PRL-MO-
treated 18-30 hpf zebrafish embryos. Expression of each transcript was compared between (1)
non-injected, (2) MO-control and (3) 2.5ng PRL-MO. RT-PCR products were electrophoresed
on a 2% agarose gel, detected by staining with ethidium bromide, and photographed. β-actin
was used as a loading control.
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Fig. 3-6. Comparison of caspase-8 transcript in prolactin morpholino and control embryos
analyzed by real-time PCR. The results were expressed as a ratio of caspase-8 in embryos
injected with 2.5ng PRL-MO to MO-control embryos. The expression level was normalized
with β-actin. Values were average of three independent experiments. Significance (P<0.05) is
denoted by different letters. Insert panel: representative results analyzed from one experiment.
Expression of each transcript was compared between (1) MO-control and (2) 2.5ng PRL-MO at
each of the developmental time points sampled.
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CHAPTER 4: PRLRα MAINTAINS NORMAL β-CELL POPULATIONS DURING 
PANCREAS DEVELOPMENT IN ZEBRAFISH 
Chapter Summary 
 
Previous studies have indicated that prolactin (PRL) plays a major role in the up-
regulation of maternal insulin levels and β-cell population in response to the increase metabolic 
demand of the fetus during pregnancy. However, little is known about the roles of PRL on β-cells 
in early pancreatic development. We examined the roles of PRL and PRL receptor alpha 
(PRLRα) by establishing a transgenic line that conditionally expresses a non-functional PRLRα 
(nPrlrα) in  β-cells under the regulation of the zebrafish insulin promoter. Antisense 
oligonucleotide morpholino-mediated PRL knockdown in whole embryos unexpectedly 
increased the β-cell population and insulin transcripts, but it was accompanied by an increase in 
endogenous PRLRα mRNA within the endocrine pancreas. The nPrlrα transgenic line was 
produced to express a hybrid transcription factor (LexPR transactivator) that functions in a 
ligand-dependent manner to induce expression of nPrlrα under the control of the LexOP.  
Addition of the ligand, mifepristone (RU486), binds to the LexPR transactivator which activates 
the LexOP to provide a spatio-temporally controlled expression of nPrlrα on the cell surface of 
insulin-expressing β-cells, providing a model of reduced PRLRα signaling. Consistent with 
results from mammalian models, this loss-of-function of PRLRα led to a reduction in the β-cell 
number. We further demonstrated that the reduced β-cell population and insulin production was 
accompanied by a reduction of known endocrine cell-specific transcription factors, hb9 and 
neuroD, which have been shown to be essential for the differentiation and maintenance of β-cell 
progenitors. Our results suggest that PRL and PRLRα functions to maintain β-cell populations by 
regulating β-cell differentiation during zebrafish pancreas development. Importantly, we have 
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established the first cell-specific in vivo system to study the role of PRLRα in β-cell 
development. It is possible that this system can provide useful information with potential 
applications in diabetes research.                         
Introduction 
 
 Increasingly prevalent cases of diabetes that are characterized by autoimmune destruction 
of β-cells and reduced insulin sensitivity are prompting an increase in investigations into the 
mechanisms responsible for pancreas development and maintenance. Extensive studies have 
implicated a variety of growth factors responsible for β-cell size, number and function, including 
growth hormone (GH) and the lactogenic hormones, prolactin (PRL) and placental lactogen (PL) 
(Vasavada et al., 2006). PRL and PL are both ligands for prolactin receptor (PRLR) which are 
actively expressed and maintained in β-cells throughout vertebrate development (Sorenson and 
Stout, 1995; Nielsen et al., 1999). These lactogenic hormones were demonstrated to act as potent 
mitogenic factors on isolated islets and in insulin-secreting cell lines (Brelje and Sorenson, 1991; 
Brelje et al., 1993). Ectopic in vivo over-expression of PL in β-cells of mice elevated plasma 
insulin level with increased β-cell insulin content, proliferation, size, and mass (Vasavada et al., 
2000). Collectively, lactogenic hormone-mediated changes in β-cell mass and function in 
isolated islets is reminiscent of the physiological changes in β-cell structure and function 
associated with pregnancy (Sorenson and Brelje, 1997). Indeed, heterozygous PRLR-/+ pregnant 
mice were recently demonstrated to suffer from a reduced serum insulin level, β-cell mass and 
number compared to homozygous PRLR+/+ mothers, indicating a critical role for lactogenic 
ligand-induced PRLR activation to maintain glucose homeostasis in pregnancy (Huang et al., 
2009). 
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 The changes in β-cell physiology have been attributed to an up-regulation of PRLR 
(Moldrup et al., 1993; Sorenson and Stout, 1995). Activation of PRLR stimulated JAK2 which 
subsequently phosphorylated the signal transducers and activators of transcription (STAT) and 
resulted in the rapid translocation of STAT5 specifically in the nucleus of β-cells (Brelje et al., 
2002, 2004). PRL treatment of in vitro cell lines and isolated islets also demonstrated the 
requirement of the JAK2/STAT5 pathway in regulating insulin and cyclin D2 transcription as a 
mechanism leading to the increased insulin production and β-cell proliferation (Galsgaard et al., 
1999; Friedrichsen et al., 2001, 2003).     
Less is known about the PRL/PRLR-mediated effects on early β-cell development. 
PRLR-deficient mice exhibited a reduction of β-cell mass, islet density, and insulin mRNA 
(Freemark et al., 2002). The decrease in β-cell mass was independent of apoptosis and was 
interpreted to reflect a defect in β-cell neogenesis. It is now generally accepted that normal adult 
β-cell mass expansion is primarily mediated by β-cell replication (Dor et al., 2004; Teta et al., 
2007), while increases in fetal β-cell population are regulated by β-cell differentiation from 
pancreatic precursor cells (Bowens and Rooman, 2005). In the fetal pancreas, the key 
transcriptional factors required for β-cell differentiation from stem cells or endocrine pancreas 
precursors has been well documented (Edlund, 2002). Pdx-1 is cell-autonomously required for 
pancreas development and functions to determine the pancreatic identity of common precursors, 
including β-cells (Jonsson et al., 1994). Although PRL-mediated β-cell hyperplasia increased 
pdx-1 in vitro, no changes of pdx-1 were observed in vivo during pregnancy or in virgin mice 
infused with PRL (Nasir et al., 2005). It has been shown that pdx-1 alone is insufficient to induce 
endocrine cell fate as demonstrated by ectopic expression targeting different endodermal 
domains by in ovo electroporation (Grapin-Botton et al., 2001) and suggests the involvement of 
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other PRL-responsive transcription factors in the regulation of β-cell number. One such factor is 
hb9 which is essential for the development of the endocrine pancreas (Harrison et al., 1999). 
Deletion in the hb9 gene in mice leads to a significant reduction in β-cell population and down 
regulation of several other transcription factors important for β-cell differentiation, including 
pdx-1 (Harrison et al., 1999; Li et al., 1999). In addition, targeted gene disruption of 
BETA2/neuroD in mice also leads to a reduction of β-cell mass, and has been suggested to be an 
important transcription factor required for islet cell differentiation and survival (Naya et al., 
1997). NeuroD is also a target of neurogenin-3 (ngn3), a marker for the precursors of all 
endocrine cell lineages (Gradwohl et al., 2000; Huang et al., 2000). Involvement of PRL in the 
regulation of these transcription factors have not been examined or demonstrated during 
embryonic development.  
 Despite an accumulation of evidence to support roles for lactogenic hormones in β-cell 
mass regulation during pregnancy, little is known about the function of PRL during early islet 
development. This is partly because rodent fetuses are inaccessible due to in utero development. 
Using the zebrafish as a model, we took advantage of their external development to explore the 
different facets of PRL function on islet development. We show that PRL and its cognate 
receptor PRLRα are involved in the regulation of β-cell number during zebrafish pancreas 
development. In contrast to the defined role of PRL/PRLR on β-cell mass expansion through 
proliferation in pregnant rodents, our results suggest the importance of endocrine cell-specific 
transcription factors, hb9 and neuroD, for maintaining normal β-cell number and insulin 
production in a PRL-dependent manner during embryogenesis. Furthermore, we established the 
first conditional transgenic line that expresses non-functional PRLRα (nPrlrα) within β-cells. 
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Methods and Materials 
 
Fish Maintenance and Microinjection 
 
 AB wild-type zebrafish, Danio rerio, were maintained according to standard protocols 
(Westerfield et al., 1993) and IACUC regulation and rules of the Institute of Molecular and 
Cellular Biology (Singapore). Embryos were staged in hours post-fertilization (hpf) and days 
post-fertilization (dpf) with reference to morphological features as previously described (Kimmel 
et al., 1995). 
 Morpholino antisense (MO) oligomers specific for PRL (PRL-MO) and a 5-mismatch 
MO for PRL (mismatch MO; 5’ TAGACCCTTGAGCCATTACTAGAAC 3’) were purchased 
from Gene Tools, LLC (Philomath, OR). 5’ capped prl mRNA was synthesized from Not I 
(Invitrogen) linearized pCS2+.EGFP-MutatedPRL using the SP6 mMessage mMachine kit 
(Ambion, TX) following the manufacturer’s instructions. PRL-MO, mismatch-MO, and prl 
mRNA were microinjected into zebrafish zygotes with modifications as previously described 
(Zhu et al., 2007). Briefly, PRL-MO were resuspended in nuclease-free sterile water to a 
concentration of 10 ng/nl (1.25 mM), which was then further diluted to a working concentration 
of 2.5 ng/nl immediately before injection with 1X Danieau solution (58 mM NaCl, 0.7 mM KCl, 
0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES at pH 7.6); similarly, 2.5 ng/nl of MO-
control was used as an injection control. The PRL-MO solutions were microinjected into 
embryos at the 1-2 cell stage using borosilicate glass microcapillaries attached to a 
micromanipulator, under a Leica MZ6 microscope (Leica, Germany). Injection was driven by 
compressed N2 gas, under the control of a PLI-100 (Harvard Apparatus, Medical Systems Corp., 
USA). Microinjection was performed with a MPPI-2 pressure injection system (Applied 
Scientific Instrumentation, USA) with volumes estimated at 1 nl per embryo. Noninjected 
118 
 
zygotes (physiological state) served as the control group for the comparison of PRL-MO and prl 
mRNA injected embryos.  
Generation of Tg(ins:nPrlrα:gfp) Zebrafish Line 
 
Transgenic fish expressing non-functional PRLRα (nPrlrα) were developed by 
modification of the LexPR:LexOP system (Emelyanov and Parinov, 2008). Briefly, the 
LexPR:LexOP system consists of two elements: a chimeric transcription factor (LexPR 
transactivator) and a cis-acting operator-promoter sequence (LexOP) containing binding sites for 
this transcription factor. The LexPR transactivator binds to the operator and activates 
transcription of the gene of interest placed under the control of the LexOP only upon the binding 
of the progesterone antagonist, mifepristone (RU486), thus conditionally regulating the 
transcription of the target gene (Fig. 4-1). The extracellular domain (ECD) of PRLRα was 
amplified with primers containing Sac II restriction sites at both ends and was subsequently 
ligated into a pDS-04GLP4 plasmid downstream of LexOP to form a fusion protein with GFP, 
removing all sequences encoding intracellular components of PRLRα required for proper 
signaling, and creating the nPrlrα. A 900 bp zebrafish insulin promoter was inserted into the 
pDS-04GLP4 vector upstream of LexPR at the Xho I and Asc I positions to specifically drive 
expression of nPrlrα in insulin-producing β-cells. Modifications to the construct were verified 
for correct insertion by standard sequencing methods. Ten pg of plasmid DNA was co-injected 
into zebrafish embryos directly into the one-cell with 50 pg of in vitro synthesized transposase 
mRNA. The injected fish were raised and out-crossed to the AB wild-type zebrafish, and the 
resulting embryos were screened for mifepristone (RU486)-induced GFP expression. For 
screening, RU486 was added to the egg water at a final concentration of 1 µM at 12 hpf and GFP 
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expressing F1 siblings were selected to establish stable transgenic lines: tg(ins:nPrlrα:gfp). F2
Whole Mount In Situ Hybridization (WISH) with the Insulin and PRLRα Probes 
 
offspring maintained GFP expression (Table 4-1).   
 
Whole mount in situ hybridization (WISH) using digoxigenin (DIG)-labeled riboprobes 
was carried out as previously described (Korzh et al., 1998). Recombinant DNA clones 
containing gene encoding PRLRα, insulin, hb9, and neuroD were linearized with specific 
restriction enzymes, followed by in vitro transcription reaction with T7 or SP6 RNA polymerase 
(Ambion, TX, USA) for synthesis of the anti-sense RNA probe. The embryos were fixed with 
4% paraformaldehyde (PFA) overnight (O/N), washed 4X for 20 min with PBST, and pre-
hybridized O/N at 68°C. Next, the embryos were hybridized with the DIG-labeled probe in 
hybridization buffer [50% formamide, 5X standard saline citrate (SSC; 0.75 M NaCl, 0.075 M 
sodium citrate), 50 μg/ml heparin, 500 μg/ml yeast tRNA, and 0.1% Tween-20] at 68°C O/N and 
excess probes were removed with the following washes: 100%-, 75%-, 50%-, 25%-hybridization 
buffer, and 2X SSCT for 15 mins and ending with 2X washes with 0.2X SSCT at 68°C. Finally, 
embryos were blocked at room temperature for two hours with blocking buffer (Roche) and 
incubated with 1:2000 anti-DIG antibody conjugated with alkaline phosphatase at 4°C overnight. 
Hybridization of the probe was detected by incubating with NBT (nitroblue tetrazolium; 0.03%) 
and BCIP (5-bromo, 4-chloro, 3-indolyl phosphate; 0.02%) in 0.1 M TBS at a pH 9.5 until 
desired color development occurred (30 min to 1 hr) at room temperature. For sectioning, stained 
embryos were embedded in 1.5% bacto-agar and incubated in 30% sucrose at 4°C overnight. The 
embedded embryos were sectioned with a cryostat microtome (Microm HM 505E, Zeiss) in 
cross section orientation at 12 μm thickness and collected on polysine microscope slides 
(Thermo Scientific). Sections were fixed with 4% PFA in phosphate buffered saline (PBS) for 10 
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min, washed with PBS, and preserved with 1:1 PBS:glycerol under a glass cover slip and sealed 
with nail polish to prevent drying. Photographs were taken using a camera mounted to an 
Olympus AX-70 microscope (Olympus, Japan) using the 20X or 40X objectives with bright field 
illumination. 
The numbers of β-cells were determined by counting DAPI positive nuclei in the areas of 
insulin positive cells of the embryos younger than 24 hpf as the pancreatic β-cells exist in a 
single layer. For embryos that were older than 24 hpf, embryos were sectioned as described 
above at 12 micron thickness following WISH with insulin antisense probe. Sections were then 
stained with DAPI, and the numbers of pancreatic β-cells were determined by counting the DAPI 
stained nuclei within the area corresponding to insulin-positive cells in serial sections (Fig. 4-
3A). 
Quantitative Real-Time PCR (qRT-PCR) for Insulin and PRLRα Genes 
 
Total RNA was obtained from approximately 100 embryos using the RNeasy Mini Kit 
(Qiagen, Germany), and purified following the manufacturer’s instructions. The cDNA synthesis 
and subsequent quantitative real-time PCR (qRT-PCR) were carried out in a single reaction 
mixture using One-Step RT PCR kit (Qiagen, Germany) in a DNA Engine Opticon System (MJ 
Research, USA), with SYB Green used as the reporter. The amplification protocol for prlrα 
consisted of 50°C for 30 min for cDNA synthesis, followed by an initial denaturation of 95°C for 
5 mins, followed by forty cycles of 95°C denaturation for 15 secs, 60°C annealing for 30 secs, 
and 72°C extension for 30 secs with gene specific primers: forward 5’-
TCTGCCCACTACATATGC-3’, and reverse 5’-ACCGCTTTGACGTTTTCC-3’. For 
quantitation of insulin transcripts, insa was measured with the same protocol and primers 
described by Papasani et al., 2006. Quantitation of prlrα and insa gene expression was 
121 
 
normalized using amplification of EF1α (forward, 5’-AGACTGGTGTCCTCAAGCCTG-3’; 
reverse, 5’-TGAAGTTGGCAGCCTCCATGG-3’) with established protocol (Fong et al., 2005) 
in each sample in order to standardize the results by eliminating variation in mRNA quality. 
Western Blot Analysis 
 Embryos at 24, 36, 48, and 72 hpf were dechorionated using 23-gauge needles (BD 
Biosciences) and transferred to cold Ringer’s solution (116 mM NaCl, 2.9mM KCl, 1.8 mM 
CaCl2, and 5 mM HEPES) with EDTA (final conc. 1mM) and PMSF (final conc. 0.3mM; 
general protease inhibitor) (Westerfield et al., 2000). Embryos were de-yolked in deyolking 
buffer without calcium (55mM NaCl, 1.8mM KCl, 1.25mM NaHCO3) (Link et al., 2006) by 
repeated pipetting with a 200 μl pipette tip until the majority of the yolk cells dissolved into the 
solution. The extent of yolk removal with minimal disruption to the embryo tissue was 
monitored under a stereomicroscope. The embryos were shaken for 5 minutes at 1100 rpm 
(Thermomixer, Eppendorf) followed by centrifugation at 300 x g for 30 sec to pellet and collect 
the tissues. The supernatant was discarded and 1 µl of lysis buffer was added per embryo along 
with 20% 5X SDS loading buffer. An extract equivalent to approximately 10 embryos was 
loaded per lane i.e. 10 μl. Proteins were resolved by electrophoresis of the extracts through 12 
percent SDS polyacrylamide gel electrophoresis (SDS-PAGE), and electrophoretically 
transferred to a nitrocellulose membrane using a semi-dry blotting apparatus (Liu and 
Londraville, 2003) for 38 min at 20V (Polvino et al., 1983). The membrane was blocked with 5% 
nonfat milk in TBST (50 mM Tris, 100mM NaCl, 0.1% Tween 20, pH 7.4) for 1 h and incubated 
with anti-GFP (1:1000; Santa Cruz Biotechnology) or anti-β-tubulin antibody (1:2000) at 4°C 
overnight. Excess primary antibody was removed by washing the membrane four times for 5 min 
with TBST, followed by incubation for 1 h at room temperature with horseradish peroxidase 
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conjugated to goat anti-mouse antibody (GE Healthcare, Selangor, Malaysia), and finally washed 
(3 times for 15 min) with TBST. Thereafter, blots were treated with SuperSignal West Dura 
Subsrate (Thermo Scientific) according to manufacturer’s instructions. The amount of GFP and 
β-tubulin proteins between the different treatments were recorded by autoradiography Hyper film 
(Amersham Biosciences, UK) using an auto-developing machine (Kodak X-OMAX 2000 
processor; Carestream Health). Detection of GFP in tg(ins:gfp) between NI and PRL-MO 
embryos served as an indirect method to determine the approximate insulin protein level, while 
β-tubulin served as the loading control. Similar results were obtained at least three different 
times from independent experiments.  
Tissue Mounting and Photography 
 
Embryos treated by WISH for PRLRα or insulin and/or in combination with whole-
mount immunohistochemistry with an anti-GFP antibody to detect insulin or nPrlrα expression 
were washed with PBST twice for 10 minutes each and transferred to 50% glycerol/PBS, 
equilibrated at room temperature for one hour. For whole mounts, a single chamber was made by 
placing stacks of 3-5 small electricity tape on both sides of a 25.4X76.2 mm microscope slide. A 
selected embryo was transferred to the chamber in a small drop of 50% glycerol/PBS and 
oriented with a needle. A 22X44 mm cover glass with a small drop of the same buffer was placed 
over the embryo to secure its position. The orientation of the embryo was adjusted by gently 
moving the cover glass. For flat mounting specimens, the yolk of the selected embryo was 
removed completely with 23G needles. The embryo without yolk was then placed onto a slide 
with a small drop of 50% glycerol/PBS and adjusted to a proper orientation by removing excess 
liquid and with the help of needles. A small fragment of cover glass (a bit larger than the 
specimen) was placed on top of the embryo. Care was taken to avoid bubbles and a drop of 50% 
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glycerol/PBS was added to fill the space under the cover glass. This specimen was sealed with 
nail polish along the edge of the cover glass to prevent it from drying. Photographs were taken 
with a Zeiss Axioplan fitted with a Zeiss AxioCam with either 20X or 40X objectives. Images 
were taken by DIC in bright field illumination or with FITC to observe GFP expression. 
Statistical Analysis 
 
The significance of the mean differences between various experimental groups was 
determined by one-way ANOVA followed by Tukey test analysis. A P value <0.05 was 
considered statistically significant. 
Results 
 
Expression of PRLRα in Pancreatic β-cells 
  
Based on WISH, no significant expression of the PRLRα was observed in organs/tissues 
other than the pancreas and kidney in embryos ranging from 15 hpf to 5-day-old embryos (Fig. 
2.1-9; Fig. 2.1-10). The expression of PRLRα was readily detectable in both the pancreas and 
kidney in zebrafish embryos examined between 17 hours post-fertilization (hpf) to 3 days post-
fertilization (dpf) (Fig. 2.1-9D-K, M; Fig. 2.1-10A-E, K), whereas PRLRβ is restricted to only 
the kidney (Fig. 2.1-11A-J). We hypothesized that expression of both PRLRα and PRLRβ in the 
kidney are related to the well-known function of PRL in regulating water/ion balance in the 
embryos, while the expression of PRLRα in the pancreas is related to a novel function of PRL 
during embryonic development of the pancreas. Expression of PRLR in the pancreas is well 
established in adult vertebrates, with localization restricted to the β-cells. Therefore, we focused 
on examining the roles of PRLRα in the pancreas. In order to avoid potential cross-reactivity 
between insulin and PRLRα as might be the case when using double in situ hybridization, we 
combined WISH and immunohistochemistry. We first verified that expression of GFP in the 
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tg(ins:gfp) line truly represents endogenous insulin expression by co-localizing GFP (using an 
anti-GFP antibody) with insulin transcripts by means of WISH. The GFP expression in 
tg(ins:gfp) co-localized well with native insulin transcripts based on overlap between signals 
detected from GFP and insulin (Fig. 4-2A-C), indicating that the tg(ins:gfp) line is a useful 
model to visualize the effects of PRL/PRLRα on β-cells. PRLRα-expressing cells were again 
ascertained by WISH and co-localization with GFP in the tg(ins:gfp), and demonstrating that 
PRLRα is expressed in β-cells (Fig. 4-2D-F).  
Effects of PRL/PRLRα on the Number of Pancreatic β-cells during Embryonic 
 
Development 
 
The effects of PRL and PRLRα on the number of pancreatic β-cells were examined by 
knockdown of PRL (referred to as PRL morphants), over-expression of PRL, or expression of 
non-functional PRLRα (nPrlrα).  The number of β-cells increased in control embryos (non-
injected and mismatch-MO) between 17 to 72 hpf (Fig. 4-3C). Embryos injected with the 
mismatch-MO were generally developmentally delayed compared to the non-injected control 
embryo, showing a slight decrease but no significant difference in β-cell number compared to the 
non-injected control embryos (Fig. 4-3C). Surprisingly, knockdown of PRL increased the 
number of β-cells between 17 and 72 hpf, while over-expression of PRL decreased the number of 
β-cells between 17 and 24 hpf compared to the mismatch-MO and non-injected control (Fig. 4-
3B, C). In contrast, expression of nPrlrα exhibited a significantly reduced β-cell number 
compared to the non-injected control between 24 and 72 hpf (Fig. 4-3C); and with mismatch-MO 
at 72 hpf but not at 24 and 48 hpf. GFP expression of nPrlrα was not detectable at 17 hpf, thus 
we were unable to examine the effects of nPrlrα on β-cell number.   
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Effects of PRL Expression on Insulin Transcripts and Protein during Development 
Expression of insulin transcripts in the developing pancreas was examined using qRT-
PCR to determine whether increase in numbers of pancreatic β-cells also resulted in increased 
production of insulin mRNA. Zebrafish possesses two isoforms of insulin, insa and insb. Both 
forms of insulin are expressed in the pancreas, but expression of insb has been shown to decrease 
between 6-72 hpf (Papasani et al., 2006).  So, we focused on the expression of insa. The insa 
transcript was low at 12 hpf and was at least ~2-fold less compared to later stages where PRLRα 
is expressed and β-cells have differentiated. PRL knockdown significantly increased the insa 
transcript ~1.8- to ~2-fold between 36 and 72 hpf compared to the non-injected (NI) control, 
whereas the overexpression of PRL reduced insa transcripts ~1.9-fold at 24 hpf compared to the 
NI control, but recovered after 48 hpf to comparable levels with non-injected embryos (Fig. 4-
4B). This result is consistent with the observed increase in the number of β-cells in the same time 
window (Fig. 4-3C), i.e. from 24 to about 48 hpf. Both insa transcript and β-cell number 
recovered to comparable levels with NI controls or mismatch-MO controls in prl mRNA injected 
embryos after 48 hpf. It is likely that the injected prl mRNA does not persist in the embryos 
beyond 48 hpf, leading to the recovery in the number of β-cells in the injected embryos. 
Accounting for this, the result is consistent between gain-of-function and loss-of-function of PRL 
signaling, and suggests that PRL may play a role in determining the number of β-cells in the 
developing pancreas.  
Due to lack of any specific antibody for zebrafish insa, we examined the insa protein 
level indirectly by measuring the level of GFP produced in tg(ins:gfp) from non-injected controls 
and PRL morphants. Expression of GFP in tg(ins:gfp) is under the control of the insulin 
promoter, and provides a relative measurement of endogenous insulin production in pancreatic β-
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cells. Increases in GFP protein were observed in PRL knockdown embryos compared to the 
control at all time points examined, from 24 to 72 hpf (Fig. 4-4A).  
Generation of Non-functional PRLRα (nPrlrα) and Analysis of its Impact on β-Cell 
Development and Function 
The LexPR:LexOP construct was utilized because it enabled spatio-temporal control of 
transgenes, and in our case, the expression of a chimeric PRLRα-GFP gene directed to the β-
cells. We replaced the intracellular domain of PRLRα with gfp and generated several stable 
transgenic lines (ins:nPrlrα:gfp) for the expression of non-functional PRLRα (nPrlrα) 
specifically in the insulin-producing β-cells (see Materials and Methods for detail). One major 
advantage of this system is that our transgene is strictly controlled in a ligand-dependent 
(Mifepristone, RU486) and cell-specific manner (insulin promoter). Induction of nPrlrα 
expression is easily achieved by administration of RU486 in the fish water, allowing temporal 
control to study different developmental or physiological state at any time point within the life 
cycle of the zebrafish.   
The founder fish with the chimeric nPrlrα transgene potentially integrated into their 
genome was crossed with AB wild-type fish and identified to be a founder by administration of 
RU486 into the water of their progeny (F1 offspring) at 24 hpf. After 6 hrs of RU486 treatment, 
GFP expression within the pancreas was used as an indicator for proper nPrlrα integration and 
were classified as F1 offspring that were raised to sexual maturity. The process was repeated 
again to identify F2 offspring. From our screen of 200 fish, four GFP transgenic lines were 
analyzed (Table 4-1). The ratios of GFP expressing progeny in F1 offspring ranged from 16.7%-
38% and were generally higher in F2 offspring (Table 4-1). The ratio of F1 offspring was less 
than the expected 50% for transgenes that integrate in all germ cells, indicating that our founder 
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fish experience the commonly observed mosaic nature of transgenes integration only into a 
subset of germ cells (Udvadia and Linney, 2003). Crossing GFP expressing F1 with AB wild-
type did produce the approximately 50% GFP expressing progeny (F2
The expression of nPrlrα was similar to the endogenous insulin expression reported 
previously (Argenton et al., 1999; Biemar et al., 2001), and localized at the cell surface (Fig. 4-
5). Based on the GFP expression, we isolated F
) as would be expected for 
Mendelian inheritance of transgenes (Udvadia and Linney, 2003).     
2 embryos that expressed nPrlrα and analyzed 
them for changes in β-cell population. Significant reductions in the numbers of insulin positive 
β-cells were observed in embryos induced to express nPrlrα by treatment with RU486 (Fig. 4-
3C; Fig. 4-6C, G, K). F2 embryos that were not administered RU486 did not exhibit a reduction 
in β-cell number (Fig. 4-6A, E, I). Moreover, treatment of AB wild-type embryos with RU486 
had no effect on β-cell population (Fig. 4-6B, F, J) compared with non-induced F2 embryos. 
These results indicate that RU486 alone has no effect on pancreatic β-cell population and that the 
expression of nPrlrα is responsible for the observed decreased in β-cell number and insulin 
expression. The timing of RU486 treatment did not seem to have major effects on β-cell number 
because short exposure of F2 embryos to RU486 at 24 hrs and 48hrs (for 24 hrs intervals) or 
continued treatment beginning at 12 hpf resulted in similar reduction in the numbers of 
pancreatic β-cells when examined at 48 and 72 hpf (Fig. 4-7). Interestingly, the number of β-cells 
appeared recover in F2
 
 embryos injected with PRL-MO when simultaneously induced with 
RU486 (Fig. 4-6D, H, L) compared to nPrlrα expressing embryos alone (Fig. 4-6C, G, K). The 
loss of β-cells in nPrlrα is inconsistent with results from PRL-MO and PRL mRNA injections. 
We expected the nPrlrα embryos to have similar effects as PRL knockdown.  
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Effects of PRL Knockdown and Over-expression on the Expression of PRLRα 
The increase in β-cell number and insulin in PRL knockdown embryos and decrease of β-
cell number and insulin in the embryos over-expressing PRL were surprising results to us 
because previous studies consistently demonstrated that PRL treatment increases β-cell number.  
We examined the expression levels of PRLRα transcript to determine whether PRL knockdown 
had any effect on PRLRα levels. The expression of PRLRα was much higher in the pancreas of 
PRL knockdown embryos compared to the NI control, while the expression of PRLRα in the 
kidney appeared to be similar (Fig. 4-8A). qRT-PCR in whole embryos indicated that the levels 
of PRLRα transcripts appeared to be higher in PRL knockdown embryos compared to the NI 
control embryos between 24 and 72 hpf; however, the differences between the two groups was 
not statistically different (Fig. 4-8B). Nevertheless, our data suggests that PRLR may be up-
regulated when the level of PRL is diminished (as in the case of MO knockdown) in a 
compensatory manner.  
Effects of PRL Knockdown and nPrlrα on Hb9 and NeuroD Transcriptional Factors 
 
No apparent difference was found in the β-cell population undergoing cell proliferation as 
a result of an absence in overlap between insulin-producing cells and the cell proliferation 
marker PH3 of PRL morphants compared to those in the NI control embryos (Fig. 4-9). To 
determine whether neogenesis may be involved in the increased β-cell population of PRL 
morphants, we examined two important transcription factors involved in the differentiation of 
endocrine pancreas precursors into β-cells, hb9 and neuroD. The expression of hb9 was up-
regulated in PRL morphants (Fig. 4-10B, F, J), whereas hb9 was down-regulated in nPrlrα 
embryos between 24 and 72 hpf (Fig. 4-10C, G, K) and was almost absent at 72 hpf in nPrlrα 
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compared to the NI control (Fig. 4-10K). Injection of PRL-MO in nPrlrα embryos increased hb9 
positive cells (Fig. 4-10). 
An up-regulation in neuroD positive cells was observed in the pancreas between 18 and 
21 hpf in PRL morphants (Fig. 4-11). In contrast, a reduced number of neuroD expressing cells 
was observed in nPrlrα embryos (Fig. 4-11).  
Effects of PRL Knockdown and nPrlrα on Islet Cell Migration 
 
Two transgenic lines (ins:gfp and ins:rfp) expressing fluorescent proteins in pancreatic β-
cells were used for determining the migration of the primary islet cells. Newly differentiated 
insulin positive cells appeared as a bilateral column of cells in PRL morphants at 15 hpf, which 
was similar as those in the control embryos (data not shown). These β-cells migrated posteriorly 
and clustered into a single primitive islet at the midline at 24 hpf, and then migrated to the right 
side of the embryos at 48 hpf in both PRL morphants and nPrlrα similar to those in control 
embryos (Table 4-2).        
Discussion 
 
 In an attempt to understand the roles for pituitary hormones during early development, we 
investigated the function(s) of PRL in the developing pancreas. To date, the PRL receptor 
(PRLR)-deficient mouse has served as the principal model for investigating functions of PRL on 
pancreas development in vivo (Freemark et al., 2002). However, the in utero development of the 
rodent model restricts analysis of PRL function to postpartum and later stages. Using zebrafish as 
an alternative model, we examined the effects of PRL and PRLRα signaling deficiency in early 
zebrafish pancreas development. Using the tg(ins:nPrlrα:gfp) line which expresses non-
functional PRLRα (nPrlrα) within β-cells induced by RU486, we demonstrated the requirement 
for PRLRα to regulate normal β-cell number prior to the formation of the primary islet and 
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continuing throughout embryogenesis. Based on data from PRL knockdown and embryos 
expressing nPrlrα, maintenance of β-cell number by PRL/PRLRα appears to involve the β-cell 
differentiating factors hb9 and neuroD. These data indicate a conserved function of PRLRα 
among vertebrates in regulating β-cell populations and suggests an alternative mechanism for 
maintenance of β-cell number during early pancreas development in zebrafish that is distinct 
from self-replication of pre-existing β-cells, which is the mechanism proposed for pregnant 
mammals.   
 In rodent and human fetuses, PRLR is initially expressed within the exocrine ductular 
epithelial cells and acinar cells at early gestation followed by a shift in expression to insulin-
producing β-cells by late gestation and the perinatal period (Royster et al., 1995; Freemark et al., 
1997). Zebrafish possess a second distinct form of PRLR, PRLRβ, but only PRLRα is expressed 
within the pancreas and appears to be the sole receptor responsible for PRL functions in the 
developing pancreas (Fig. 2.1-9; Fig. 2.1-10). In contrast to the mouse, PRLRα is initially 
expressed relatively early during embryogenesis at 17 hpf within the pre-pancreatic region 
located between the bilateral pronephric ducts, and is expressed in β-cells. It is initially detected 
in the exocrine tissue in the mouse. The differences in PRLRα expression patterns in the mouse 
relative to zebrafish are likely due to evolutionary differences in the systems that specify the 
different morphogenetic events of pancreas development in these species. In the zebrafish, 
differentiation of β-cells are initially observed by 15 hpf resulting in bilateral rows of cells 
adjacent to the midline that eventually coalesce to the midline by 24 hpf (Biemar et al., 2001), 
while markers for exocrine tissues are only evident much later at around 48 hpf at a time when 
the primary islet is surrounded by exocrine tissue (Field et al., 2003). In rodents, β-cells develop 
from pancreatic duct epithelial cells, which remain near the pancreatic ducts, and eventually 
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migrate into the dorsal bud to develop into mature islets during late gestation (reviewed by 
Edlund, 2002; Hills, 2005). It is possible that the PRLR detected in the exocrine tissue of both 
rats and humans represent newly differentiated β-cells that have not migrated into the dorsal bud, 
rather than exocrine cell types. This hypothesis is supported by the identification of insulin-
positive cells in the exocrine tissue or around duct cells in mammals (Wang et al., 1995; Bonner-
Weir et al., 2000; Bogdani et al., 2003).    
In both zebrafish and mammals, expression of PRLR was observed after the initial 
differentiation of β-cells, suggesting no involvement in morphogenesis, specification of the 
pancreas or initial β-cell differentiation. After the first appearance of β-cells, the β-cell 
population continues to expand by differentiation from precursors and ultimately migrates to the 
head region of the developing exocrine tissue (Biemar et al., 2001). We examined the effect of 
PRL on β-cell migration and found that the movement of β-cells into the exocrine compartment 
is independent of PRL. β-cells coalesce to the anterior exocrine compartment situated on the 
right side of the body-axis in both PRL morphants and embryos expressing nPrlrα. Although β-
cell migration was not monitored in the mouse, islets were observed appropriately embedded in 
the head of the exocrine tissue postpartum in PRLR-/- null mice, suggesting no abnormality in β-
cell migration in the mouse (Freemark et al., 2002). Together, these results suggest PRL/PRLRα 
function does not involve the regulation of β-cell migration during early pancreas development 
of either mice or zebrafish.                  
In the vertebrate pancreas, PRL and growth hormone (GH) have been repeatedly 
demonstrated to act as potent stimulators of β-cell proliferation and insulin gene transcription, 
which enhances insulin secretion by lowering the threshold for glucose-stimulated insulin 
secretion (Parsons et al., 1992; Brelje et al., 1993; Sorenson and Brelje, 1997; Friedrichen et al., 
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2003). In addition, hypopituitary dwarf mice (deficient in both PRL and GH) and mice made 
deficient in PRLR by targeted deletion are consistently associated with impaired insulin 
production and reduction in β-cell mass (Parson et al., 1995; Dominici et al., 2002; Freemark et 
al., 2002; Huang et al., 2009), which is indicative that PRL operates in association with its 
cognate receptor to play an important role in the establishment or maintenance of normal β-cell 
function in the developing pancreas. Contrary to these findings, we were surprised to observe an 
increase in β-cell number, insulin transcripts, and insulin promoter regulated gfp expression in 
PRL morphants, while over-expression of PRL mRNA reversed these effects. It is important to 
note that antisense morpholino-mediated knockdown of PRL does not completely abolish 
endogenous levels of PRL. Thus, the seemingly contradictory results may be explained by a 
compensatory mechanism mediated by residual PRL or other growth factors such as GH. 
Examination of PRLRα levels between control and PRL morphants revealed an increase in 
PRLRα transcripts within the pancreas of the PRL knockdown embryos, but not in the kidneys 
(Fig. 4-8A). The up-regulation of PRLRα gene expression in this case may reflect the ability of 
residual PRL and/or GH, to stimulate PRLR transcription as previously described (Moldrup et 
al., 1993; Brelje et al., 2002). The mechanism leading to PRLR gene transcription involves 
hormone activation of PRLR and/or GHR, leading to the stimulation of the JAK2/STAT5 
signaling pathway directly targeting the PRLR promoter (Galsgaard et al., 1999). Similarly, the 
increase in insulin transcripts observed in PRL morphants may also up-regulate insulin 
transcription by virtue of the same mechanism; STAT5 binding to the insulin promoter via the γ-
interferon activating sequences (GAS), a known STAT5 DNA binding domain (Galsgaard et al., 
1996). Alternatively, the increase in β-cell number and insulin transcripts in PRL morphants 
suggests that PRL may have a repressive effect on PRLRα such that high PRL levels repressed 
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PRLRα, which is relieved when PRL levels drop. Although the mechanism regulating the 
potential feedback loop between PRL and PRLRα in β-cells is not known, the consequence of the 
resulting up-regulation of PRLRα under this scenario remains the same: increase in insulin 
transcripts and β-cell number. Future research will be required to determine the mechanism, 
residual PRL/GH or the feedback relationship between PRL and PRLRα or both, that could 
explain for the observed β-cell phenotype in PRL morphants. 
 To further address the paradoxical differences between the effects on pancreas 
development of zebrafish PRL knockdowns and PRLR-/- mice, we examined the effect of PRL 
on β-cell development in the context of PRLRα signaling deficiency in zebrafish. Mifepristone 
(RU486) induction of the tg(ins:nPrlrα:gfp) line specifically expressed a chimeric PRLR in 
which the intracellular domain of PRLRα was replaced with a gfp sequence, rendering the 
chimeric PRLR non-functional in β-cells due to the lack of the Box 1 domain which is essential 
for the constitutive association of JAK2 and PRLR signaling (Bole-Feysot et al., 1998). Embryos 
expressing nPrlrα exhibited a dramatic reduction in total β-cell number at all time points 
examined, consistent with the mouse knockout model (Freemark et al., 2002; Huang et al., 
2009). A previous study in zebrafish demonstrated that knockdown of PRLRα, and consequently 
down-regulating PRLRα signaling, stimulated the production of PRL in lactotrophs of the 
pituitary (Liu et al., 2006). Based on the previous results, reduced levels of PRLR signaling due 
to the expression of nPrlrα, would also be expected to stimulate the production of PRL in our 
model. Unlike the up-regulation of PRLRα observed in PRL morphants, the expected increase in 
PRL hormones in the pituitary of nPrlrα embryos appears to be insufficient to compensate for 
the reduced PRLRα signaling. PRLRα signaling is initiated by PRL binding to two PRLRs, 
leading to receptor dimerization that activates JAK2 autophosphorylation and other post-receptor 
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signaling (Rui et al., 1994). In view of the well characterized mechanism of PRL-activated 
PRLR signaling, three potential avenues of PRL binding in β-cells of RU486-induced nPrlrα 
expression exists: 1.) homodimerization of endogenous PRLRα, 2.) homodimerization of nPrlrα, 
and 3.) heterodimerization of nPrlrα with endogenous PRLRα. The fact that nPrlrα embryos 
exhibited a reduced number of β-cells similar to PRLR null mutant mice (Freemark et al., 2002) 
suggest the latter two mechanisms are likely activated, preventing any compensatory activity 
related to increased PRL hormones in these embryos. Interestingly, morpholino-mediated PRL 
knockdown in nPrlrα expressing embryos appears to restore normal insulin expression and β-cell 
number. It should be noted that PRL morphants increased PRLRα transcripts (Fig. 4-8A), and 
conversely, nPrlrα is expected to increase PRL. The increase in endogenous PRLRα transcripts 
in response to reduced PRL hormones could potentially increase PRL-mediated 
homodimerization of endogenous PRLRα, leading to normal PRLRα signaling; with 
simultaneous increase in PRL, as a consequence of nPrlrα, enhancing these effects. Moreover, 
despite an up-regulation of PRL production in PRLRα morphants, Liu et al. (2006) indicated that 
lactotrophs failed to respond to environmental salinity, implying that PRLRα is critical in 
mediating PRL functions. This is consistent with our observation that increases in PRLRα in the 
pancreas of PRL morphants enhanced β-cell number although PRL levels are low, while 
expression of nPrlrα reduced β-cell number even with the expected increase in PRL. However, it 
remains unclear how the two opposing compensatory mechanisms of PRL knockdown and 
nPrlrα contribute to the recovery of β-cell number when combined, compared to their actions 
alone. Future studies will be required to better understand the compensatory mechanism of the 
PRL/PRLRα system in β-cells.      
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Interestingly, in all tg(ins:nPrlrα:gfp) examined, only a subset of β-cells were found to 
express nPrlrα. Expression of nPrlrα was generally associated with weaker staining of insulin 
positive cells. It is likely that the expression of nPrlrα in the β-cells directly interfered with 
JAK2/STAT5 mediated insulin transcription (Galsgaard et al., 1996) resulting in weaker staining 
of insulin. Alternatively, stronger stained β-cells for insulin could represent recently 
differentiated β-cells because they lack expression of nPrlrα which is also under the regulation 
of the insulin promoter and may require more time for the translation and translocation of nPrlrα 
to the membrane. Starting at 48 hpf, the primary islet is exclusively clustered in the center of the 
exocrine tissue head (Field et al., 2003). In comparison to the control embryos, the remaining 
insulin-positive cells in nPrlrα embryos were observed to be loosely clustered with some 
scattered β-cells located at the periphery of the islet. It is plausible that the β-cells located 
adjacent to the exocrine compartment are recently differentiated β-cells derived from a pool of 
pancreatic precursors at the margin of the primary islet. Recently, E. coli nitroreductase induced 
β-cell ablation in zebrafish demonstrated that the mechanism for β-cell recovery is partly due to 
non-insulin producing progenitor cells proliferating and differentiating into mature β-cells 
(Pisharath et al., 2007). These non-insulin producing β-cell progenitors were generally located at 
the periphery of the islet (Pisharath et al., 2007) as were the proliferating cells we observed (Fig. 
4-9). Several other groups have also demonstrated the existence of intra-islet precursors that are 
capable of generating new β-cells (Tsanadis et al., 1995, Fernandes et al., 1997; Guz et al., 2001; 
Pang et al., 1994). Therefore, the restricted expression of nPrlrα to weakly stained insulin-
positive cells and scattered residual β-cells in nPrlrα embryos located peripherally within the 
islet, suggests that the lack of nPrlrα expression in strongly stained β-cells is due to their recent 
differentiation from non-insulin producing cells.       
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            In fetal pancreas development, it is well known that β-cells are generated from a 
population of pancreatic progenitor cells (Edlund, 2002; Wilson et al., 2003; Piper et al., 2004). 
These progenitor cells differentiate into mature β-cells and persist throughout embryogenesis as a 
source for the expansion of β-cell mass (Jensen et al., 2000; Gu et al., 2003). Despite an increase 
in β-cell number in our PRL morphants, we did not observe a significant increase in β-cells 
positive for the cell proliferation marker PH3 (Fig. 4-9), suggesting a mechanism independent of 
β-cell replication from pre-existing β-cells. This is in good agreement with Yee and colleagues 
(2001) who also demonstrated that β-cell proliferation was not a major mechanism leading to 
increased β-cell mass during normal zebrafish embryogenesis. More recently, it was suggested 
that β-cells of the primary islet initially arise by differentiation of pancreatic precursors into β-
cells in early zebrafish pancreas development, with a separate smaller population of β-cells 
arising from mitotic expansion of pre-existing β-cells (Moro et al., 2009). Cyclin D2-/- mutant 
mice clearly showed that cell replication is dispensable for β-cell mass formation during 
embryonic development but is essential for postnatal β-cell expansion (Georgia and Bhushan, 
2004). Together, these results suggest that early β-cell development during zebrafish 
embryogenesis could be regulated at least partially by neogenesis of endocrine pancreas 
precursor cells while cell proliferation contributes to the β-cell mass expansion of adult zebrafish 
islets.   
If the population of β-cells in the embryonic pancreas increases in number as a result of 
differentiation from non-insulin producing precursor cells, it is important to examine the 
pancreatic progenitor cell differentiation factors, hb9 and neuroD. We would expect levels of hb9 
and neuroD to be up-regulated in the presence of PRL/PRLRα and down-regulated in the 
absence of PRLRα signaling. Hb9 (HLXB9 in mammals) is an important transcription factor for 
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the initial morphogenesis of the pancreas and is required for the differentiation of β-cells in 
rodents (Harrison et al., 1999; Li et al., 1999). In zebrafish, hb9 also appears to be required for 
the differentiation of insulin-producing cells, with hb9 knockdown reducing or eliminating β-cell 
populations (Wendik et al., 2004). Samples prepared from nPrlrα expressing embryos exhibiting 
a reduced number of β-cells also showed a reduction in hb9 expression within the pancreatic 
islets throughout embryogenesis. The second transcription factor we monitored was neuroD. 
Targeted deletion of neuroD resulted in a severe reduction in insulin-producing β-cells (Naya et 
al., 1997). As expected, nPrlrα embryos had a reduced number of neuroD positive cells (Fig. 4-
11), which is likely accompanied by decreased insulin levels because neuroD also regulates 
insulin gene transcriptional activity (Naya et al., 1995). This observation is consistent with the 
decrease β-cell number and less intense staining for insulin in nPrlrα embryos (Fig. 4-6A, G, K). 
Increases in β-cell populations of PRL morphants, on the other hand, was demonstrated to 
increase the level of hb9 and neuroD. The up-regulation of both these transcription factors is 
consistent with the observed increase in β-cell number and PRLRα transcripts. These results 
suggest that the increase in β-cell number of PRL morphants or decrease in β-cell number of 
nPrlrα embryos is accompanied by a corresponding increase or decrease in the expression of the 
β-cell differentiation factors, hb9 and neuroD.  
The regulation of β-cell function and development mediated by PRL/PRLRα is complex, 
but we attempt to consolidate these data by proposing a mechanism of PRL/PRLRα function in 
relation to β-cell population during early zebrafish pancreas development (Fig. 4-12). The 
cellular mechanisms mediating PRL functions on β-cells have been extensively studied. PRL has 
been demonstrated to mediate its biological functions on β-cells through the PRLR, leading to 
the activation of the JAK2/STAT5 pathway (Sorenson and Stout, 1995; Brelje et al., 2002, 2004). 
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Subsequently, phosphorylation of STAT5 complex binds to the promoters of PRLR, insulin, 
glucokinase and cyclin D2 that contain functional STAT5 binding sites in β-cells leading to their 
transcriptional activation (Galsgaard et al., 1996, 1999; Friedrichsen et al., 2003, Weinhaus et al., 
2007). Furthermore, the use of constitutively active STAT5 and dominant negative STAT5 
(Friedrichsen et al., 2001) produced effects similar to those exerted by lactogenic hormones, 
supporting the importance of STAT5 in mediating PRLR signaling in β-cells.  During zebrafish 
β-cell development, we observed that expression of nPrlrα, which lacks JAK2 in the intracellular 
domain, produced embryos with fewer β-cells and less insulin expression (Fig. 4-6C, G, K). This 
suggests that the presence of nPrlrα interfered with normal JAK2 activation and consequently 
STAT5 which renders the β-cells less active in stimulating insulin transcription. The defect in 
JAK2/STAT5 pathway in nPrlrα embryos could similarly reduce the transcriptional activity of 
PRLRα, glucokinase, and cyclin D2 during zebrafish embryogenesis but additional investigation 
will be required to determine the direct effect of PRLRα on these genes in zebrafish β-cell 
development. 
Although the JAK2/STAT5 mechanism is the principal pathway mediating PRL function, 
there are examples that indicate insulin transcription is independent of STAT5 (Fleenor and 
Freemark, 2001). The human insulin promoter and rat insulin-2 promoter do not possess the 
classical STAT5 recognition sites, but treatment with PRL increases the transcriptional activity of 
insulin in rat insulinoma cells (Fleenor and Freemark, 2001). Similarly, PRL induces the 
pancreas specific pdx-1 promoter that also lacks STAT5 binding sites (Nasir et al., 2005). 
Interestingly, PRL (Galsgaard et al., 1996; Weinhaus et al., 2007), pdx-1 (Babu et al., 2007), and 
neuroD (Naya et al., 1995; Moates et al., 2003) share two downstream targets involved in β-cell 
function, insulin and glucokinase. Recently, it was demonstrated that pdx-1 and neuroD 
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physically interacted at a response element on the insulin promoter in β-cells which might be 
important for regulating insulin transcription (Babu et al., 2008). It is possible that PRLRα may 
activate both pdx-1 and neuroD in β-cells during early zebrafish pancreas development either 
working synergistically or complementarily to regulate insulin gene transcription. Targeted 
deletion of hb9 in mice resulted in a decrease in both pdx-1 and insulin expression, which would 
suggest that hb9 acts upstream of pdx-1 (Harrison et al., 1999). However, ectopic expression of 
pdx-1 in the chick indicated that pdx-1 is capable activating hb9 (Grapin-Botton et al., 2001). 
Similarly, neuroD was shown to activate hb9 expression which was enhanced with isl-1 and lhx-
3 (Lee et al., 2004) in motorneuron cells. Isl-1 is also an important transcription factor involved 
in various aspects of pancreas development (Du et al, 2009), suggesting that neuroD and isl-1 
could also regulate hb9 expression in pancreatic β-cells. Furthermore, knockdown of PRL2 in 
zebrafish resulted in a reduction in isl-1 expression in the eyes (Huang et al., 2009), indicating 
that PRL may be an upstream regulator of isl-1 gene activity. Together, these results suggests an 
alternative PRL mediated signaling pathway independent of JAK2/STAT5 that involves the 
activation of key transcription factors involved in β-cell development in zebrafish.  
Nevertheless, it is currently unknown whether PRL/PRLRα directly or indirectly 
regulates the expression of pdx-1, neuroD, hb9, and isl-1. Although the transcriptional activities 
of these genes appear to be independent of STAT5, we cannot exclude the possibility that STAT5 
may act as a co-factor for these transcription factors or activate other trans-acting activators 
important for insulin transcription. The mechanism of these PRL responsive genes may act 
synergistically, complementary, or even independent but awaits additional studies to determine 
their interactions in zebrafish β-cell development. It is also important to note that the 
JAK2/STAT5 pathway is the main mechanism responsible for the increase in β-cell population 
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during pregnancy (Sorenson and Brelje, 2009). In contrast, the β-cell differentiation factor, pdx-
1, is not up-regulated in β-cells of PRL infused pregnant or virgin mice (Nasir et al., 2005). This 
suggests the possibility that PRL stimulates different mechanisms, neogenesis by up-regulating 
β-cell specific transcription factors vs. proliferation involving JAK2/STAT5 signaling, in 
response to the requirement for β-cell mass expansion at different developmental time points 
(embryonic vs. adults) in zebrafish. This suggestion would be consistent with recent findings that 
neogenesis of β-cells is the major mechanism of β-cell expansion in fetal rodents, while 
proliferation was the major contributing factor to β-cell number in adults (Georgia and Bhushan, 
2004).       
In conclusion, our study provides additional insights into the role of PRL during early 
endocrine pancreatic development. Our data corroborates previous findings with in vitro and in 
vivo mammalian experiments, indicating a conserved function of PRL in zebrafish. We show that 
PRL is not involved in early endocrine pancreas specification, cell migration, or the initial β-cell 
differentiation. PRL is, however, important for the maintenance of the primary β-cell population. 
It appears that both PRL and PRLRα are critical for mediating signal transduction that leads to 
increases in β-cell number and insulin transcription. The mechanism mediating changes in β-cell 
mass likely involves both neogenesis from pancreatic precursors and β-cell proliferation during 
embryonic pancreas development in zebrafish. It is currently unclear which mechanism 
predominates or whether PRL/PRLRα controls β-cell populations similar to the mechanism 
observed in pregnant mice models and presents an interesting area for future research.    
In addition, we developed the first functional and β-cell specific tg(ins:nPrlrα:gfp) line 
that will facilitate future studies on PRL function within the endocrine pancreas at various 
developmental windows and physiological states.    
Fig. 4-1. Schematic diagram illustrating the structure of non-functional PRLRα plasmid DNA
construct. A 900 bp insulin promoter was inserted upstream of the LexPR transactivator
sequence to specify expression of the transgene (nPrlrα). The LexPR transactivator is a hybrid
element containing a bacterial LexA DNA binding domain (LexA-DBD), a truncated human
progesterone receptor ligand binding domain (hPR-LBD), and the activation domain of the
human NF-kB/p65 (NF-kB-AD). Addition of mifepristone (RU486) binds to the hPR-LBD of
the LexPR transactivator which subsequently binds to the LexA operator-promoter (LexA-OP)
via the LexA-DBD. The result is transcription of the nPrlrα placed downstream of the LexA-
OP.
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Founder Sex F1 (%) F2 (%)
A Male 38/100 (38.0%) 30/55 (54.5%)
B Male 24/79 (30.4%) 65/110 (59.1%)
C Male 45/130 (34.6%) 54/110 (49.1%)
D Male 20/120 (16.7%) 33/90 (36.7%)
Table 4-1.Transgene transmission rates of tg(ins:nPrlrα:gfp) lines in F1 and F2.
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Fig. 4-2. Expression of prolactin receptor α (PRLRα), insulin (ins), and gfp in pancreatic β-cells
of transgenic zebrafish, tg(ins:gfp). A: a representative flat mount image from whole mount in
situ hybridized (WISH) of embryos with insulin antisense probe for detecting insulin transcript;
B: A representative flat mount image of the same embryo stained with anti-GFP antibody for
detection of the expression of GFP protein under the control of insulin promoter (see material
and methods for detail). C: A superimposed image of panel A and panel B. D-L: Co-localization
of prlrα and GFP expressions in representative images from sections of zebrafish embryos
following WISH and immunohistochemistry. The expression of prlrα transcript was detected by
WISH (D; purple) and GFP was detected with anti-GFP antibody staining (E; green). F:
Superimposed images of (D) and (E). Arrowheads indicates the pancreatic β-cells (B and E) and
arrows indicate prlrα expression in the kidney. Auto-fluorescent of the yolk is noted by *. Scale
bar: 50 μm.
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Fig. 4-3. Effects of prolactin antisense morpholino (PRL-MO), over-expression of prolactin (prl
mRNA), and expression of non-functional prolactin receptor α (nPrlrα) on the number of
insulin-producing β-cells in the zebrafish pancreas. A: Representative section images of embryo
subjected to whole mount in situ hybridization using insulin antisense probe followed by nuclei
staining with DAPI (4’,6-diamidino-2-phenylindole; fluorescent dye that binds to DNA). B:
Representative images of insulin-positive cells at 17 hpf from NI control, mismatch-MO, PRL-
MO, and over-expression of PRL mRNA. C: Results shown as mean±SEM of total number of β-
cells in serial sections of individual embryos (n=3-5). Significance (P<0.05) is denoted by * in
comparison with NI controls. s, somite; n, notochord, sb, swimbladder, G, gut.
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Fig. 4-4. Effects of prolactin antisense morpholino (PRL-MO) and over-expression of PRL on
the expression of insulin. A: Representative Western analysis of PRL-MO knockdown on the
expression of GFP protein controlled by an insulin promoter in zebrafish embryos; Lane1: non-
injected control embryos, Lane2: PRL-MO. Anti-β-tubulin was used as the loading control. B:
Effects of PRL-MO knockdown and over-expression of PRL on insulin a (insa) transcript
analyzed by quantitative real-time PCR. The expression levels of insa were normalized by the
EF1α, and shown as (mean±SE) from three independent experiments. Significance (P<0.05) is
denoted by *.
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Fig. 4-5. Expression of non-functional prolactin receptor α (nPrlrα) in pancreatic β-cells at 24
hours post-fertilization (hpf). A: A representative image of a section prepared from insulin-
positive cells after whole mount in situ hybridization (WISH) using an insulin antisense
ribopobe. B: The same section as shown in panel A immunostained with an anti-GFP antibody
to detect in intracellular domain of the nPrlrα and co-stained with DAPI. C: This panel shows
an image in which panels A and B were superimposed.
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Fig. 4-6. Effects of expression of non-functional prolactin receptor α (nPrlrα) and prolactin
antisense morpholino (PRL-MO) on the expression of insulin during zebrafish pancreas
development. Dotted-line indicates the border of the developing exocrine pancreas.
Tg(ins:nPrlrα:gfp) were treated with RU486 (nPrlrα Pos.; C, G, K) and without RU486 (nPrlrα
Neg.; A, E, I). Only tg(ins:Prlrα:gfp) exposed to RU486 expressed nPrlrα. Wild-type embryos
were exposed to RU486 served as the control for non-specific effect due to chemical treatment
(AB-WT+RU486, B, F, J). nPRLRα Pos.+PRLMO represents tg(ins:nPrlrα:gfp) embryos
injected with PRL-MO and treated with RU486 (D, H, L).
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Fig. 4-7. Effect of different RU486 exposure times on insulin-positive cells in tg(ins:nPrlrα:gfp)
line at 48 and 72 hpf. Tg(ins:nPrlrα:gfp) embryos were raised without RU486 (A, D), exposed
to RU486 at 12 h (B, E), 24 h (C), and 48 h (F). Embryos were processed at 48 and 72 hpf for
whole mount RNA in situ hybridization with an antisense insulin riboprobe followed by
sectioning at 12 um thickness. Arrowheads indicate insulin-positive cells. Scale bar, 50μm.
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Fig. 4-8. Effects of prolactin antisense morpholino (PRL-MO) on the expression of PRLRα
transcripts in zebrafish embryos. A: Representative images of whole mount in situ hybridized
(WISH) embryos using an antisense PRLRα riboprobe. Arrowheads indicate pancreas. Arrows
indicate kidney. B:Real-time quantitative analysis of prlrα in PRL-MO knockdown and over-
expression of PRL compare to those in the control embryos. Scale bar: 50 μm.
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Fig. 4-9. Comparison of cell number between non-injected and PRL-MO-injected embryos at 48
hours post-fertilization (hpf). Representative serial sections of NI and PRL-MO-treated 48 hpf
embryos. β-cells were identified with anti-GFP antibody in tg(ins:GFP) lines (green) and
proliferating cells with anti-PH3 antibody (red). Arrowheads indicate proliferating cells within
the islet. Scale bar: 100 μm.
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Fig. 4-10. Effects of prolactin antisense morpholino (PRL-MO) and expression of non-
functional prolactin receptor α (nPrlrα) on the expression of hb9 transcript analyzed by whole
mount in situ hybridization. Arrows indicate gas bladder, and arrowheads indicate the endocrine
pancreas.
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Fig. 4-11. Effects of prolactin antisense morpholino (PRL-MO) and expression of non-
functional prolactin receptor α (nPrlrα) on the number of neuroD positive cells at 18 and 21
hours post-fertilization (hpf) in zebrafish embryos. Significance (P<0.05) was denoted by *.
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Phenotype
Treatment
24hpf 48hpf 72hpf
No GFP Midline Left Midline Right Left Midline Right
Non-
injected 0.66% 99.3% 2.22% 0.00% 97.8% 0.00% 0.00% 100%
PRL-MO 0.00% 100% 1.00% 0.00% 99.0% 0.90% 0.00% 99.1%
nPrlra 0.00% 100% 1.11% 0.00% 98.9% 1.00% 0.00% 99%
Table 4-2. Percentage of numbers of the primary islet (insulin-producing β-cells) migrated in
embryos injected with prolactin antisense morpholino (PRL-MO) or expressing non-functional
PRLRα (nPrlrα) compared to the non-injected control embryos.
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Fig. 4-12. A proposed model of the PRL/PRLRα-mediated mechanism by which β-cells develop
and/or functions during zebrafish embryogenesis. PRL binds to PRLRα on β-cells and activates:
(1) the JAK2/STAT5 signaling pathway to directly induce target genes via promoters containing
GAS motifs and leading to gene transcription and maintaining β-cell function; (2) the activation
of JAK2 could lead to the activation of neuroD, hb9, and pdx-1 which regulates insulin
synthesis and promote a β-cell fate in pancreatic precursors; (3) PRLRα could regulate neuroD,
pdx-1, and hb9 independent of JAK2 where they control insulin and glucokinase transcriptional
activity alone, simultaneously, or as cofactors (4) and possibly involving STAT5 (5). The extent
of PRLRα signaling may be dependent on the feedback loop between PRLRα (6) and PRL (7)
levels. Solid arrows represent proven pathways and dotted arrows are potential mechanisms.
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CHAPTER 5: CONCLUSION AND FUTURE DIRECTION 
In summary, I have demonstrated that prolactin (PRL) and its cognate receptor PRLRα, is 
an important anti-apoptotic factor potentially regulating anterior structure development and a 
potent hormone responsible for the maintenance of β-cell populations throughout zebrafish 
embryogenesis. The biological relevance of PRL during embryonic development is supported by 
the following evidence: 1.) PRL and the cognate receptors for PRL, PRLRα and PRLRβ, are 
expressed as early as the one-cell stage and are maintained or fluctuate throughout zebrafish 
embryogenesis; 2.) morphological abnormalities of PRL morphants are rescued using in vitro 
transcribed prl mRNA and constitutively active signaling molecules known to be activated by 
PRLRs (JAK2a, STAT5.1, PI3K, and AKT); 3.) physical defects of PRL morphants are 
independent of off-target effects resulting from the activation of the p53 pathway commonly 
disturbed by morpholino treatment; 4.) the amount of PRL protein is reduced in PRL morphants; 
and 5.)  in vivo inhibition of PRLRα and PRLRβ phenocopied many defects observed in PRL 
morpholino-injected embryos. 
PRL morphants exhibited an increase in cell death within the central nervous system (i.e. 
eyes and brain), as evident by activation of caspase-8 and caspase-3. This likely leads to the 
DNA damage detected by the Neutral Comet and TUNEL assay. The appearance of cell death in 
embryos experiencing a reduction in PRL and not GH, suggests a specific function of PRL as an 
anti-apoptotic factor in zebrafish embryos that is not shared with other members of the same 
hormone family. In addition, GHR and SLR knockdown, together or independently, did not 
produce any defects in eye or head size (data not shown). In contrast, the cell death in PRL 
morphants was rescued with prl mRNA and constitutively active JAK2a, indicating that PRLR 
activation and the JAK2a pathway is involved in mediating suppression of apoptosis. We cannot 
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exclude the possibility that the PI3K/AKT pathway also plays a role in cell survival. Activation 
of the PI3K/AKT pathway has been shown to mediate critical events leading to cell growth and 
survival (Hennessy et al., 2005). PRLR could simultaneously activate both the JAK2/STAT5 and 
PI3K/AKT signaling transduction to promote cell survival or these different pathways could be 
up-regulated in a cell-specific manner. Closer examination of these signaling pathways within 
specific cells in the eyes and brains will help resolve this issue. 
 The pancreas and kidneys are two additional targets of PRLRα but no apoptotic cells 
were observed in these regions. The absence of apoptosis within these organs may reflect 
differences in the effects of PRL on these tissues compared to the eyes and brain. Although the 
development of the vertebrate eye is not exclusively derived from the ectoderm, the retina and 
central nervous system originate from neuroepithelial tissues (Baily et al., 2004). During neural 
plate formation, various neuronal cell types are overproduced and approximately 70% of these 
cells undergo programmed cell death through the course of development to define specific 
neuronal sub-populations (Roth and D’Sa, 2001). The survival of these neuron populations is 
dependent on proper regionalization and innervation to target cells for exposure to trophic 
factors. In this scenario, PRL may be acting as one of these anti-apoptotic trophic factors and 
suggests neuronal cells are more sensitive to apoptosis due to the complex network of neuronal 
interactions compared with other cell types. Furthermore, the function of PRL could be mediated 
indirectly through the IGF system. In contrast, the kidney and pancreas are derived from the 
intermediate mesoderm and endoderm, respectively. Formation of these organs develops from 
mesenchymal-epithelial inductive interactions that lead to specialization of epithelial cells to a 
nephrogenic fate or pancreatic fate (Burrow, 2000; Drummond, 2003). The outcome of 
mesenchymal-epithelial induction is to generate specialize cells that will eventual proliferate to 
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increase the population, thus apoptosis is not likely to occur. Nonetheless, programmed cell 
death was observed in two regions during vertebrate kidney development: the nephrogenic zone 
of the developing kidney cortex, and the medullary papilla (Coles et al., 1993). The equivalent 
structures in the zebrafish kidney are not developed until 40 hpf (Drummond, 2003). We did not 
examine apoptosis beyond 35 hpf, and it remains to be answered if PRL also acts as an anti-
apoptotic factor in these equivalent structures, but it is unlikely because PRLRs are restricted to 
the pronephric tubules. Unlike the kidney, apoptosis appears to be a rare event in the adult 
pancreas (Tetra et al., 2005) and is only observed during the neonatal period with simultaneous 
activation of proliferation, suggesting a remodeling event of the endocrine pancreas for adult 
function (Kaung, 1994; Scaglia et al., 1997). The apoptosis assays were performed on PRL 
morphants and we know now that there was an increase in PRLRα transcripts. It is possible that 
the absence of apoptosis in the pancreas may be due to the PRLRα-mediated up-regulation of the 
JAK2/STAT5 transcripts and the pro-survival molecule Bcl-xL (Fujinaka et al., 2007). However, 
heterozygous and homozygous PRLR null mutant mice did not exhibit an increase in pancreatic 
cell apoptosis, during neonatal development or in pregnancy, indicating that the role of PRL in 
the pancreas does not involve regulation of cell death (Freemark et al., 2002; Huang et al., 2009).           
Recently, a second PRL, PRL2 compared to our PRL1, was identified in non-mammalian 
vertebrates and shown to be expressed only in extra-pituitary tissues (eye, brain, and kidney) 
(Huang et al., 2009). It was demonstrated that PRL2 is potentially involved in retinal neuron 
differentiation, but no indication of the eye size or apoptosis was available. It is of great interest 
to re-examine the specific nuclear layers of the retina undergoing apoptosis in PRL morphants 
and compare the regions affected with results from PRL2 knockdown to better understand 
whether the duplicated PRLs in zebrafish possess overlapping and/or unique functions, as with 
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the PRLRs. In view of PRL2 acting as a retinal neuron differentiation factor and the observation 
of apoptotic cells in both the eye and optic tectum, there is also a need to analyze the topographic 
mapping of the retinotectal projections between the two structures. Proper interactions between 
the retina and optic tectum are essential for normal development of the visual system (D’Souza 
et al., 2005), and perhaps PRL is important in this process.              
The pancreas is another important target of PRL and was demonstrated to exert a robust 
effect on the β-cell population during zebrafish development. PRLRα was expressed 
immediately after the initial β-cell differentiation and its expression co-localized with β-cells 
thereafter. The absence of PRLRβ within the pancreas indicates that PRLRα acquired an 
additional role in maintaining normal β-cell function after the divergence of fish from tetrapods 
and during the fish specific whole genome duplication event in the lineage leading to the modern 
teleost. Tg(ins:nPrlrα:gfp) lines treated with RU486 induced the expression of non-functional 
PRLRα (nPrlrα) in β-cells and the resulting embryos displayed a reduction in total β-cell 
number. The β-cell phenotype in nPrlrα embryos is reminiscent of the reduced β-cell population 
observed in targeted deletion of the PRLR gene in mice (Freemark et al., 2002; Huang et al., 
2009), leading to the suppression of PRLR signaling. We suggest that the expression of nPrlrα 
also reduced PRLRα signaling through a mechanism of heterodimerization between native 
PRLRα and RU486 induced nPrlrα or homodimerization of nPrlrα in our system. In 
comparison, morpholino-mediated PRL knockdown unexpectedly increased β-cell population 
and insulin transcripts, but it was also accompanied with an increase in endogenous PRLRα 
mRNA within the endocrine pancreas. It is worth noting that while PRL morphants had an 
increase in β-cell number, insulin transcripts, and insulin promoter regulated gfp protein, it 
resulted in overall smaller body and reduced anterior structures. In contrast, a reduction of the β-
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cell population was seen in nPrlrα embryos, yet the body size was relatively normal compared to 
controls (data not shown). Future studies should aim to identify the physiological significance of 
reduced β-cell number on the metabolic state of the embryo throughout embryogenesis, the effect 
of reduced β-cells in relation to adult pancreas development and function and the potential 
relevance to organ development in zebrafish.   
In addition to reduced β-cell number, nPrlrα embryos also revealed a severe reduction in 
β-cell differentiation transcription factors, hb9 and neuroD. These results suggest a novel 
mechanism for PRL in regulating β-cell number that contrasts with its defined role in β-cell 
proliferation in postnatal and pregnant mice. Within the endocrine pancreas of zebrafish, PRL 
targets β-cells through the PRLRα. It is not known whether PRL also activates the JAK2/STAT5 
signaling mechanism that controls expression of PRLR, insulin, cyclin D2, and glucokinase 
during zebrafish embryogenesis as it does in isolated islets or in vivo in rodent models. 
Furthermore, no evidence is available to indicate the involvement of the JAK2/STAT5 in 
regulating the transcription of hb9 or neuroD. However, it was recently demonstrated that 
epidermal growth factor, which belongs to the same cytokine family with PRL, could transiently 
express ngn3 through the JAK2/STAT3 in vitro (Baeyens et al., 2006). PRL could potentially 
function through a similar mechanism to increase ngn3, which is an upstream regulator of 
neuroD, and subsequently activate neuroD. Ngn3 is considered the marker for all endocrine 
pancreas precursor cells and is required for differentiation of all islet cell types (Gradwohl et al., 
2000). We observed that in some instances, PRLRα was expressed in pancreatic cells that did not 
express insulin. These non-insulin expressing cells could potentially be endocrine pancreas 
precursor cells that require PRLR to regulate differentiation into mature β-cells by stimulating 
the transcriptional activity of neuroD, pdx-1, and hb9. Our study also indicated the continued 
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presence of β-cells in nPrlrα embryos, albeit fewer than wild-type animals. The locations of the 
remaining β-cells appeared to be dispersed, with many residing at the periphery of the islet, 
unlike the tight core of β-cells observed in normal embryos. This might indicate the continued 
presence of β-cell progenitors within the developing zebrafish pancreatic islet to compensate for 
the loss of β-cells observed in nPrlrα expressing embryos. Identification of these potential β-cell 
progenitors and analysis of the relationship between PRL, PRLRα, ngn3, hb9, and neuroD 
expression within these non-insulin producing cells would help determine the involvement of 
PRL/PRLRα in β-cell differentiation and provide a better understanding on the mechanism of β-
cell expansion during early pancreas development in zebrafish.     
Finally, there appeared to be an intrinsic feedback relationship between PRL and PRLRα 
related to β-cell development during zebrafish embryogenesis. PRL knockdown mediated by 
antisense morpholino produced embryos with an increase in β-cell number and PRLRα 
transcripts within the pancreas. The up-regulation of PRLRα is reminiscent of a previous study in 
which inhibition of endogenous PRL secretion by bromocriptine in mice stimulated the 
expression of PRLR in the fallopian tube (Shao et al., 2008). In contrast, treatment of PRL by 
subcutaneous injections inhibited PRLR expression (Shao et al., 2008). The observed decreased 
in β-cell populations of our embryos over-expressed with prl mRNA would be consistent with a 
decreased in PRLRα expression. These results suggest that high levels of PRL inhibits, while 
low levels of PRL stimulates expression of PRLRα within the pancreas. The level of PRLRα 
expression has also been demonstrated to regulate PRL production. In zebrafish, PRLRα 
knockdown mediated by antisense morpholino demonstrated an increase in PRL transcripts in 
the pituitary gland (Liu et al., 2006). Along the same line, disruption of PRLR signaling by 
targeted deletion of PRLR in mice caused an increase in circulating PRL levels (Binart et al., 
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2000; Halperin et al., 2007). Expression of nPrlrα in our embryos maintained a reduced β-cell 
number phenotype, suggesting that the expected up-regulation of PRL is insufficient to 
compensate for the reduced PRLRα signaling. It has been demonstrated that the increase in PRL 
levels of PRLR null mutant mice is controlled at the hypothalamus and pituitary level (Schuff et 
al., 2002), but the expression of nPrlrα in our model is restricted to the pancreas and it is unclear 
how PRL is suspected to be up-regulated in these embryos. Interestingly, injection of PRL-MO 
in nPrlrα expressing embryos exhibited a recovered β-cell population comparable to the control 
embryos. The exact mechanism controlling the feedback loop between PRL and PRLRα in 
relation to the β-cell number is unclear during zebrafish embryogenesis, but investigation into 
this relationship will be important to further define the function of PRL on β-cell development.                   
In conclusion, this study has provided strong evidence to define functional roles for PRL 
in embryonic development, which has been argued for many years. PRL and PRLRα were 
demonstrated to serve at least two functions during embryogenesis in zebrafish, an anti-apoptotic 
factor and a regulator of β-cell populations. The observation that PRL and PRLRα signaling were 
capable of interacting with developmental genes (hb9 and neuroD) in vivo in zebrafish has 
provided a suitable alternative model to study the emerging field of developmental 
endocrinology. The establishment of the tg(ins:nPrlrα:gfp) line also provides a valuable tool to 
further examine the specific functions of PRL/PRLRα in β-cell function, development and/or 
regeneration in a cell and developmental stage specific manner. This is the first study that 
examined specific functions of PRL during embryogenesis, and future studies will be required to 
better understand the complexity of PRL function in a variety of biological settings during early 
vertebrate development.  
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